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1. Introduction 
In recent decades, the increase in both life-expectancy and associated bone-
related diseases has consistently brought forth greater medical challenges in the 
field of bone regeneration. Material science research for healthcare applications 
has been stimulated to respond to this greater need for bone substitute materials. 
These materials, when applied for healthcare, are commonly known as 
“biomaterials”. A biomaterial can be  defined as ‘‘a substance that has been 
engineered to take a form which, alone or as part of a complex system, is used 
to direct, by control of interactions with components of living systems, the 
course of any therapeutic or diagnostic procedure, in human or veterinary 
medicine”[1]. 
To improve the clinical performance of biomaterials, input from a number 
of scientific disciplines is required. Consequently, both scientists and engineers 
have focused on improving the design, properties, long-term survivability and 
development of new types of biomaterials to repair, replace or regenerate bone 
tissues [2, 3]. Biomaterials can be derived from metals, polymers, human or 
animal bones, corals, synthetic ceramics and composites [4]. 
 
2. Inorganic materials  
Nowadays, autografts (a tissue or organ that is grafted into a new position in 
the body of the individual from which it was removed) remain the most 
effective option for bone repair and substitution followed by allografts (a tissue 
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or organ obtained from one member of a species and grafted to a genetically 
dissimilar member of the same species). However, despite the advantage of 
being osteogenic and osteoinductive, autografts and allografts present important 
drawbacks, such as high costs and limited availability. Consequently, there is a 
great need to develop synthetic alternative biomaterials for bone replacement or 
substitution. Synthetic inorganic materials have been applied clinically to repair 
or substitute bone tissue. These substitute materials need to possess appropriate 
mechanical and biological properties in order to be used for load-bearing 
applications and to achieve a strong fixation of the implant with bone tissue [4]. 
Biomaterials can be classified as bioactive or bioinert depending on their 
ability to bond to and stimulate bone tissue. Bioactive materials, such as 
calcium phosphate ceramics, several classes of bioglasses, calcium carbonates 
and calcium sulfates, stimulate bone tissue formation and directly bond to bone 
without an intervening soft tissue layer. On the other hand, bioinert materials 
such as titanium, aluminum oxide, stainless steel, cobalt-chromium, alloys and 
some ceramics (e.g. alumina, zirconia and carbon) do not bond directly to bone. 
Another property of major importance for biomaterials is osteoinductivity, 
which is “the mechanism of cellular differentiation towards bone of one tissue 
due to the physicochemical effect or contact with another tissue” [5]. This has 
aroused intense interest in the biomaterials field, and it will be further discussed 
in this chapter [4, 6]. The most common commercially available bone 
substitutes materials are inorganic (metallic and non-metallic), such as titanium 
and its alloys and calcium phosphate ceramics and their composites [7]. In the 
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following paragraphs, the biomedical applications of these inorganic materials 
will be discussed. 
Metallic materials, such as titanium and its alloys, are commonly used as 
implants for orthopedic and dental applications to replace hard tissue. This is 
due to their biocompatibility, high strength, low modulus of elasticity and low 
density. However, the high stiffness and fracture toughness of metallic 
materials are not optimal for the distribution of load to the surrounding bone 
tissue, which can reach low levels at certain areas at the interface and induce 
stress shielding. In these areas, the lack of load transfer can result in bone 
resorption and consequently implant loosening and failure. 
For optimalization of interaction with bone tissue at the interface, implant 
material surface modifications to enhance the surface biocompatibility and 
osseoconductive properties of these metallic implants have been extensively 
investigated. The physico-chemical properties of implant materials can be 
modified in order to increase the biological fixation of implant materials made 
of titanium and its alloys to bone [8]. Chemical pre-treatments on the titanium 
surface, such as alkali treatment or ions removal, have proved to enhance the 
bone-bonding strength [9]. Another approach has been the physical treatment of 
the metal by modifying the specific macrostructure and microstructure, e.g. 
titanium foam, which allows osteoblast cells to grow into an interconnected 
porosity [10]. Furthermore, the surface roughness of the material has been 
observed to significantly influence its ability to promote apatite nucleation and 
cell attachment compared to smooth surfaces [11-13]. 
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Ceramics are common materials for dental and medical applications (e.g. 
repair of periodontal defects, augmentation of alveolar bone, sinus lifts, tooth 
replacement, repair of large bone defects, spinal fusion, and ear and eye 
implants) due to their appropriate biological properties, such as 
biodegradability, bioactivity and osteoconductivity. These ceramic materials are 
similar in composition to the bone mineral phase and are characterized by their 
hardness, strength, low electrical conductivity, and brittleness. However, due to 
their inferior mechanical properties, their application under load-bearing 
conditions is limited. One exception to this is long-term clinical performance of 
α-alumina (Al2O3) for orthopedic purposes (e.g. total hip prostheses) [14, 15] 
which has been in use for over three decades. However, in most cases ceramics 
are used as coatings on mechanically strong bioinert or biotolerant implants. 
These ceramic coatings and the main pros and cons of each coating technique 
will be discussed in detail in this section. 
 
3. Structure and properties of bioceramics 
All inorganic non-metallic solids prepared from powdered materials and 
created by the application of high temperature are classed as ceramics. Due to 
the mixed ionic-covalent bonding between the atoms, there are consistent 
properties that characterize ceramic materials: strength and hardness but 
brittleness at room temperature, resistance to chemical corrosion and high 
temperatures more than polymers and metals, and possession of low electrical 
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conductivity. The majority of ceramics have many and varied crystal structures 
resulting in an extremely wide range of properties [16]. Due to their unique 
properties, ceramic materials are widely used in engineering and biomedical 
applications.  Synthetic ceramics used for repair, reconstruction or replacement 
of damaged human body parts, or to function in intimate contact with living 
tissue are called “bioceramics”. For biomedical applications, a number of 
parameters have to be considered, including density, biocompatibility, strength 
and wear performance. Different types of bioceramics are detailed below, 
including polycrystalline ceramics (e.g. alumina or calcium phosphates), 
zirconia ceramics, bioactive composites, bioactive glasses and glass-ceramics 
[17]. 
Aluminum oxide, also known as alumina (Al2O3), is widely used in 
engineering bioceramics, for example in orthopedics and dentistry. Because of 
the strong bonding between the atoms, alumina has to be produced at a very 
high sintering temperature. It is usually white but is sometimes pink (88 % 
alumina) or brown (96 % alumina) depending on impurities or additives. The 
composition of aluminum oxide can be easily changed to enhance certain 
desirable material characteristics, such as the hardness or color. It also has 
excellent size and shape capability, which is advantageous for bioengineering 
applications. The low friction, wettability and hydrophilic surface of alumina 
(i.e. alumina crystal structure bonds with water) give it a superior load-bearing 
surface in a physiological environment. Similar to the majority of ceramics, its 
use as a structural material is restricted by its brittleness. To help alleviate this, 
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it can be toughened or reinforced by combining with composites of other 
materials with suitable mechanical properties (e.g. alumina matrix composite) 
[18]. 
Zirconia ceramics have good mechanical properties and low temperature 
degradation. This ceramic has a stress-induced phase transformation that results 
in a resistance to crack-propagation. This is due to a change in crystallographic 
structure depending on the temperature (at temperatures below 1170 ºC, 
zirconia exists in monoclinic form, at the temperature 1170 ºC monoclinic 
structure transforms to tetragonal form which is stable up to 2370 ºC and 
tetragonal crystal structure transforms to cubic structure at 2370 ºC) [19]. 
However, this phase transformation also occurs at the surface of the ceramic 
when present in body fluid, causing a progressive roughening (i.e. aging) that 
compromises the lifetime of zirconia implants. Currently, alumina-zirconia 
composites are being investigated as possible materials for orthopedic 
applications [20, 21]. 
Bioactive glass is a silicate glass-based, amorphous material. The first 
bioactive glass is known as 45S5 and was developed by Hench in the early 70s 
[22]. This bioactive glass was produced by melting high purity oxides (SiO2, 
Na2CO3, CaCO3 and P2O5) at very high temperatures. Bioactive glass releases 
ions when in contact with body fluid. Consecutive reactions with these ions 
occur on the surface of bioactive glass leading to the formation of a carbonated 
hydroxyapatite layer similar to bone mineral that creates a strong bond with soft 
and hard tissue [23]. Recently, the development of bioactive glasses based on 
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borate and borosilicate compositions has been investigated due to the  faster 
chemical release of ions compared to silicate 45S5 bioactive glass [24-26]. 
Glass ceramics are materials with higher mechanical strength than bioactive 
glass due to the different crystalline phases of various types of glass [27]. The 
main characteristic of glass ceramics (phosphate based glasses) is that they have 
a high ion dissolution rate. In order to control the degradation rate, the 
composition of glass ceramics can be changed by adding metal oxides (such as 
TiO2, Al2O3, B2O3) [28-30]. These additives are incorporated into the phosphate 
based glass composition to stabilize the glass network resulting in a slower 
degradation of the glass [24]. 
Lastly, calcium phosphates are bioactive materials that can resorb over time 
when in contact with hard tissue [31, 32]. Like most ceramics, calcium 
phosphates have poor mechanical properties and for this reason they are mostly 
used as coatings and filler materials. As already mentioned, these calcium 
phosphate ceramics are similar to the mineral component of bone and therefore 
are not harmful and can remain in a biological system [2]. 
 
4. Bioactivity, osteoconductivity and osteoinductivity of 
calcium phosphate ceramics 
Synthetic bone implant materials made of calcium phosphate ceramics have 
shown certain capacity for stimulating bone tissue. Depending on their 
physicochemical properties upon implantation, they are considered to be 
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bioactive, osteoconductive and/or osteoinductive. The following paragraphs 
discussed each of these mentioned properties. 
Bioactive ceramics for load-bearing applications are used as coatings for 
titanium and its alloys to improve the biocompatibility of metal implants [2]. 
Calcium phosphate ceramics are known to allow direct physicochemical 
bonding with bone and to enhance bone tissue formation [4]. This phenomenon 
occurs when part of the CaP ceramics is dissolved in form of ions into the 
microenvironment. Once these liberated ions are released, protein adsorption 
and precipitation of the biological apatite crystals takes place creating a layer 
on the surface of the calcium phosphate biomaterial. This creates a favorable 
environment for the surface colonization by osteoblastic cells, which produce 
newly formed mineralized bone tissue in direct contact with the ceramic 
material [33]. Bioactive coatings accelerate stability by promoting a rapid 
fixation of implants with the bone. Among the bioactive ceramics most 
commonly investigated for use in bone regeneration are β-tricalcium phosphate 
(β-TCP), hydroxyapatite (HA) and bioactive glass, which are also 
biocompatible and osteocounductive but differ in resorption rate. By changing 
surface properties of CaP ceramics, bone integration and bonding can be 
influenced [34, 35]. 
Osteoconductivity  was defined by Wilson-Hench as the process by which 
bone is directed so as to conform to a material’s surface [36]. This apparent 
growth of bone tissue along an implant surface is essential for the stability of 
long-term orthopedic and dental implants [33]. All bioactive materials are also 
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osteoconductive and they participate in the phenomenon that takes place at the 
bone/implant interface [4]. 
Some synthetic materials have the capacity to induce bone and are therefore 
considered osteoinductive materials [37]. This property has been defined as 
“the mechanism of cellular differentiation towards bone of one tissue due to the 
physicochemical effect or contact with another tissue” [5]. Calcium phosphate 
ceramics are commonly known for being osteoconductive, however, in the past 
decade a variety of studies have reported the intrinsic osteoinductive properties 
of diverse calcium phosphate ceramics. These CaP osteoinductive materials 
include porous synthetic HA [38-40],  β-TCP [41], porous biphasic calcium 
phosphate (BCP) which is the mixture of HA and TCP [42, 43] and coral-
derived hydroxyapatite [40]. Moreover, to further enhance the osteoinductive 
capacity, these materials can be subjected to some engineered modifications of 
physicochemical properties such as geometry, topography (i.e. surface 
structure), macroporosity, microposrosity, particle size and chemical 
composition [4]. Finally, the selected model, implantation site, procedure and 
study duration to investigate osteoinduction may also influence this property 
[37]. 
5. Calcium phosphate ceramics used as coatings 
Bioceramics can be produced in crystalline and amorphous forms and 
generally can be classified based on their chemical composition into two 
groups: calcium phosphates (CaPs) and others. CaP ceramics comprise a family 
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of compounds with different chemical compositions, crystallographic structures 
and solubility (See Table 1). Bone and calcium phosphate ceramics share 
common properties in mineral phase that make them excellent candidates for 
tissue replacement including biodegradability, bioactivity and osteoconductivity 
[4]. However, the use of CaP ceramics presents difficulties with degradation 
rate control and resorption. These issues are due to their limited solubility in the 
body fluid and no apparent degradation by cellular activity (i.e. bone resorbing 
cells) [44, 45]. Also, it is known that the use of CaP ceramics in parts of the 
body where substantial mechanical loading is experienced is not feasible due to 
their poor mechanical properties. 
CaP ceramics are frequently used as bioactive coatings to modify the 
surface of bioinert metals or polymers. This modification facilitates the use of 
implants under loaded conditions and integrates the implant with the 
surrounding tissue. An ion-exchange reaction occurs between the bioactive 
implant surface and surrounding body fluid, initiating the formation of a 
carbonate apatite layer that leads to active bone growth onto the implant 
surface. 
Improving the properties of coating materials relative to the bulk material 
can facilitate the clinical application of these implants. Biological 
characteristics of the coating can differ between coatings applied with different 
techniques. For this reason, it is essential to understand the coating deposition 
technique. Furthermore, the coated layers must be adequately adjusted by a 
post-treatment (e.g. heat treatment to increase crystallization). It has been 
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demonstrated in several reports that cellular behavior and implant fixation can 
be controlled by material properties [46, 47]. Material surface modifications in 
both implant and CaP ceramic coatings can be applied by varying material 
properties such as surface topography, elasticity, chemistry, surface roughness, 
coating fatigue and stress and post and pre-treatments of the materials. 
The most commonly investigated synthetic CaP ceramic materials for use in 
bone regeneration are hydroxyapatite (Ca5(PO4)3OH, HA), which is the mineral 
that occurs naturally in bone tissue and the most abundant inorganic phase in 
the human body, and β-tricalcium phosphate (Ca3(PO4)2, TCP). To deposit such 
coatings, several techniques can be used, including biomimetic depositon, 
electrostatic spray deposition, pulsed laser deposition, ion beam deposition, 
sputter deposition and plasma spray, which are discussed in more detail in the 
next section. 
 
6. Coating techniques 
Different coating deposition techniques can be used for the modification of 
bone implant surfaces. The most commonly used coating techniques are by dry 
coating deposition, although a recent trend involves the development of wet-
chemical deposition (i.e. biomimetic deposition) for both inorganic and organic 
coatings. 
 Biomimetic deposition 
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The biomimetic deposition technique, which mimics the natural deposition 
of biologic apatite, has opened up a new way to develop biomaterials. The 
apatite-like CaP coating is deposited by placing the substrates to be coated into 
simulated body fluid (SBF) medium kept at 37 ◦C. The SBF solution allows the 
in situ chemical precipitation from a metastable supersaturated solution similar 
in ion concentrations to those of human blood plasma with respect to the apatite 
nucleation [48]. 
Some of the advantages of this technique are its simplicity, the possibility to 
coat complex geometrical shapes at room temperature, coating with more 
similar chemistry with the biological one, and the deposition time. This makes 
the technique suitable for covering polymeric substrates. However, the main 
disadvantage is that the adhesion of the CaP coating, especially on inert 
polymeric substrates, is very poor [49, 50]. 
 Plasma-spraying 
Plasma-spraying was the first coating technique for biomedical applications; 
this technique is also very successful technique for applying CaP coatings on 
implants due to its high deposition rate. The coating process consists in a DC 
(direct current) electric arc, which is stuck between two electrodes, while a 
mixed stream of gasses passes through this arc turning the gasses into a plasma 
of high temperature (which rapidly decreases as a function of distance) and 
high speed. Appropriated cooling techniques keep the temperature of surface to 
be coated below 100 to 150 ºC. Plasma spraying  
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Figure 1. A representative ESD process 
 
produces coatings with desired chemistry and crystallinity, despite poor control 
of the thickness and surface morphology [51]. 
 Electrostatic spray deposition 
The principle of electrostatic spray deposition (ESD) technique is based on 
the generation of a dispersion of solid or liquid particles in a gas under the 
influence of a high voltage. The liquid is pumped through a nozzle and a 
spherical droplet is then formed, when high voltage is applied between the 
nozzle and the substrate a spray of highly charged droplets are attracted onto 
the surface of the substrate depositing a thin layer. A representative ESD 
process is shown in Figure 1. 
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This technique has several advantages, such as simplicity, wide choice of 
CaP phases to be sprayed, extensive control over surface property and high 
deposition efficiency [52, 53]. Some of this  
technique disadvantages are chemical homogeneity in the deposited coating and 
substrate adhesion.  
 Pulsed laser deposition 
Laser deposition is a technique in which intense ultraviolet laser beam 
pulses are used to evaporate CaP ceramic from a rotatory target situated inside 
of a vacuum chamber. The substrates are located at a certain distance parallel to 
the target on a heated substrate holder. 
This technique allows deposition of thin, dense, well adhering coatings with 
controlled chemistry and crystallinity [54, 55]. A major advantage of this 
technique is the possibility of coating CaP ceramics on polymeric substrates at 
low temperature [56]. However, a non-uniform coverage makes this technique 
not very well suited for large area deposition [57]. 
 Ion beam deposition 
Ion beam deposition is a technique, in which CaP target material and 
substrates are placed in a vacuum chamber; there is bombardment by a beam 
from an ion gun. The generated ions are accelerated in an electric field and 
deposited onto the substrates in a cold plasma atmosphere. However, the 
deposited CaP coatings have inherent properties and the chemical composition 
of the coating may differ from that of the bulk material [58-60]. The CaP 
coating presents an amorphous phase after deposition that can be post-heat 
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treated to increase crystallization and high adhesion to the substrate materials 
[61]. 
 Sputter deposition 
Sputtering deposition is a deposition technique that takes place in a vacuum 
environment. CaP target material is irradiated with high energetic ions, 
accelerated by high voltage, which bombard and collide with atoms on the 
target surface. Subsequently, the atoms of the target material are ejected a very 
high speed onto the substrate surface. As a result, a thin coating chemically 
bonded with the substrate is deposited [62]. 
 
Figure 2. Typical experimental system for RF magnetron sputtering. 
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There are several modes of sputtering, such as radiofrequency (RF) 
magnetron sputtering, RF diode sputtering, ion-beam sputtering[63], direct 
current (DC) sputtering [64] and reactive DC sputtering. RF magnetron sputter 
deposition is used to deposit CaP ceramic; this is due to the insulator properties 
of ceramics. This mode of sputtering uses an alternative current source and is 
further enhance by a magnetic field. Typical experimental system for 
Radiofrequency (RF) magnetron sputtering is shown in Figure 2. 
This deposition technique allows the use of a wide range of 
materials and produces thin, uniform coatings with excellent 
adhesive properties. 
 
7. Biological properties of inorganic coatings 
7.1. Bone healing around the implant surface 
Bone implants are surgically placed within the bone tissue. The process of 
bone growth around the implant is following the same biological cascades of 
bone defect healing [65]. Bone is one of tissues that have the ability to undergo 
complete regeneration [66]. Bone healing is divided into three overlapping 
phases: inflammation, repair, and remodeling. The inflammatory phase begins 
immediately after the initial tissue damage to bone and surrounding soft tissues, 
and persists for 3-4 days until the formation of bone is initiated [67]. The trau-
matic interruption of the blood vessels leads to ischemic necrosis of bone tissue, 
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histologically characterized by the presence of empty lacunae. Consequently, a 
fibrin-rich clot forms at the defect site, known as hematoma, and initiates 
spontaneous wound healing. The hematoma acts as a scaffold for cells, and sets 
the stage for the repair phase by releasing growth factors, stimulating 
angiogenesis and bone formation [68]. Platelets are likely to be the first source 
of healing factors at a traumatized site. In addition to coagulation factors, they 
release platelet-derived growth factor (PDGF) and transforming growth factor-
β1 (TGF-β1), both of which stimulate the osteogenesis process [69]. The 
angiogenic properties of the defect hematoma appear to be mediated via 
vascular endothelial growth factor (VEGF) and angiopoietin proteins. VEGF is 
an essential endothelial-cell-specific mediator of neo-angiogenesis, whereas 
angiopoietin-1 and -2 directly control vascular growth [44, 45]. Angiopoietin 
proteins are also suggested to act during the whole period of new bone tissue 
formation. They seem to be related to the formation of larger vessel structures 
and the development of lateral branches from existent vessels. Indeed, the 
branches of blood vessels emerging from surrounding tissue, are necessary for 
revascularizing the hypoxic defect site [45]. Macrophages, generated by the 
differentiation of monocytes, are attracted to the defect site and assist in the 
removal of necrotic bone as well as initiate early bone resorption by osteoclasts. 
Resorption of necrotic bone fragments is particularly important as initiation for 
bone formation processes [48]. Within a few days, the osteogenesis phase starts 
and coincides with recruitment of mesenchymal stem cells. Proliferation and 
differentiation of these stem cells into osteoprogenitor cells is stimulated by 
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numerous growth factors, among which TGF-β1 and bone morphogenic 
proteins (BMPs) play a major role [66]. Osteoprogenitor cells differentiate into 
osteoblasts [68]. After two weeks, the blood supply is well established and 
osteoblasts deposit layer upon layer of woven bone, which are subsequently 
replaced with mature bone [48]. At the end of the repair phase, bone 
remodeling starts and lamellar bone is deposited in the defect. Therefore, the 
remodeling phase is characterized by a morphological adaptation of new bone 
to the original tissue [67]. 
 
7.2. Cellular response to bioactive ceramics 
The use of ceramic materials, mainly CaPs, for implant surface coatings 
provides a physical matrix suitable for deposition of more new bone (Figure 3). 
Bone formation on the implant surface may be directly influenced by the 
quality of such coatings, and osteogenic cell interactions and behavior. CaP 
coatings display growth-guiding properties inducing, osteoblast proliferation, 
differentiation, extracellular matrix (ECM) production and mineralization of 
new bone [70]. 
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Figure 3. Light micrographs showing an apparent difference in bone contact 
between (A) CaP-coated implant surface and (B) non-coated implant surface 
(original magnification x10). 
 
Generally, CaP implant coatings are suggested to improve the cellular reactions 
to the implant surface as a direct result of CaP incorporation with protein 
molecules, facilitate cell attachment and adhesion (Figure 4) [71, 72]. 
Immediately after implantation, CaP coatings are found to increase the 
protein adsorption to the implant surface. This adsorbed protein layer will 
subsequently mediate the interaction of the implant material with the cells 
arriving from the surrounding tissue [73].  
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Figure 4. Schematic drawing of biological reactions to the implant surface. 
After implantation, hydrated ions are incorporated into the surface, followed by 
adsorption of proteins, leading to osteoblastic cells attachment, differentiation, 
and production of the extracellular matrix (ECM). 
 
 
Cellular interactions with extracellular proteins are mediated by integrins. 
These specific cell membrane molecules transduce signals from the 
extracellular matrix (ECM) to the cell and vice versa. Then, the signaling 
pathways through integrins can regulate cell activity to a certain extent [74]. 
Integrins consist of two glycoprotein subunits, the α-chain and the β-chain, 
which are non-covalent bonds. Both subunits contain extracellular and 
intercellular tails (Figure 5). Integrins interact with the ECM proteins through 
their extracellular tails and receive signaling through their intracellular tails 
[75]. Consequently, integrins are suggested to mediate cellular-substrate 
interactions including cell attachment, adhesion, spreads, proliferation, and 
differentiation [76, 77]. Osteoblasts are capable of expressing a wide variety of 
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integrins, which bind to specific amino acid sequences, such as the tripeptide 
amino acid sequence arginine-glycine-aspartic acid (RGD) recognition motif 
present in many ECM proteins, including collagen, fibronectin, vitronectin, 
bone sialoprotein, and osteopontin [78]. The interaction of integrins with ECM 
ligands is necessary for the expression of osteoblastic-specific genes [79]. After 
the binding of a protein ligand, intercellular signaling will be initiated. This 
signaling pathway inside the cell is complex, and involves the accumulation of 
several proteins, like focal adhesion kinase (FAK), src, vinculin, and actin 
filaments. FAK and vinculin are the cytoplasmic side of focal adhesion and 
seem to be responsible for transmitting signals to actin filaments. Both FAK 
and vinculin molecules require the interaction between integrins and the ECM 
ligands for their expression [78, 79].  
Using osteoblast-like cells culture, the number of FAK-positive focal 
adhesions increased continuously on CaP-coated substrate, whereas the number 
of vinculin-positive adhesions decreased [80-83]. It may be that the production 
of vinculin molecules is inhibited after the cells become stably attached to CaP 
surface. Although it is unclear why the number of vinculin-positive focal 
adhesions decreased, it is likely that vinculin is inhibited after the cells become 
stably attached to the CaP surface faster than non-coated surface [84]. 
Differences in integrin expression have been also shown for cells when cultured 
on titanium substrates coated with a CaP layer [83]. The differences in integrin 
expression can possibly be explained by the differences in adsorbed proteins 
conformation [73]. 
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 CaP-coated implants have been reported to adsorb more specific ECM 
proteins, mainly vitronectin and fibronectin, compared to non-coated implants 
[85]. As CaP ceramics can affect protein conformation, the biological activity 
of these proteins may increase and then the cellular integrin expression also 
increase .[73, 86]. Beside the ligand-binding activities, integrins are able to 
cooperate with many additional enzymes and growth factors that are expected 
to accumulate on the implant surface, which subsequently results in the 
regulation of cell cycle progression and mobility [78, 79]. Moreover, CaP 
coatings were found to stimulate the expression of proteins that are known to be 
features of the osteoblasts lineage. The release of Ca2+ and PO4
- ions from the 
coating is speculated to regulate the initiation of messenger ribonucleic acid 
(mRNA) transcription of cellular differentiation to osteoblasts [87]. These ions 
may also stimulate several intracellular signaling molecules in osteoblasts and 
favor the mineralization process during bone formation [88]. Furthermore, the 
presence of a CaP coating is found to induce the precipitation of bone-like 
apatite on the implant surface. The osteogenic cells might, in turn, recognize the 
bone-like apatite layer and be more activated to initiate osteogenesis [89, 90]. 
Beside the chemical composition, it has been proposed that the use of nano-CaP 
granules for implant coatings increases the concentration of vitronectin and 
collagen [91]. Again, the presence of these proteins on the implant surface 
enhances the osteogenic cell integrin-signaling pathways [92, 93]. 
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Figure 5. Integrins-mediated cell adhesion to extracellular matrix 
(ECM) on the implant surface. The subunits structure of the integrin (α-
chain and β-chain) bind ECM proteins ligands. Focal adhesions 
assembly is containing signaling components regulating osteoblastic cell 
functions. 
 
As can be concluded from the above, it is important to realize that protein 
adsorption as well as integrin expression are very dynamic processes in vivo. 
The adsorbed proteins to the implant surface are enzymatically degraded and 
undergo several changes that may also alter the integrin expression during the 
various stages of osteogenesis [73]. Other parameters involved in the protein-
cellular interactions include the techniques used to deposit CaP coating, the 
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thickness of the applied coating, and the final physicochemical characteristics 
of the coating [70, 94]. 
 
7.3. Bone-bonding to calcium phosphate ceramics 
When a biomaterial is implanted in the body, a reaction takes place at the 
material/tissue interface. This reaction leads to changes in both tissue and 
surface material. It is essential to understand the in vivo host response to the 
material and the attachment mechanism between implant and tissue, to ensure a 
long functional life of the biomaterial [2, 17]. 
All biomaterials evoke a response from living tissue, which classifies them 
generally as first, second and third generation biomaterials. A first generation 
biomaterial aims to “achieve a suitable combination of physical properties to 
match those of the replaced tissue with a minimal toxic response in the host” 
[95]. A shift in research focus from investigating only bioinert tissue response 
to bioactive materials yielded the second generation of biomaterials. Some of 
these second generation biomaterials are CaP ceramics; their bonding 
mechanism is through the formation of a carbonate apatite layer on the 
biomaterial surface, which is chemically and crystallographically equivalent to 
the bone tissue mineral phase. This carbonate apatite layer creates an ideal 
environment for cellular attachment and subsequent new bone formation with 
strong bonding to the material surface [17, 95]. Biomaterials with certain 
capacities to stimulate adsorption of proteins and specific cellular responses are 
CALCIUM PHOSPHATE CERAMICS FOR BONE REGENERATION 
 
34 
 
currently of interest. Such stimulating biomaterials constitute the third 
generation of biomaterials [95]. 
Failures of implanted biomaterials occur at the biomaterial-tissue interface. 
When biomaterials are almost inert and the interface is not chemically or 
biologically bonded, there is relative movement due to lack of interfacial 
mechanical stability which isolates the material from the body tissue [2]. This 
movement influences the deterioration in function of the implant or of the tissue 
at the interface or of both, and it may differ depending on both the material and 
the extent of relative motion [17]. In healthy patients, bone implants are quite 
successful, however, it has been observed that the rate of implant failure is 
substantially higher in elderly patients. This could be due to volume or bone 
density deficiency or impaired vascularization, which provokes lack of 
osseointegration and further implant failure [96]. 
 
7.4. Degradation of calcium phosphate ceramics 
Synthetic bioresorbable materials have been developed for medical 
applications, however, it is a challenge to match material resorption rates with 
body tissue remodeling by self-healing. 
Bioactive ceramics can be degraded either by biochemical dissolution ion 
processes or by acidic environments due to cellular bone remodeling processes 
(i.e. osteoclastic activity) [44, 45]. As already mentioned in this chapter, the 
most commonly investigated synthetic calcium phosphate ceramics are 
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hydroxyapatite (HA), β-tricalcium phosphate (β-TCP) and biphasic calcium 
phosphate (BCP). One distinguishing aspect of CaP ceramics are their 
resorption rates. Hydroxyapatite resorbs very slowly and more closely 
resembles natural bone hydroxyapatite than β-TCP and therefore is being more 
commonly used for bone ingrowth.  However, HA’s slow resorption rate can be 
a disadvantage when new bone is formed in the porous HA network because it 
cannot experience the mechanical loading that it needs to remodel if the HA 
remains strong. If the initial material would degrade and allow the bone to be 
loaded, long-term persistent remodeled bone would be more likely to occur [17, 
65]. In the case of BCP, biodegradation kinetics depend on the HA/TCP ratio; 
the higher the ratio, the lower the degradation rate. 
When the process of bone resorption (i.e. osteoclast activity) takes place, the 
environment becomes acidic. Therefore, the in vivo behavior of CaPs can be 
predicted to a large extent by their solubility (Table 1 shows the solubility of 
CaPs compounds). To mimic the degradation of calcium phosphate ceramics in 
vivo, an in vitro experiment is usually performed by measuring the amount of 
Ca2+ ions released over time when soaking the material in an acidic buffer (pH 
5) [2]. 
In order to control the solubility of calcium phosphate ceramics, different 
ions can be incorporated. CO3
2, Mg2+, or Sr2+ ions can increase the solubility-
biodegradability when incorporated in the hydroxyapatite matrix while F- ions 
can decrease it. In contrast, the solubility of b-TCP is decreased by 
incorporation of either Mg2+ or Zn2+ ions [2, 44]. Furthermore, the degradation 
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of calcium phosphate ceramics also depends on several parameters such as their 
composition, particle size, crystallinity, both design and preparation conditions 
and technique used to apply the calcium phosphate coating. Further 
investigation should be done to control the biodegradation of calcium 
phosphate ceramics. 
 
8. Objectives of this thesis 
Calcium phosphate (CaP) based ceramics are synthetic materials commonly 
used as bone substitutes and for bone implant surface modification [97]. 
Specific properties, including biodegradability, bioactivity, osteoconductivity, 
and osteoinductivity, make CaPs biologically appealing materials for bone 
implantology applications [98, 99]. The dissolution behavior of bulk ceramics 
due to chemical composition (CaP phase) has been associated with 
osteoinductive potential in vivo [100]. More specifically, hydroxyapatite (HA), 
tricalcium phosphate (TCP) and biphasic calcium phosphate (BCP) are CaPs 
that have shown varying degrees of osteoinductive capacity, which inversely 
corresponds to their biological stability (i.e. TCP > BCP > HA) [100]. In 
addition to compositional effects, surface morphologies have been shown to 
affect biological performance [101, 102]. Micro- and nano-scale morphology of 
the CaP surface can strongly influence osteoblast and stem cell adhesion, 
proliferation, and differentiation [103-105]. 
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Although the development of CaP ceramics as either coatings or bulk 
materials in vitro and in vivo has been widely studied, material properties 
related to the biological performance of CaP ceramics are still not well 
understood. For instance, only few attempts have been made to evaluate the 
biological potential of CaP phases, such as TCP or TTCP sputter coatings in 
vivo. Additionally, the biological effects of CaP surface morphology has only 
recently become a topic of research (yuan et al., Ripamonti et al.), while the 
power of a pure materials-based treatment option for bone regenerative 
medicine basically relies on the instructive capacity of material properties on 
the biological surrounding. Therefore, the main objective of this thesis was to 
study the physicochemical and biological properties of various calcium 
phosphate ceramics as either CaP coatings or bulk CaP ceramics for their use in 
biomedical applications, with major focus on CaP composition and surface 
morphology. 
The following research questions were addressed: 
1. What is the current knowledge on coatings using inorganic and/or 
organic materials and which techniques are available for the deposition 
of such coatings on metallic materials? (Chapter 2) 
2. What are the effects of CaP composition in sputter coatings on in vitro 
and in vivo performance? (Chapter 3) 
3. What is the influence of calcium phosphate target composition on 
surface and mechanical properties of sputtered coatings? (Chapter 4) 
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4. What is the role of hemispherical concavities on the in vitro 
mineralization of bioceramic materials? (Chapter 5) 
5. What is the influence of SBF volume change, disk material, and 
surface hemispheres on mineralization? (Chapter 6) 
6. How do cells populate hemispherical concavities and to what extent 
does concavity size influence 3-dimensional cellular organization? 
(Chapter 7) 
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1. Introduction 
Load-bearing bone implants for dental and orthopedic applications to 
replace hard tissue are generally made from bioinert materials, including 
titanium, stainless steel, cobalt-chromium, alloys or certain ceramics (e.g. 
alumina and zirconia). Extensive efforts have been dedicated to the 
optimization of the interaction with bone tissue at the implant interface via 
surface modifications to enhance the surface biocompatibility and 
osteoconductive properties of these implants. Still, implant failure remains a 
problem for especially clinical cases characterized by compromised local or 
systemic conditions (e.g. osteoporosis and diabetes) [1]. 
Biomaterials research is evolving from the use of bioinert and biologically 
passive implants toward actively interacting implants that stimulate tissue 
regeneration. Currently, there is an increasing interest in biomaterials that are 
capable of activating protein adsorption processes and specific cellular 
responses. Surface physico-chemical properties need to be modified in order to 
transform passive inert implant surfaces into active ones able to instruct the 
biological environment toward regeneration of bone tissue (Fig. 1). For 
instance, physical surface modifications in topography or macrostructural 
properties have been reported to concentrate more bone morphogenetic proteins 
(BMPs) and stimulate osteogenesis [2,3]. On the other hand, chemical surface 
modifications have been shown to play an essential role in bone tissue 
responses [4-10]. For ceramic coatings, the liberation of certain ions from the 
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implant surface into the surroundings increases local super-saturation of the 
biologic fluid causing precipitation of carbonated apatite that incorporates 
calcium, phosphate and other ions, as well as proteins, and other organic 
compounds [11]. Furthermore, the immobilization of biomolecules into the 
coating materials allows implants to deliver drugs and growth factors [12]. 
 
Figure 1. Schematic overview of a bone implant. 
 
In addition, when referring to organic coatings, the use of organic 
compounds derived from the extracellular matrix (ECM) of bone attempts to 
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stimulate mineralization and/or adhesion of cells onto the bone implant 
surfaces. 
This review aims to provide an overview of surface modifications for load-
bearing bone implants. Special attention is devoted to the most recent 
developments of inorganic and organic coatings for bone implants that actively 
interact with bone tissue to aid skeletal repair and reconstruction. 
 
2. Inorganic coatings 
Bone tissue is a composite that exhibits a rich hierarchical structure. The 
cells within bone tissue are embedded in an extracellular matrix made of 
organic and inorganic compounds, which permit bone tissue to remodel and 
adapt its structure in response to mechanical stress (Fig. 2). More specifically, 
the strength of bone tissue is related to the orderly interspersed inorganic 
crystals within the organic compounds [13,14]. These crystals have an apatite 
structure (i.e. Ca10(PO4)6(OH)2 for hydroxyapatite), in which calcium and 
phosphate are the most prominent elements. Synthetic inorganic materials have 
therefore been extensively explored to mimic the mineral part of bone tissue for 
bone implantology applications. 
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Figure 2. Hierarchical levels of bone structure. 
 
2.1. Properties and bonding mechanism of CaP-based 
ceramics 
Calcium phosphate (CaP) ceramics are synthetic materials that share 
common mineral phase properties with bone tissue and are biodegradable, 
bioactive and osteoconductive [15]. CaP ceramic materials are characterized by 
their hardness, strength, low electrical conductivity, brittleness and inferior 
mechanical properties. Due to their inferior mechanical properties, the 
application of CaP ceramics as bulk materials under load-bearing conditions is 
limited. Used as implant surface coatings, these CaP ceramics provide a 
physical matrix at the implant surface suitable for interaction with bone tissue. 
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CaP ceramics bond to bone tissue through the release of ions from the 
implant surface inducing apatite nucleation, followed by the formation of a 
carbonated apatite layer on the biomaterial surface [16]. This apatite layer at the 
surface is chemically and crystallographically equivalent to the bone tissue 
mineral phase. As such, this carbonated apatite layer creates an ideal 
environment for protein and cellular attachment and subsequent strongly 
bonded bone formation. Several parameters of CaP ceramics, either in bulk or 
coating form, have been demonstrated to alter protein binding, cell-material 
interactions and implant resorption rate. These inherent parameters include 
chemical composition, crystallinity, surface area, surface charge, surface 
topography and porosity, elasticity and fatigue of the implant surface. 
 
2.1.1. Pure CaP-based coatings 
CaP-based ceramic coatings were originally developed to improve bone-
implant attachment and enhance surface reactivity, for example of dental 
implants and metallic prostheses, because of their favorable bioactivity and 
osteoconductivity. Surface properties of the implant material such as coatings 
roughness, chemical purity, and topography should be optimized to improve 
osseointegration. Bioactive materials, such as CaP ceramics, several classes of 
bioglasses, calcium carbonates and calcium sulfates, evoke specific biological 
responses, stimulate bone tissue formation and directly bond to adjacent bone 
tissue.  
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There are several CaP phases, the most commonly used for bone ingrowth 
has been hydroxyapatite (HA; Ca10(PO4)6OH2), which has crystalline and 
molecular structure similarities to the inorganic phase of bones and teeth [17-
19]. Other structures include brushite (DCPD, CaHPO4.H20), and tricalcium 
phosphate (α-TCP and β-TCP, Ca3(PO4)2) have been used as bioactive coatings 
to modify the surface of bioinert metals or polymers [20]. At physiological pH 
(between 7.2-7.6), HA is the most stable CaP phase. The partial dissolution of 
the ceramic (i.e. release of ions) initiates the re-precipitation of biological 
apatite crystals and subsequent proteins and cells attachment to the implant 
surface. Amorphous CaP coatings have higher dissolution and re-precipitation 
rates than the crystalline CaP coatings and present faster bone formation21 and 
produce higher cell differentiation in vitro studies [21,22]. However, crystalline 
CaP coatings are preferred when long-term stability of the implant is desirable. 
The biological properties of these CaP-based ceramic coatings are related to 
their chemical composition, Ca/P ratio, crystallographic structures and 
solubility. Consequently, the release of ions and the interaction with body fluid, 
cells and tissue of CaP implant coatings differs related to specific CaP coating 
structure [23,24]. 
 
2.1.2. Incorporation of active ions into CaP-based ceramic 
coatings 
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In an attempt to further increase the biological performance of CaP-based 
ceramic coatings, research focused on the incorporation of ions into the ceramic 
lattice. Ionic doping  not only changes the chemical composition but also 
physicochemical properties, such as morphology and crystallinity. Numerous 
articles have claimed that silicon (Si) substitution into the crystal structure of 
CaP ceramics, in particular HA, positively influences the biological response 
compared to pure CaP coatings [25-27]. For example, Patel et al. [26] 
compared granules of pure HA and Si-substituted HA when implanted in a 
rabbit model; more bone ingrowth and bone-implant coverage were found with 
the incorporation of silicate ions into the HA structure. Similar results were 
obtained by Hing et al. [27] using porous HA and silicate-substituted HA 
scaffolds. The authors claimed that the presence of Si ions is responsible for an 
increased collagen deposition, cells differentiation, bone ingrowth and repair. 
However, a recent critical review on Si-substituted CaP coatings has shown that 
there is no experimental evidence that Si ions are released (at sufficiently high 
concentrations) from the CaP lattice in vitro or in vivo studies [25]. The 
heterogeneity of studies based on Si-substituted CaP remain inconclusive 
regarding the cause for the positive biological responses: topographical effects 
or the release of Ca ions instead of the Si ions release. A mayor criticism is 
moved concerning the analysis of the effective principle through Si ions could 
enhance bone deposition or formation [25]. The incorporation of magnesium 
(Mg) ions into HA in an in vivo study has shown that Mg-substituted HA 
enhances the osteoconductivity and resorption compared to commercial HA. 
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Landi and Tampieri highlighted how Mg substituted hydroxylapatite (HA) has 
chemico-physical properties that increase solubility compared to synthetic HA 
that resemble more the characteristics of natural HA [28]. Experiments 
substituting calcium by strontium (Sr) ions have been performed in several 
calcium phosphate ceramics, such as HA [29, 30], β-TCP31 and α-TCP [32]. 
Fielding et al. showed that the addition of silver (Ag) and Sr dopants to the HA 
coating enhanced cell proliferation and differentiation activity compared with 
pure HA coating [33]. Lithium (Li) incorporation into the CaP coating changes 
the coating morphology and interferes with the CaP crystallization. The 
presence of lithium has been demonstrated to enhance MG63 cell attachment 
and early proliferation [34].  Lastly, zinc (Zn) incorporation has also been 
widely studied. In vivo studies demonstrated more bone apposition when using 
low concentrations of zinc (~0.3 wt.%), whereas long-term implantation studies 
with low concentrations of zinc or high concentrations of zinc (~0.6 wt.%) led 
to an increased resorption of bone [35,36]. 
 
2.1.3. CaP-based ceramic coatings with entrapment of 
biomolecules 
HA ceramics have been used as a delivery system for chemicals [37], 
antibiotics [38] and anticancer drugs [39]. A final approach toward inorganic 
surface modifications with enhanced biological performance involves the 
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entrapment of biomolecules into a ceramic coating, enabling active release of 
drugs 
 
Figure 3. Classification and interaction of instructive coatings. 
 
(e.g. anti-microbial coatings). By local delivery of antibiotic drugs from a 
coated implant, the occurrence of post-surgery infections can be reduced, 
enhancing the short and long term stability of a bone implant [12]. The use of 
CaP coatings as delivery vehicles for antimicrobial agents such as 
chlorhexidine has already reported its efficacy in an in vitro study by Campbell 
et al. In this study the incorporation of chlorhexidine within the hydroxyapatite 
(HA) coatings showed an initial rapid release followed by a period of slower 
sustained release. The in vitro evaluation results showed that a large “inhibition 
zone” was formed around the HA/chlorhexidine coating compared to HA 
coating [10]. Moreover, for compromised situations such as osteoporosis, the 
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incorporation of bisphosphonate drugs (e.g. alendronate) into the inner layers of 
CaP coatings has shown beneficial results on osteoblast cells differentiation 
[40]. CaP coatings used as local delivery of drugs or antimicrobial agents offers 
the possibility of improving efficacy (i.e. dosage near the affected site) and 
reduce the treatment duration. 
A classification of the different instructive inorganic and organic coating 
materials and their interaction when implanted is shown in Fig. 3. 
 
3. Organic coatings 
The bone tissue extracellular matrix (ECM) is composed of a hierarchical 
and complex structure of inorganic and organic phases. The inorganic or 
crystalline phase of bone represents 50% of the total volume and 70% of the 
weight, and mainly consists of a stiff, carbonated and nano-sized apatite. The 
organic phase of bone tissue constitutes the remaining volume, which 
comprises collagen (40% in volume of the organic phase) and other proteins, 
such as proteoglycans, glycoproteins (alkaline phosphatase, osteonectin), bone 
sialoproteins and growth factors. 
In the last decades, organic biomolecules derived from the ECM have been 
increasingly considered a fundamental source in the development of organic 
bone implant coatings [41]. Bone implants surfaces can be enriched [42-44] 
using organic biomolecules to obtain instructive medical devices able induce a 
biological response at the tissue-implant interface. Organic-based coatings 
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involve immobilization of structural proteins, Bone Morphogenetic Proteins 
(BMPs) and growth factors and peptides to stimulate cell adhesion onto implant 
surfaces [45, 46] and an approach on the use of pharmacologically active 
biomolecules. 
 
3.1. Surface modifications by ECM proteins 
Collagen is the main component of the bone tissue organic phase and it has 
a fundamental structural and functional role. The minimum element is the 
collagen fibril that is composed of a structured repetition of tropocollagen 
molecules (300 nm size) that are interconnected in a right-helix structure. 
Between tropocollagen molecules, there is a gap zone, in which the nano-sized 
hydroxyapatite crystals can start nucleation and mineralization. Moreover, the 
structural presence of collagen in the ECM is fundamental to obtain the 
mechanical properties of bone tissue. 
Collagen has been used as a coating material to retain biomolecules at the 
implant surface and improve their activity. Collagen-based coatings are able to 
bind an important ECM protein called fibronectin, which plays a major role in 
the interaction between implant surfaces and the surrounding biological 
medium (e.g. cell adhesion, growth, migration and differentiation) [47]. 
Different research groups have also tried to use collagen to increase 
proliferation or differentiation of osteoblasts and osteoprogenitor cells. Douglas 
et al. showed the positive effect of a layer of collagen promoting osteoblasts 
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focal adhesion. Rammelt et al. showed a comparison between collagen and 
other biomolecules in an in vivo experiment on a rat model. Their analysis is 
not focus on the biochemical mechanism of action of these biomolecules but it 
remarks the efficacy of the coated samples in new bone formation [48-50].    
Osteoblasts (bone forming) and osteoclasts (bone resorbing) are the most 
important cell types in bone tissue. These cells maintain the balance between 
dissolved and deposited mineral phase. This balance between osteoclasts and 
osteoblasts is defined as bone turn over and it is controlled through several 
signaling pathways. The key element to regulate the bone turn over is to affect 
cell differentiation and proliferation. Lastly, in vivo experiments using 
collagen-coated bone implants have reported successful results, evidenced by 
an improved bone implant contact, bone density and bone formation [51-53]. 
 
3.2. Surface modifications by growth factors and 
biomolecules 
Osteotropic biomolecules (e.g. growth factors, GFs) have been used to 
improve tissue response and bone formation. GFs are widely used to obtain cell 
differentiation in in vitro procedures. Several GFs, including bone 
morphogenetic protein (BMP), transforming growth factor-beta (TGF-β), 
fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), and 
insulin-like growth factor (IGF), have shown an active role in bone tissue 
formation also after their immobilization onto implants surface [54-56]. 
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Stadlinger et al. investigated GFs that belong to the TGF-β superfamily (e.g. 
BMP-2, BMP-4, BMP-7 and TGF-β1) and showed successful results in terms 
of bone to implant contact, bone density and osteoinduction in a pre-clinical 
study[57]. 
The synergistic effects of collagen and other biomolecules, such as GFs, 
bone sialoproteins or with hydroxyapatite, have shown potential as initiators of 
mineralization by deposition of calcium phosphate onto implant surfaces [41, 
58, 59]. 
 
3.3. Surface modifications by peptides 
The use of complete proteins as a coating material can introduce 
biological effects that can become an obstacle to bone cells recruitment or to 
bone initial contact. The immobilization of these biomolecules is often 
associated with their tendency to lose their 3D-conformation and hence 
impedes with their biological activity. As such, their adsorption to an implant 
surface often decreases the efficacy of immobilized proteins.  The use of short 
peptide sequences derived from entire proteins as coating material can offer a 
solution to this problem [60, 61]. The Arg–Gly–Asp RGD peptide sequence 
[62, 63] has been widely used and presents a predominant binding site for cells 
via integrin receptors. Various other peptide sequences have been used 
similarly onto implanted materials. Bone implants surfaces enriched with a 
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layer of these peptides demonstrated improved biological effects in vitro in 
terms of cells proliferation, mineralization and adhesion [64-66]. 
 
3.4. Use of pharmacologically active biomolecules 
An alternative selection of molecules for bone implant coatings is offered 
by pharmaceutical research. Especially for compromised health conditions (e.g. 
patients with osteoporosis, osteopenia or diabetes) pharmaceutical drugs can be 
used for surface modifications in order to provide a localized therapy. 
Molecules with specific active properties, defined as active principles, represent 
the fundamental material in drugs composition. The use of active principles in 
reduced amounts and in situ (i.e. local administration instead of systemic 
administration) is a challenge for several medical fields. Adsorption of locally 
deliverable drugs onto bone implants can be obtained through immersion of 
implants in a solution that contains active principles prior to implantation. Anti-
osteoporotic drugs, such as bisphosphonates [67] or antibiotics like 
chlorhexidine [68], are currently adopted to enhance the biological performance 
of implants used in compromised bone conditions [69]. Bone implants can be 
coated with active biomolecules to become able to face lower bone density in 
osteoporotic patients or reduce fibrotic tissue formation in diabetic conditions. 
Bisphosphonates can be added as a coating material to reduce the number or the 
activity of osteoclasts in order to modify the balance between bone forming and 
bone resorbing cells. 
CALCIUM PHOSPHATE CERAMICS FOR BONE REGENERATION 
70 
 
Immobilization of active biomolecules onto bone implants is the most 
recent development in surface engineering to obtain instructive coatings [70]. A 
recent review on bisphosphonates (BPs) showed that BPs that have an affinity 
for CaP materials can be incorporated into CaP coatings by soaking the 
implants into BPs solution and achieve stronger primary fixation by the 
inhibition of osteoclast action [71]. 
 
4. Coating deposition techniques     
The most commonly used coating techniques are physical coating 
deposition methods, although there is a trend toward the utilization of wet- 
 
 
Table 1. Characteristics of deposition techniques. 
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chemical deposition techniques (e.g. biomimetic and sol-gel deposition 
techniques) for inorganic and organic coatings (Table 1). The deposition of 
uniform and adherent coatings of any organic biomolecule requires a deposition 
technique that does not cause damaged to the biomolecule. The major 
drawbacks of biomolecules used for surface modification include the sensitivity 
of these biomolecules to physicochemical conditions and hence the requirement 
of controlled settings during deposition.  
In fact, high temperatures or exposure to ion beams or plasmas can alter the 
organic structure of the biomolecules reducing their activity. Several wet-
chemical deposition techniques that allow preservation of biomolecule activity 
have been explored in the past few decades [46]. 
 
4.1. Wet-chemical deposition techniques 
Biomimetic deposition mimics the natural deposition of biological apatite 
and opened up a new way to develop biomaterials. It was introduced by 
Kokubo et al. in 1990 and the system originally involved simple immersion of 
(pre-treated) titanium substrates into a so-called simulated body fluid (SBF) to 
obtain deposition onto the surface of the substrates of a biologically active 
bone-like CaP layer [72]. The deposition is performed under physiological 
conditions (37°C, pH 7.4, p(CO2)=0.05 atmosphere and appropriate electrolyte 
concentrations) [73] and biomolecules can be dissolved in the liquid and hence 
be incorporated in the growing coating. Several reports have shown the cell and 
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tissue response (i.e. differentiation of stem cells into osteoblasts that deposit 
bone matrix on the ceramic surface) by the incorporation of biomolecules in 
combination to CaP coatings using the biomimetic deposition technique [74-
76]. One of the main advantages of biomimetic deposition, in fact, is the 
possibility of co-precipitating ceramic (nano)particles with biomolecules (e.g. 
osteogenic agents) [77]. Bone implants have been immersed in a suspension 
containing antibiotics78 or active principles like bisphosphonates [79-81] to 
obtain adsorption of these bioactive biomolecules onto the implant surface. 
Each application showed different response according with the expected role of 
the active agent incorporated onto implants through biomimetic deposition. 
The sol-gel coating technique involves the immersion of a substrate into a 
concentrated solution with a gel-like texture [82-83]. This technique provides a 
resourceful approach to synthesize inorganic polymer and organic–inorganic 
hybrid materials under mild conditions. Moreover, sol-gel technique includes 
inherent advantages such as single step manufacturing process, material 
homogeneity at the molecular level and chemical bonding between the substrate 
and the coating [84]. 
The electrospray deposition (ESD) technique is an electrochemical coating 
method with promising applicability for inorganic and organic coatings. ESD, 
schematically represented in Fig. 4, shares the benefits of preserving 
biomolecules as the wet chemical deposition methods, such as biomimetic or 
sol-gel, and the deposition control of dry methods described for inorganic 
coating materials. 
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Figuree 4. Schematic representation of electrospray deposition 
(ESD) apparatus. 
 
 
ESD method is applicable to solutions or suspensions containing precursor 
that precursors are particles or molecules that carry an electrical charge or that 
can be dispersed in electrolytic solutions. Also the targets, onto which the 
coating is applied, have to be conductive. ESD allows for a strong control over 
physicochemical coating properties such as thickness or chemical composition 
[87]. 
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Although dip coating [88], sol–gel and biomimetic coatings are suitable for 
coating a complex shape (e.g. porous, 3D, etc.), all these techniques suffer from 
weak adhesive strength.  
 
 
4.2. Physical deposition techniques 
Other physical coating techniques such as plasma-spraying, pulsed laser 
deposition, ion beam deposition and sputter deposition offer advantages over 
wet-chemical depositions with respect to interfacial strength and crystallinity. 
Plasma-spraying was the first coating technique for biomedical 
applications; this technique is also is also very successful for applying CaP 
coatings on implants due to its high deposition rate. Plasma spraying produces 
coatings with desired chemistry and crystallinity, despite poor control of the 
thickness and surface morphology [89]. Pulsed laser is a technique that allows 
deposition of thin, dense, well adhering coatings with control chemistry and 
crystallinity [90]. Ion beam deposition technique (Fig. 5 A) is a vacuum 
technique used to deposit coatings from precursor materials vaporized. Inherent 
properties and chemical composition of the coating may differ from that of the 
bulk material due to the high energy involved [91]. Lastly, one of the most 
frequently applied techniques used to prepare CaP coatings by physical vapor 
deposition process is radio-frequency (RF) magnetron sputtering (Fig. 5 B). 
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Figure 5. Schematic representation of physical deposition technique. (A) 
Ion beam deposition scheme. (B) Radio frequency magnetron sputtering 
apparatus. 
 
This technique deposits thin coatings chemically bonded with the substrate 
which improves adhesion between the coatings and the substrate [92]. 
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5. Future perspectives 
The science of surface modification has shown significant progress in 
clinical applications through the development of more active inorganic and 
organic coating materials on implant surfaces. However, many scientific and 
technological challenges remain in biomaterials research. Further research and 
full understanding of fundamental aspects of the field such as the process of 
bone formation, attachment of proteins and specific cells, cell adhesion, bone 
stimulation or induction by inorganic and organic coatings are essential. 
The use of CaP as a bone implant surface coating is well established in the 
field of biomaterials research, although the validity and efficacy of efforts 
focused on substitution within the crystal lattice have yet to be thoroughly 
explored. CaP-based coatings employed as a local delivery system of 
antimicrobials or pharmaceuticals offer great potential for medical applications, 
but still more precise control on local release kinetics is required. 
Deposition of coating materials can strongly modify implant surface 
characteristics. Different coatings are obtained by selecting precursor materials 
for deposition, but also the coating techniques have a strong role in the final 
surface modifications. A deposited layer of calcium phosphate can assume 
totally different nano-, micro- and macromorphology if biomimetic, 
electrospray or RF magnetron sputtering deposition technique is used (Fig. 6A-
C). 
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Incorporation of organic compounds into coatings, such as proteins derived 
from ECM, BMPs and other growth factors, peptides or pharmacologically 
active biomolecules have shown to play an effective role in stimulating cell 
adhesion to implant surfaces. Nevertheless, optimization of coating 
degradation, immobilization of biomolecules and effective concentrations are 
needed to improve functionality and biological efficacy. A representation of 
surfaces treated with biomolecules with two different methods is given in Fig. 6 
D and E. 
 
 
Figure 6. Overview of scanning electron microscopy images of surfaces of 
coated titanium sample substrates. Different coating techniques are considered 
and different precursor materials. Inorganic coating: (A) Calcium phosphate 
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biomimetic deposition. (B) Calcium phosphate electrospray deposition (C) 
Calcium phosphate RF magnetron sputtering deposition. Organic coating: (D) 
Wet chemical deposition of biomolecules (Alkaline Phosphatase) (E) Collagen 
deposited with electro spray deposition. Composite coating: (F) Calcium 
phosphate and collagen electrospray deposition. 
 
 
The heterogeneity of available biomaterials and deposition methods is 
leading to a continuous evolution of surface modifications that combine 
different techniques and materials to obtain solutions for specific needs, such as 
improved retention of deposited materials or to create composite coating layers 
(Fig. 6F). 
Finally, initial research steps have been taken regarding the optimization of 
surface properties for bone implants to be used in compromised situations (e.g. 
osteoporosis and diabetes research). More reactive surfaces, with direct tissue 
interaction, have been engineered to improve bone quality. Future research 
strategies should consider validating therapeutic safety and effectiveness of 
therapeutic coatings. 
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1. Introduction 
Calcium phosphate (CaP) based ceramics are commonly used synthetic 
materials for bone substitutes and bone implant surface modification [1]. 
Properties including biodegradability, bioactivity, osteoconductivity, and 
osteoinductivity make calcium phosphates biologically appealing implant 
materials [2,3]. Differences in dissolution behavior of bulk ceramics are due to 
changes in chemical composition (CaP phase) and have been associated with 
osteoinductive potential in vivo [4]. More specifically, hydroxyapatite (HA), 
tricalcium phosphate (TCP) and biphasic calcium phosphate (BCP) have shown 
different levels of osteoinductive capacity that inversely correspond to their 
biological stability (i.e., TCP > BCP > HA) [4]. However, because of the 
inferior mechanical properties of bulk CaP ceramics, their application under 
load-bearing conditions is limited. Under load-bearing conditions, CaP 
ceramics are used as coating on mechanically strong bioinert implant materials, 
such as titanium (or titanium alloy), for optimization of the interaction with 
bone tissue at the interface [5]. 
Compared to bulk ceramics, as-deposited coatings possess distinctive 
network structures and properties (i.e., surface roughness, coating thickness, 
and crystallinity) and therefore can evoke a different response in vivo. The most 
commonly investigated synthetic CaP ceramic materials for use as coatings are 
HA (Ca10(PO4)6OH2) [6-8] and TCP (Ca3(PO4)2) [9,10]. These CaP-based 
ceramics differ in composition, crystal structure and resorption rate. HA resorbs 
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slowly and resembles more closely natural bone mineral than TCP [11]. 
Therefore, HA is more commonly used for medical application. Among CaP-
based ceramics, tetracalcium phosphate (TTCP; CaO.Ca3(PO4)2) has the highest 
solubility at pH < 4.0 and is the only CaP ceramic with a Ca/P ratio greater than 
HA [12]. TTCP is formed only by a solid-state reaction above 1300 ºC and in 
aqueous solutions complete hydrolysis of TTCP to HA occurs. However, very 
little research has been done on the use of TTCP as a CaP coating [13,14] and, 
to our knowledge, no attempts have been made to evaluate the performance of 
either TCP and TTCP sputtered coatings in vivo. Nevertheless, this seems to be 
interesting due to the suggested osteoinductive potential of the various CaP 
phases [4]. 
Plasma spraying of CaP ceramics onto metallic implants has been 
commonly used for biomedical applications, despite poor control of thickness 
and surface morphology [15-17]. However, radio frequency (RF) magnetron 
sputtering has several advantages over plasma spraying of CaP such as 
deposition of dense, uniform, and continuous coatings that have high CaP 
coating-substrate bonding strength [18]. After sputtering onto a metallic 
implant, the stoichiometry, CaP ratio, crystallinity, phase composition, and 
structure of the CaP ceramic are different relative to the bulk material. As a 
final step, post-annealing treatment is necessary to crystallize the coating, 
which also influences the final coating properties [19]. The resultant coating 
properties might enhance implant fixation and the bone formation processes. 
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The aim of this study was to evaluate the effect of CaP-sputtered coatings 
with different phase composition on i) in vitro dissolution, and ii) in vivo bone 
response. For this purpose, three different CaP-based target materials (i.e. HA, 
TCP, and TTCP) were used for coating preparation, after which coating 
characterization, in vitro dissolution experiments, and in vivo implantation in a 
rabbit femoral condyle model (6 weeks implantation) were performed. We 
hypothesized that different CaP-based target materials affect coating properties 
and lead to coating-specific dissolution/precipitation behavior in vitro and bone 
response in vivo. 
 
2. Materials and Methods 
Materials 
Commercially available pure Ti discs (thickness 1.5 mm, diameter 12 mm) 
and cylindrical Ti implants (length 8 mm, diameter 3.25 mm) were Al2O3 grit-
blasted before deposition. The target materials used in the deposition process 
were HA granulated powder obtained from CAMCERAM® (CAM 
Bioceramics, Leiden, The Netherlands) and a copper disc provided with either a 
plasma-sprayed β-TCP or TTCP coating (CAM Bioceramics, Leiden, The 
Netherlands). The chemical composition and purity of the different target 
materials was confirmed by X-ray diffraction (XRD). 
 
Coating deposition  and characterization 
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The coatings for this study were deposited using RF magnetron sputtering 
equipment (Edwards High Vacuum ESM 100 system, Crawford, England) 
[18,20,21]. Substrates were cleaned ultrasonically in acetone and ethanol before 
deposition to remove impurities. Subsequently, substrates were placed on a 
rotating holder. The distance between target and implants was 80 mm. During 
deposition, argon pressure was kept at 5 x 10-3 mbar and a sputter power of 400 
W with a coating thickness of 1 µm was used. A non-coated implant was used 
as control for the experiments. 
After deposition, all coatings were subjected to an additional heat-treatment 
of 15 seconds in air at final heating temperature of up to 650 ºC in an infrared 
furnace (Quad Ellipse Chamber, Model E4- 10-P, Research Inc, Minnesota, 
United States) [22]. The following ceramic coatings were generated: 
1. HAH  Coating deposited using HA as target material + HT 
2. TCPH  Coating deposited using β-TCP as target material + HT 
3. TTCPH  Coating deposited using TTCP as target material + HT 
CaP-coated substrates were characterized using scanning electron 
microscopy (SEM, Jeol, SEM6310, Tokyo, Japan), reflection Fourier-transform 
infrared spectroscopy (FTIR, Perkin Elmer, Spectrum One, Groningen, The 
Netherlands) and thin-film X-ray diffraction (XRD, Philips, PW3710, 
Eindhoven, The Netherlands). To determine the Ca/P molar ratio, the coatings 
were dissolved in concentrated nitric acid. After digestion, the samples were 
diluted to 5 ml of 1% HNO3 and the solution was analyzed by inductively 
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coupled plasma optical emission spectroscopy (ICP-OES, iCAP 6000 Thermo 
Fischer Scientific Inc.) for Ca and P ions. 
 
In vitro evaluation 
The in vitro dissolution of the CaP-based coatings was evaluated in 
conventional SBF with an ionic composition almost equal to human plasma 
[23]. Ionic concentrations of the SBF were 142.0 mM Na+, 5.0 mM K+, 1.5 mM 
Mg2+, 2.5 mM Ca2+, 147.8 mM Cl-, 4.2 mM HCO3
-2, 1.0 mM HPO4
-2, and 0.5 
mM SO4
-2. Tris-HCl served as a buffer to maintain a constant pH value of 7.4. 
The coated and uncoated discs (three specimens per time period per type of 
CaP coating) were immersed in 4 ml of SBF for 1, 2 and 4 weeks. In total, 36 
CaP-coated discs were immersed in SBF (n=3 for HAH, TCPH, TTCPH and 
uncoated Ti-discs). SBF temperature was maintained at 37 ºC and the solution 
was refreshed weekly. At each time point, the discs were removed from the 
SBF, washed with distilled water and dried at room temperature. Subsequently, 
all discs were characterized using XRD, FTIR, ICP-OES and SEM. 
 
In vivo experiment 
Animals and regulations 
The research protocol for animal experimental procedures was approved by 
the ethical committee of King Saud University (Riyadh, Kingdom of Saudi 
Arabia), and national guidelines for care and use of laboratory animals were 
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observed. A total of 20 New Zealand white rabbits (female; 6 months old) 
weighing between 3.2 and 5.1 kg were used. 
 
Surgical procedure 
Surgery was performed under general anesthesia by intramuscular injections 
of a combination of a dose of 35mg/kg ketamine and a dose of 5mg/kg 
xylazine. The rabbits were immobilized on their back and the hind limbs were 
shaved, washed and disinfected with povidone-iodine. The left and right 
femoral condyles were then exposed to a medial longitudinal incision. A hole 
(3.2 mm in diameter and 8 mm in depth) was created in the center of the 
condyle using a dental drill (KAVO, Intrasept 905, KAVO Nederland BV, 
Vianen, the Netherlands). A 2 mm drill bit was first used to establish a 2 mm 
diameter defect. The bone defect was gradually widened to a final diameter of 
3.2 mm. Debris was removed from the defect by irrigation with physiological 
saline solution. The implants were placed into the defects. Subsequently, the 
periosteum and muscle were closed with a continuous 4-0 Vicryl suture. 
Finally, the skin was closed with continuous intracutaneous 4-0 Vicryl sutures. 
Post-surgery pain was controlled for two days postperatively by the 
administration of Fynadyne® (Fynadine, Schering Plough Animal Health 
Benelux, Utrecht, the Netherlands) intramuscularly. To reduce the post-
operative infection risk Enrofloxacin 5-10 mg /kg (Baytril, Bayvet Division, 
Chemagro Ltd, Etobicoke, Ontario; 5-10 mg/kg) was administered. The 
implants were randomized according to a balanced split plot design to exclude 
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the effect of implantation location and possible variations in individual rabbits. 
Each rabbit received 2 implants, in total 40 implants were placed (n=10 for 
HAH, TCPH, TTCPH and uncoated implants). Rabbits were euthanized six 
weeks after implantation and the femoral condyles were harvested and fixed in 
10% formaldehyde solution, and dehydrated in ethanol for evaluation. 
 
Micro-computed tomography 
For micro-computed tomography, harvested femoral condyles were 
wrapped in parafilm® to prevent drying. For quantitative 3D analysis, all 
specimens were vertically placed onto the sample holder, with the long axis of 
the implant perpendicular to the scanning beam, and scanned using Skyscan-
1072 X-ray microtomograph, TomoNT version 3N.5, Skyscan®, Belgium. 
Subsequently, a high resolution scan was recorded at a 30 µm voxel resolution. 
Then, using CT Analyzer (version 1.4, Skyscan®), a cone beam reconstruction 
was performed onto the projected files. The region of interest (ROI) was 
specified for distinct areas starting at the implant surface: inner (0-300 µm), 
middle (300-600 µm) and outer (600-900 µm) surrounding the implant over a 
constant length (4 mm). Thereafter, for all images a threshold was manually 
selected to discriminatively assign bone tissue and preserve its morphology, 
while excluding the metallic implant material. Per implant, the parameters of 
bone volume and tissue volume were measured, after which the amount of bone 
volume per zone was determined and expressed as a percentage. 
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Histological processing and analysis 
Each specimen was hemisected along the longitudinal axis of the implant 
with a diamond saw blade. Subsequently, one half containing the implant was 
fixed in 4 % formaldehyde for 2 days, dehydrated in increasing ethanol 
concentrations (70-100 %) and embedded in methylmethacrylate (MMA). After 
polymerization in MMA, thin sections (10 µm) were sawed in a longitudinal 
direction to the axes using a modified sawing microtome technique [24]. MMA 
sections were stained with methylene blue/basic fuchsine, basic fuchsine was 
used to color mineralized and unmineralized bone tissue (i.e., osteoid) [25]. 
Implants from the second half of the specimens were carefully removed from 
the bone tissue to avoid interface damage. Afterwards, the specimens were 
decalcified with a specific-purpose apparatus (TDE30, Sakura; Sakura Finetek 
Europe B.V. Alphen aan den Rijn, The Netherlands) for three weeks, 
dehydrated through a graded series of ethanol, embedded in paraffin and cut 
into sections along the longitudinal axis of the implant. Using a microtome 
(Leica RM 2145), 5 µm thick sections were prepared and stained using elastica-
van Gieson (EVG), Masson-Goldner, and tartrate-resistant acid phosphatase. 
All sections were examined with a light microscope (Leica Microsystems AG, 
Wetzlar, Germany). 
 
Histomorphometrical analysis 
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To evaluate the peri-implant bone response, histomorphometrical analyses 
were performed using a computer-based image analysis technique (Leica® 
Qwin Pro-image analysis system, Wetzlar, Germany). Sections of MMA-
embedded specimens (n=3 per specimen) were quantitatively analyzed for the 
percentage of bone-to-implant contact (BIC) and peri-implant bone volume 
(BV). BIC was defined as the relative implant surface distance at which direct 
bone-to-implant contact was present. To determine the peri-implant BV, three 
zones surrounding the implant were defined starting at the implant surface, i.e., 
inner 0-300 µm, middle 300-600 µm and outer 600-900 µm over a length of 4 
mm. Consecutive elastic-van Gieson stained sections were used to verify 
assignment of tissue as bone tissue in the ROI. 
In addition, Masson-Goldner stained sections were analyzed (n=3 per 
specimen) to specifically determine the presence of unmineralized bone matrix 
(i.e., osteoids) in contact with the implant surface. To determine the presence of 
osteoclast-like cells in a peri-implant region of 900 µm (over 4 mm implant 
length) tartrate-resistant acid phosphatase (TRAP) staining was used.  Results 
are presented as a percentage of TRAP-positive stained sections of the total 
number of sections analyzed. 
  
 
Statistical analysis 
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All statistical analyses were performed with GraphPad Instat® 3.05 software 
(GraphPad Software Inc, San Diego, CA, USA), using analysis of variance 
(ANOVA) combined with a post-hoc Tukey-Kramer Multiple Comparisons 
Test. Results were considered significant at p < 0.05. Chi-square test was 
applied to assess the presence of TRAP-positive staining. 
 
3.Results 
Characterization and in vitro evaluation 
Ca and P and the Ca/P ratio were determined by ICP-OES (Table 1). This 
analysis revealed that all the as-sputtered and heat-treated coatings had a higher 
Ca/P ratio compared to the theoretical value of the initial target materials. The 
Ca/P ratio for HAH, TCPH and TCPH coating was in the range of 2.07, 2.17 
and 2.30 respectively. 
 Figure 1 shows the XRD patterns of the sputtered coatings before, during 
and after 4 weeks incubation in SBF. The XRD patterns of the as-sputtered 
coatings showed an amorphous structure without specific reflection lines (data 
not shown). Heat treatment at 650 ºC changed the amorphous structure into a 
more random apatite structure with peaks at 25.9 º, 31.9 º and 32.4 º 2θ (Figure 
1, lower lines). The XRD-patterns of the HAH coating did not show any change 
during the four week incubation period (Figure 1A). Typical reflection peaks at 
25.9º, 31.7º, 32.0º and 34.0º 2θ were attributed to the apatite phase.  
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* Theorical Ca/P ratio 
** Experimentally determined Ca/P ratio by ICP-OES 
after coating deposition + heat treatment (HT) 
 
Table 1. Nomenclature, chemical formula and Ca/P ratio of CaP-based 
ceramics. 
 
After 4 weeks incubation, the XRD patterns of the TCPH (Figure 1B) and 
TTCPH coatings (Figure 1C) showed an increase in crystallinity with more 
intense CaP diffraction peaks. 
Nomenclature 
Chemical 
Formula 
Abbreviation 
Ca/P 
ratio* 
Ca/P ratio 
after 
HT** 
Hydroxyapatite Ca10(PO4)6(OH)2 HA 1.67 2.07 ± 0.01 
β-Tricalcium 
phosphate 
Ca3(PO4)2 TCP 1.5 2.17 ± 0.01 
Tetracalcium 
phosphate 
CaO·Ca3(PO4)2 TTCP 2.0 2.30 ± 0.01 
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Figure 1. XRD pattern of HAH (A), TCPH (B) and TTCPH (C)  coatings after 
0, 1, 2 and 4 weeks of immersion in SBF. 
 
The phase composition was confirmed by the FTIR analysis. HAH coating 
showed bands at 1090, 1050, 970, 670 and 575 cm-1, which were assigned as 
the stretching and bending motion of phosphate characteristics for 
hydroxyapatite (Figure 2A). These P-O bonds remained present and unchanged 
throughout the four weeks incubation in SBF. For the spectrum of the TCPH 
and TTCPH coatings (Figure 2B,C), the bands present at 1090, 1050, 670 and 
575 cm-1 split up into sharper bands. Furthermore, carbonate apatite (CO3-AP) 
bands became apparent at wavelengths of 1454 and 1404 cm-1 with increasing 
incubation time, revealing that carbonate was mainly substituting for phosphate 
anions in a crystalline CaP environment. 
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Figure 2. Fourier transform infrared of HAH (A), TCPH (B)  and TTCPH (C)  
coatings after 0, 1, 2 and 4 weeks of immersion in SBF. 
 
 
Scanning electron micrographs of the heat-treated and SBF incubated coatings 
are shown in Figure 3. SEM examination of the heat-treated coatings showed a 
homogeneous layer and a complete coverage of the substrate surface. After two 
weeks incubation in SBF, TCPH and TTCPH coatings showed morphological 
changes. For both coatings, local surface dissolution was observed, precipitates 
formed, and in the case of TTCPH coating the precipitate had a rod-like 
morphology (Figure 3, higher magnification). 
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Figure 3. Scanning electron micrographs of HAH, TCPH and 
TTCPH coatings after immersion in SBF for 0 (magnification 
1000x), 2 and 4 weeks (magnification 4000x). Right panels show 
higher magnifications (10000x) of the 4 week specimens. 
 
 
 This heterogeneous morphological appearance for TCPH and TTCPH 
coatings was maintained up to 4 weeks incubation. On the other hand, HAH 
coatings did not show any morphological changes during the 4 weeks 
incubation in SBF. 
Changes in the concentration of calcium (Ca+) and phosphate (PO4
3-) ions in 
SBF of the CaP coatings during the 4-week incubation period are shown in 
Figure 4. HAH coating had stable Ca+ ion concentrations during the first 3 
weeks of incubation, after which the concentration of Ca+ ions in SBF 
decreased. For the TCPH and TTCPH coatings, Ca
+ 
ion concentration increased 
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over the first 2 weeks of incubation with a subsequent stabilizing Ca+ ion 
concentration. HAH coatings showed an increase of PO4
3-ion concentration 
during the 4-week incubation. TCP coatings showed an increase of PO4
3-ion 
concentration during the first 2 weeks, after which the concentration in SBF 
solution decreased. TTCPH showed an increase of PO4
3-ion concentration 
during the first 3 weeks, after which the concentration decreased. 
 
Figure 4. Calcium and phosphate ion concentration of the SBF solution during 
the 4-weeks incubation period of the different experimental coatings. 
 
 
General observations of in vivo implantation 
All 20 animals remained in good health and did not show any wound 
healing complications. At the end of the implantation period, a total of 40 
implants were harvested. At retrieval, no signs of inflammatory or adverse 
tissue reaction were observed around the implants. Post-mortem radiographs as 
obtained via micro-CT imaging revealed that the implants were located in 
trabecular bone (Figure 5 A-C). 
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Figure 5. A) Surgical procedure of the titanium cylinder inserted in the femoral 
condyle of a rabbit. Post-sacrifice radiographs obtained with micro-computer 
tomography showing that the implants (i.e., metallic structures appear white) 
were mainly located in trabecular bone. B) cross-sectional view. C)  top view of 
the implant. D) Results of micro-computed tomography (microCT) analysis of 
peri-implant BV percentage for the different experimental implants (non-
coated, HAH, TCPH and TTCPH) in three different zones: inner (0-300 µm), 
middle (300-600 µm) and outer (600-900 µm). *p<0.05 and **p<0.01. 
 
 
 
Micro-CT analysis 
Peri-implant BV measurements were performed for three different regions 
of interest: 0-300 µm (inner), 300-600 µm (middle) and 600-900 µm (outer). 
Mean BV of the inner, middle and outer zone are depicted in Figure 5D. As a 
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general trend, the highest BV (range: 43-49 %) was observed in the inner zone, 
intermediate BV (range: 31-37 %) in the middle zone and the lowest BV 
(range: 26-35 %) in the outer zone. Additionally, statistical analyses showed 
significant differences in BV for the inner zone compared to the middle (12.2 
%, p < 0.01) and outer zone (17.7 %, p < 0.01) for HAH coatings and for the 
inner zone compared to the middle (9.2 %, p < 0.05) and outer zone (13 %, p < 
0.01) for the TCPH coatings. 
 
Descriptive histological evaluation 
Histological examination was carried out to evaluate the peri-implant bone 
response using MMA-embedded and paraffin-embedded sections. 
MMA-embedded specimens stained with methylene blue/basic fuchsin 
(MB/BF) showed no indications of an inflammatory response at the implant 
interface. MMA-embedded specimens showed new bone formation around and 
bone apposition to all experimental implants. The non-coated implants had 
apparently less new bone formation around the implant than the HAH, TCPH 
and TTCPH coated implants (Figure 6). 
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Figure 6. Representative histological sections (methylene 
blue/basic fuchsin stain) of the different experimental 
implants (non-coated, HAH, TCPH and TTCPH) after 6 
weeks of implantation in the femoral condyle of rabbits. 
 
 
Results from Elastica-van Gieson (EVG) staining performed on the paraffin 
embedded specimens showed bone formation and bone apposition around all 
coated implants (Figure 7A). Masson-Goldner staining showed presence of 
immature new bone tissue (osteoid; unmineralized; red staining) as well as 
mineralized bone tissue (blue staining) at all the implant-tissue interface 
(Figure 7B). Further, specimens displaying TRAP-positive staining contained 
osteoclast-like cells mainly close to the interface region of the implants (Figure 
7C). 
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Figure 7. Histological sections after 6 weeks of implantation in the 
femoral condyle of rabbits: A) Elastica-van Gieson stain of the different 
experimental implants (non-coated, HAH, TCPH and TTCPH). White 
area represents the original implant location; implants were removed 
for subsequent decalcification, paraffin-embedding and sectioning. B) 
Masson-Goldner stain at a higher magnification of the interface. C) 
Tartrate-resistant acid phosphatase positive staining at a higher 
magnification that shows the presence of osteoclast. 
 
 
Histomorphometry 
BIC data for the different experimental groups are shown in Figure 8A. The 
results of BIC measurements showed a similar response (values range: 60-69 
%) for all experimental coatings. 
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 Figure 8. A) Results of histomorphometrical analysis of BIC 
percentage measurements for the different experimental implants (non-
coated, HAH, TCPH and TTCPH). B) Peri-implant BV percentage 
measurements for the different experimental implants (non-coated, 
HAH, TCPH and TTCPH).  *p<0.05 C) Results of histomorphometrical 
analysis of osteoid-implant contact measurements of non-coated, HAH, 
TCPH and TTCPH. 
 
 
Peri-implant BV was measured for distinct zones in the peri-implant region 
(Figure 8B). Significantly higher peri-implant BV was observed in the vicinity 
of the implant surface of the inner zone 0-300 µm compared to middle 300-600 
µm for the HAH coating (difference 16.6 %, p < 0.05) and TTCPH coating 
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(difference 13 %, p < 0.05). Further, similar peri-implant BV were found 
between the groups for individual zones in the peri-implant region (p > 0.05). 
Osteoid-implant contact values were within a range of 38-46 % without 
significant differences between the 
experimental implants (Figure 8C). TRAP-
positive staining was present in 17 % of the 
sections of non-coated, 40 % of the 
sections of HAH, 60 % of the sections of 
TCPH, 75 % of the sections of TTCPH 
coated implants (Table 2). Although a 
higher percentage of TRAP-positive 
staining was found in coated than non-
coated specimens, no statistical differences were found  (p > 0.05). 
 
4. Discussion 
The aim of this study was to evaluate the effect of phase composition of 
different CaP-sputtered coatings prepared with different CaP target materials on 
i) in vitro dissolution, and ii) in vivo bone response. We hypothesized that CaP-
based target materials would lead to coating-specific dissolution/precipitation 
behavior in vitro and bone response in vivo. This study showed that the initially 
deposited coatings all have a similar apatitic structure based on XRD and FTIR 
analyses. However, when tested in vitro, the experimental groups showed 
Groups 
TRAP-positive 
presence 
pocentage 
Non-coated 17 % 
HAH 40 % 
TCPH 60% 
TTCPH 75 % 
Table 2. Percentage of 
specimens with TRAP-positive 
presence at the region close to 
the interface. 
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different dissolution/precipitation behavior. Furthermore, results from the in 
vivo test showed that despite similar BIC and peri-implant BV for all 
experimental implants, the presence of TRAP-positive staining in the peri-
implant region suggests an apparent increase in bone remodeling around the 
implant surfaces with increasing coating dissolution (i.e., TTCP > TCP > HA). 
In this study, sputtered coatings with specific CaP content and properties 
were obtained using various starting CaP targets with different stoichiometry 
(i.e., HA, β-TCP and TTCP). Phase purity of these targets was confirmed by X-
ray diffraction patterns. SEM examination showed that all as-sputtered and heat 
treated coatings had a homogenous and dense structure. XRD measurements 
revealed that all the as-sputtered coatings were amorphous. In accordance with 
previous studies, after an additional heat treatment, the XRD of all the sputtered 
coatings changed to a random apatite structure [26-28]. Ca/P ratios of all 
coatings were higher than initial Ca/P ratios of the corresponding target 
materials as demonstrated by additional ICP-OES measurements (Table 1). The 
higher Ca/P ratio of these coatings can be explained by preferential sputtering 
of calcium in growing films [27], and by the fact that orthophosphate ions are 
more volatile than calcium ions during sputtering and are pumped away before 
being deposited on the substrate [3, 27-29]. In particular, TCPH had a higher 
Ca/P ratio than expected, which may be due to more orthophosphate ions in 
TCP than in HA or TTCP. Although several studies have examined the 
properties of HA and β-TCP sputtered coatings [29-32], as far as the authors are 
CALCIUM PHOSPHATE CERAMICS FOR BONE REGENERATION 
 
118 
 
aware, only one study has been published dealing with TTCP sputtered coatings 
[19]. 
Solubility of the various types of coatings was investigated during in vitro 
incubation in SBF. Calcium and phosphate ion deposition and formation of a 
calcium phosphate layer when exposed to SBF are necessary to initiate the 
growth of bone-like apatite on biocompatible implants. Surface morphological 
differences were already observed for the TCPH and TTCPH coatings after two 
weeks of immersion indicating that precipitation had occurred. FTIR and XRD 
analyses revealed that the precipitate observed on the TCPH and TTCPH 
coatings was carbonate apatite, the amount of which increased with immersion 
time in SBF, while the HAH surface remained unchanged. Calcium and 
phosphate ions are released due to local surface dissolution of TCPH and 
TTCPH coatings, which supersaturates the SBF promoting apatite nucleation 
and subsequently apatite precipitation. This phenomenon was not observed for 
the HAH coating, but several studies of CaP precipitation have demonstrated 
that the dissolution rate of β-TCP and TTCP is higher than that of 
hydroxyapatite [33-35]. After heat treatment, a different calcium phosphate 
phase could be expected for each CaP coating given the initial differences in 
Ca/P ratio of the target material. However, XRD measurements revealed that 
the heat treatment only induced a random apatite structural formation for all the 
as-sputtered coatings. It could be argued that the energy during heat treatment 
requires adjustment for individual CaP phases to achieve a more crystalline 
phase for each coating type in the present study. Also, the differences in coating 
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dissolution are likely due to differences in atomic organization at the surface 
and the fraction of the as-sputtered CaP coating that was crystallized after the 
additional heat treatment. 
The chemical composition of the coating surface is important, because the 
implant surface is the level at which the bone healing process starts. The 
femoral condyle rabbit model was chosen for the in vivo study because of its 
fast healing response and for comparison with other studies performed in our 
laboratory [36]. Previous work using RF magnetron sputtering to prepare 
bioactive CaP coatings showed accelerated implant stability by promoting rapid 
implant to bone fixation in different animal models, using rabbits [36-38], goats 
[32,39,40] dogs [41-44], rats [45], and primates [46]. A recent study showed 
favorable effects of CaP sputter-coatings on the bone implant interface in an 
osteoporotic rat model [45]. However, in this study measurements of BIC 6 
weeks after implantation in the rabbit model showed no significant differences 
between CaP coatings and non-coated implants. Previous studies on BIC found 
similar results using the same animal model, coating technique, and 
implantation time [36,38]. Furthermore, there is no difference in BIC between 
HA coatings and uncoated implants according to a recent review by Surmenev 
(2012) on plasma-assisted CaP coatings fabrication methods [3]. Only one 
study has shown higher BIC for crystalline HA coated implants 6 weeks after 
implantation in femoral bone in rabbits compared to non-coated control 
implants [37]. To date, no studies have reported on TTCP-sputtered coatings 
upon in vivo implantation. The absence of an effect of the various CaP coatings 
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on BIC can be due to the chosen implantation time. After 6 weeks of 
implantation, bone healing in a rabbit will be almost completed. Therefore, it is 
recommended to include shorter implantation times in future studies to allow 
for the observation of a possible effect during the initial stage of implant-bone 
healing.  On the other hand, the results of this study showed differences in peri-
implant BV formation in the inner 0-300 µm compared to middle 300-600 µm 
for the HAH and TTCPH coatings. Furthermore, there is an apparent increase 
in TRAP-positive staining percentage, which represents the presence of 
osteoclast-like cells, with decreasing coating stability. These results on BV 
formation and TRAP-positive staining indicate that variation in coating 
chemistry influences bone remodeling process directly adjacent to the implant 
surface. 
Chemical composition and structural properties have been related with the 
osteoinductive capacity of CaP bulk ceramics in literature. The chemical 
composition is often the first coating parameter to be modified in studies. In a 
recent study, functionalized nanotopographic geometries on the surface of HA 
coated titanium implants were placed in heterotopic sites 47. Induction of bone 
formation and regulation of gene products were observed to be functions of 
substrate topography, which dictated biological patterns [47]. Ripamonti et al. 
[47] conducted their study in heterotopic intramuscular sites, while CaP 
coatings were implanted in bone tissue in the current study. The difference in 
implant location between the current study and Ripamonti et al. [47] makes 
direct comparison inappropriate. However, the results of the current study 
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suggest that varying CaP stoichiometry gives different degrees of bone 
remodeling. In view of the results of Ripamonti et al. [47], surface topography 
appears hierarchically superior to CaP stoichiometry for osteoinductive 
capacity of CaP-based ceramic coatings. However, supplementary chemical 
composition seems to represent a small but important approach to further 
influence peri-implant osteogenic processes. 
 
5 . Conclusion 
This study has shown that differences in Ca/P ratio in sputter targets 
influence dissolution and precipitate formation of the resulting CaP coatings 
when tested in vitro. The in vivo study showed that neither peri-implant BV nor 
BIC were significantly affected in relation to different CaP coatings. However, 
the presence of TRAP-positive staining in the peri-implant region suggests 
increased bone remodeling around CaP-based coatings with lower stability (i.e., 
TTCPH > TCPH > HAH > non-coated controls). Future research should focus 
on combining critical surface parameters, e.g. coating composition and surface 
topography, to optimize surface properties for bone implants. 
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1. Introduction 
Calcium phosphate (CaP) ceramic materials have large compositional 
similarity to the bone mineral phase and are known to allow direct 
physicochemical bonding with bone and to enhance bone tissue formation [1]. 
In view of their favorable biological performance, CaP ceramics are used as 
coatings on mechanically strong bioinert or biotolerant implants for load 
bearing applications (e.g. metallic joint prostheses and dental implants). 
Hydroxyapatite (HA; Ca10(PO4)6(OH)2) is the main CaP crystal used for 
surface-engineering in the form of a coating on metallic implants due to its low 
solubility in combination with the aforementioned biological properties [2-4]. 
The CaP ceramic itself as well as the coating deposition process strongly 
determine the coating properties [5-8]. Plasma-spraying is the most commonly 
used technique for the deposition of CaP ceramic coatings [9, 10]. Despite the 
simplicity and versatility of plasma-spray deposition, its poor control over 
physicochemical parameters, lack of coating thickness uniformity, and poor 
coating adhesion [10-12] have limited its range of applications. Consequently, 
alternative coating deposition methods have been explored. 
Radio frequency (RF) magnetron sputtering is an alternative coating 
deposition technique, which can generate dense, uniform, and well-adherent 
coatings on different substrate materials [13, 14]. For the deposition of CaP-
coatings, RF magnetron sputtering is based on the bombardment of a CaP target 
material with high energetic ions (accelerated by high voltage from an RF 
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source). Subsequently, atoms or small clusters of atoms of the CaP target 
material are ejected at a very high speed toward the substrate surface depositing 
a thin coating that is chemically bonded with the substrate [15]. The formation 
of the coating starts when arriving atoms and/or clusters diffuse across the 
surface, resulting in the formation of a continuously growing film with time on 
the substrate surface. Furthermore, RF magnetron sputtering provides strong 
CaP coating adhesion and control over coating thickness, composition, and, to 
some extent, coating structure. 
In view of the mismatch between material properties of the substrate 
versus coating, deposited CaP coatings usually show residual stress [16-18]. 
Residual stress may increase severely with increase in coating thickness. From 
an application perspective, high residual stress is related to increased 
dissolution, promotion of peeling or flaking of the coating, and reduced 
adhesive properties, all of which compromises long-term durability and 
reliability of HA coatings [19, 20]. In order to achieve high coating integrity, 
the residual stress should be controlled with processing methods such as heat 
treatment. 
This study aimed to evaluate the residual stress within an HA-coating 
deposited using RF magnetron sputtering via two different analyses, based on 
either the Stoney formula (i.e. based on curvature measurements of the 
substrate [21]) or the sin2 ψ method (i.e. based on X-ray diffraction patterns of 
the coating [22]). Additionally, the effect of HA-coating thickness (i.e. 1 or 4 
μm) on residual stress and surface topography were addressed. We 
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hypothesized that (i) both methods to determine residual stress would show 
similar results, and that (ii) thick coatings would increase residual stress 
compared to thin coatings. 
 
2. Materials and Methods 
 
 
2.1. Materials 
Silicon wafers (100) with 75 mm diameter were used as substrates for 
coating deposition; prior to deposition, silicon wafers were ultrasonically 
cleaned in acetone and ethanol. 
The target material used in the deposition process was hydroxyapatite 
(HA; Ca10(PO4)6(OH)2) granulate with a diameter of 0.5-1.0 mm 
(CAMCERAM®, CAM Bioceramics, Leiden, The Netherlands). 
 
2.2. Coating deposition technique 
Coatings were deposited using a commercially available RF magnetron 
sputter system (Edwards High Vacuum ESM 100 system, Crawford, England) 
[13, 15]. Wafers were mounted on a rotating and water cooled substrate holder. 
The distance between target and wafers was 80 mm. During deposition, argon 
pressure was kept at 5 x 10-3 mbar and a sputter power of 400 W was used. 
Coatings with two thicknesses were prepared, i.e. 1 and 4 µm thickness, The as-
deposited coating thickness was confirmed using strips cut from a silicon wafer 
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into pieces of 1 cm2 and placed right next to the wafers and analyzed with a 
Universal Surface Tester (UST, Innowep®, Würzburg, Germany).  
After deposition, all coated wafers were subjected to an additional heat 
treatment for 2 hours at 650 ºC at a temperature ramp of 100 ºC per hour (Quad 
Ellipse Chamber, Model E4- 10-P, Research Inc, Minnesota, United States). 
 
2.3. X-ray diffraction 
The crystallographic structure of the HA target material was determined 
by X-ray diffraction (XRD, Philips, PW3710, Eindhoven, The Netherlands) 
using CuKα-radiation (PW 3710, 40 kV, 30 mA), the diffraction scans were 
recorded between 20-36° 2θ with a step size of 0.02º 2θ and a sample time of 2 
s/step. The deposited coatings were analyzed by fixing the coated substrates at 
a position of 2.5º and scanning the detector between 20-70º 2θ with a step size 
of 0.02º 2θ and a sample time of 2 s/step. 
 
2.4. Atomic force microscopy  
Surface topography and surface roughness measurement of the coatings 
were examined using Atomic Force Spectroscopy (AFM, Nanoscope Illa, 
Bruker, Santa Barbara, CA, USA). The silicon wafers were scanned under 
ambient conditions and the AFM probe (RTESPA, Bruker) was made out of 
phosphorus doped Si and the tip had a pyramidal geometry with an end radius 
of 8 nm. The cantilever had a spring constant of 40 Nm
-1
 and a resonant 
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frequency of 338 KHz. The topographic measurements were done in tapping 
mode at three different locations for each sample. Nanoscope analysis software 
(version 1.4, Bruker) was used to analyze the root mean square surface 
roughness (Rq) and the arithmetic average roughness (Ra) values of the 
deposited coatings. The average roughness measurements were based on 3µm x 
3µm AFM images of the nanostructure CaP coatings. 
 
2.5. Stress measurements 
 
2.5.1. Substrate curvature technique 
The stress of the CaP coatings was evaluated by a substrate curvature 
technique; a detailed description of the apparatus used for this study is 
contained in a previous publication [23, 24]. 
In summary, the technique is based on observations made from wafer 
curvature radii measurements using two-laser beam setup. From this 
information the wafer curvature shift (1/R) can be calculated. Substrate 
curvature measurements were determined before coating deposition, as-
deposited and after heat treatment for n=3 substrates; these measurements 
showed the change of curvature of the wafer due stress in the coating. 
Subsequently, the average residual stress   through the entire coating 
thickness was calculated using Stoney’s formula: 
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where E is the Young modulus of the substrate, ν the Poisson’s ratio for the 
substrate, D the substrate thickness, d the coating thickness (assuming that d < 
D) and R the radius of curvature of the initial flat substrate after deposition of 
the coating [for Silicon (100) E/(1-ν) equals 180.5 GPa]. 
 
 
2.5.2. X-ray diffraction stress analysis 
In addition to substrate curvature measurements, the residual stress of the 
CaP deposited coatings was analyzed by the X-ray diffraction method. A 
Philips diffractometer with Cu Kα radiation, angle of incidence θ = 0.25 ° and a 
scan of 2θ = 20-70° was used to obtain the XRD patterns. An internal standard 
of silicon powder was dispersed onto the sputtered films to correct the observed 
diffraction angles for errors caused by small sample displacement. 
Residual stress was determined by measuring the interplanar spacing 
(dobs), which is the distance between two parallel planes of atoms in a 
crystalline material, of a given reflection along several different directions in 
the sample. Knowing the unstressed interplanar spacing (d0) of the CaP 
powders, the measured lattice spacing can be converted to strain components in 
the coating and the stress can be calculated. A modification of the sin 2Φ 
method [25], assuming a Poisson ratio (υ) of 1/3 gives the cos 2Φ method were 
a suitable value for the Young’s modulus (E) was assumed. The results are 
CALCIUM PHOSPHATE CERAMICS FOR BONE REGENERATION  
138 
 
shown as a straight line fitted to the lattice strain (dobs-d0)/d0 data points plotted 
as a function of cos 2Φ. 
 
2.6. Statistical analysis 
All statistical analyses were performed with GraphPad Instat® 3.05 
software (GraphPad Software Inc, San Diego, CA, USA), using Student’s t-
tests. Results were considered significant at p < 0.05. 
 
3. Results 
 
3.1. CaP target material 
The XRD pattern of the commercial HA powder is shown in Figure 1. 
Minimal line broadening was observed with the four largest crystal planes in 
the XRD pattern for the 002, 211, 112 and 300 reflections corresponding to 
25.99°, 31.89°, 32.29° and 33.03° 2θ, respectively. This diffractogram fully 
matched with the diffraction data of standard synthetic hydroxyapatite reported 
in the International Centre for Diffraction Data (ICDD), file 24-0033 (HA). 
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Figure 1. Diffraction pattern obtained using XRD for HA target material. 
 
3.2. CaP coatings structural and morphological characteristics 
XRD patterns of the as-deposited CaP coatings showed a crystalline 
structure with a preferred (002) crystallographic orientation, showing 
reflections peaks of 002, 102, 112 and 202 corresponding to 25.73°, 28.04°, 
31.93° and 33.83° 2θ, respectively (Figure 2; insert). Heat treatment at 650 °C 
hardly altered the crystallographic structure with the main reflection peaks at 
25.87°, 32.14° and 34.00° (Figure 2). With increasing coating thickness, higher 
relative peak intensities of the main diffraction peaks were observed. 
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Figure 2. XRD pattern of the as-deposited (insert) and heat treated HA 
coatings, with 1 and 4 µm thicknesses. 
 
Atomic force microscopy (AFM) was used to analyze surface morphology 
and surface roughness of the HA coatings. AFM results (Figure 3) showed that 
the surface morphology of HA coatings was different for coatings with 
different thicknesses. Thin 1 μm coatings presented a surface morphology 
characterized by relatively large globular elevations (~2-4 μm diameter) with a 
μm-scale spacing, whereas thick 4 μm coatings presented substantially smaller 
and sharper elevation (sub-μm scale) with sub-μm scale spacing. The roughness 
of both HA coatings  (Table 1) was in the nm-scale with Rq-values of 64.4 and 
32.2 nm, and Ra-values of 52.1 and 26.6 nm for coatings with a thickness of 1 
μm and 4 μm coatings, respectively. 
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Figure 3. Reconstructed 3-dimensional AFM images of HA coatings 
with a thickness of (A) 1 μm and (B) 4 μm after heat treatment at 650 
°C. 
 
Material Area Thickness (µm) Rq* (nm) Ra** (nm) 
HA 3 x 3 µm 
1 64.4 ± 22 52.1 ± 34 
4 32.2 ± 4 26.6 ± 3 
*root mean square roughness 
**arithmetic average roughness 
 
Table 1. Surface roughness data measured by atomic force 
microscopy over a fixed scan area of 3 x 3 µm for the HA 
coatings after heat treatment at 650 °C. 
 
3.3. Residual stress measurements 
Substrate curvature measurements were used to evaluate residual stress of 
the HA coatings after deposition and after heat treatment (Figure 4). Tensile 
stress was observed for the 1 µm as-deposited HA coating (76.5 ± 8.4 MPa), 
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whereas for 4 µm thick as-deposited HA coating the residual stress was 
compressive (-63.4 ± 6.3 MPa). Heat treated HA coatings of either 1 or 4 µm 
thickness both showed a tensile residual stress (i.e. 65.2 ± 5.4 MPa, 14.0 ± 10.3 
MPa, respectively). 
 
 
Figure 4. Residual stress for as-deposited and heat treated 1 
and 4 µm HA coatings. Data represent mean ± SD (n=3). 
Statistically significant differences (Student’s t-test) are 
indicated (asterisks represent significance levels; **p < 0.01, 
***p < 0.001). 
 
As an alternative, residual stress was determined using X-ray diffraction 
data using (dobs-d0)/d0 vs. cos 2Φ for the HA coatings with 1 and 4 µm thickness 
(Figure 5). The fit of the reflection data demonstrated the presence of 
compressive stress for as-sputtered HA coatings of both 1 and 4 µm. After heat 
treatment, the fit showed a decrease in compressive residual stress for HA 
coatings of both 1 and 4 µm. 
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Figure 5. Plot of (dobs-do)/do as a function of cos 2 Φ for the 
deposited HA coatings and after heat treatments at 650°C. A) HA-
coating with 1 µm thickness, B) HA-coating with 4 µm thickness. 
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4. Discussion 
The aim of this study was to evaluate the residual stress within an HA-
coating deposited using RF magnetron sputtering via two different analyses, 
based on either curvature measurements of the substrate or alterations in the X-
ray diffraction patterns of the coating. Additionally, the effect of HA-coating 
thickness (i.e. 1 or 4 μm) on residual stress and surface topography were 
addressed. We hypothesized that: (i) both methods to determine residual stress 
would show similar results, and (ii) thick coatings would increase residual 
stress compared to thin coatings. The main findings showed agreement of both 
residual stress measurement methods on the relaxation effect of heat treatment 
on residual stress for HA coatings. However, controversial results were 
obtained for as-deposited and heat treated HA coatings, for which residual 
stress determined via diffraction pattern alterations showed compressive 
residual stress for all coatings, whereas curvature measurements indicated 
tensile residual stress for all but the as-deposited 4 μm thick HA coating. 
Techniques to determine residual stress within coatings can be categorized 
into techniques based on (i) curvature measurements, (ii) crystallographic 
lattice parameters, and (iii) strain measurements after layer removal [22]. 
Evidently, all of these different techniques have their specific pros and cons. In 
terms of accuracy, lattice-based and layer removal techniques are generally 
considered superior to substrate curvature measurement techniques. Other 
differences relate to sample preparation and instrumentation, for which 
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accounts that time consumption and costs vary considerably for different 
techniques. For reasons of accuracy and availability, this study utilized a 
curvature measurement technique and a lattice-based technique. In view of the 
former, it is imperative to realize that the measurement is based on the 
distribution and magnitude of stresses within the coating-substrate couple, 
whereas the latter depends fully on the crystallographic characteristics of only 
the coating. Additionally, it needs to be emphasized that total stress within a 
coatings is the result of three separate contributing factors: external stress (due 
to potential external loading), thermally-induced stress (due to a mismatch in 
thermal expansion coefficients of substrate and coating material), and intrinsic 
stress (related to coating microstructure and the coating growth process) [26]. 
The build-up of a polycrystalline coating is known to be accompanied by 
different stages of stress within this coating [27]. Although this study did not 
utilize continuous in situ measurements for residual stress analysis, the 
differences in residual stress for HA coatings with a thickness of 1 and 4 μm 
clearly showed an effect of coating thickness on the type and magnitude of 
residual stress. Expectedly, residual stress analysis based on curvature 
measurements showed the largest differences related to thickness, with tensile 
residual stress for 1 μm as-deposited HA coatings and compressive residual 
stress for 4 μm as-deposited HA coatings. This difference can be explained by 
the differences in the increased sputtering time and the consequent increase of 
the bombardment of argon- and calcium phosphate ions on the growing HA 
film. This effect is known as ion shot peening, which induces defects, leading 
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to large compressive stresses [28, 29]. Remarkably, lattice-based determination 
of residual stress showed compressive residual stress for as-deposited HA 
coatings, irrespective of coating thickness. Although the nature of this 
discrepancy remains unclear, a likely explanation is the setup of the X-ray 
diffraction method with an angle of incidence of 2.5°. This low angle results in 
a precise analysis of the top-layer of the deposited HA coating, without 
measuring the substrate underneath. Consequently, the residual stress will be 
influenced by the contribution of above mentioned ion shot peening effect of 
the HA film and result in a different outcome compared to the curvature 
measurement. Further, our residual stress measurements showed values 
between 80 to -60 MPa, which can be considered as low values. 
As RF magnetron sputter deposition of HA coatings is performed at 
relatively low temperatures (i.e. <150 °C), the normal procedure for HA 
coatings deposited using RF magnetron sputtering is to utilize heat treatment 
for post-deposition annealing [30, 31]. The use of silicon wafers apparently 
makes that already as-deposited HA coatings have a highly crystalline lattice 
structure, whereas as-deposited HA coatings on titanium substrates generally 
show an amorphous apatitic structure. This difference is likely explained by 
differences in the thermal conductivity (λ, in W·m−1·K−1) of substrate materials 
and their thickness (silicon substrate, λ = 149 W·m−1·K−1, thickness = 0.36 mm; 
titanium substrate, λ = 21.9 W·m−1·K−1, thickness = 2 mm). Still, to comply 
with the regular procedure for HA coatings aimed for biomedical application, 
this study included a heat treatment at 650 °C. The effect of this (integral) heat 
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treatment induced relaxation of the residual stress within the coatings, for 
which substrate curvature measurement and lattice-based techniques to 
determine residual stress showed consistency. Additionally, our observations 
corroborate previously reported data on residual stress within HA coatings 
deposited using RF magnetron sputtering and the decreasing effects of heat 
treatment on this residual stress [32]. 
Surface morphology was clearly influenced by HA coating thickness, as 
an obvious change in surface morphology was observed with increasing coating 
thickness. These differences in surface morphology were demonstrated by a 
higher surface roughness for 1 µm HA coatings compared to 4 µm HA 
coatings. The presence of large globular particles on the 1 µm HA coating 
surface could be due to collision by high energy ions and melting of clusters or 
aggregates instead of atoms from the powder material to the silicon wafer. With 
an increase in coating thickness, and therefore sputtering time, the particles 
deposited would have more time to grow, coalesce, and become sharper 
producing a more homogeneous coating. In view of the already crystalline 
nature of as-deposited HA coatings on the silicon wafer, this increased 
exposure to peri-annealing temperatures might alter surface morphology toward 
smaller elevations at regular intervals, as was observed previously by Ong and 
co-workers [16].  
From a translational perspective with in mind the biomedical application 
of 3-dimensionally HA coated bone implants, several issues related to coating 
adhesion and residual stress are important. Firstly, the deposition of HA 
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coatings on extremely smooth silicon wafers is incomparable and adhesive 
properties thereof are completely different for deposition on rough, grit-blasted 
titanium implants. Aside from the difference in thermal expansion coefficient 
(α) for both substrate materials (silicon, α = 2.6 x 10-6 K-1; titanium, α = 8.6 x 
10-6 K-1) compared to HA (α = 17.1 x 10-6 K-1), presenting a 6.6-fold mismatch 
for silicon versus a 2-fold mismatch for titanium, the effect of surface 
roughness might even be more pronounced. The stability of an HA coating 
within the body (or simulating environments) is known to be affected by 
intrinsic properties (e.g. crystallinity) [33], but also by external conditions 
including the presence of aqueous liquids [33] and loading [32]. An increased 
surface roughness (e.g. resulting from grit-blasting) will particularly benefit HA 
coating stability under the latter external conditions for reasons of increased 
interfacial surface area for interaction between substrate and coating as well as 
mechanical interlocking. Finally, the fact that heat treatment reduces the 
residual stress within HA coatings contributes to the prevention of potential 
chipping of or crack formation within the coating. 
 
5. Conclusion 
HA coatings deposited using RF magnetron sputtering show residual 
stress within the coating, which can be reduced by a post-deposition heat 
treatment. Coating thickness variation in the micrometer scale showed no major 
effects on residual stress magnitude. For reasons of accuracy and similarity to 
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the actual conditions, determination of residual stress via lattice-based 
techniques is preferable. 
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1. Introduction 
Commonly employed biomaterials in bone tissue engineering and 
regenerative medicine include bioactive ceramics and glasses, natural and 
synthetic polymers and composites thereof [1]. In particular, calcium 
orthophosphates (CaPs) are the most widely investigated materials for the 
substitution of lost or damaged hard tissue due to their similarity to the 
inorganic phase of bone as well as excellent biocompatibility and bioactivity 
[2-4]. Noticeably, several CaPs recently were demonstrated to exhibit 
osteoinductive capacity, i.e. the ability to induce bone tissue formation at an 
ectopic location which in turn requires the differentiation of osteoprogenitor 
cells into bone-forming osteoblasts [5-7]. 
CaPs are available in a number of chemical compositions and 
crystalline phases, among which hydroxyapatite (HA), β -tricalcium phosphate 
(β -TCP) and biphasic HA/TCP ceramics are the most common for bone 
replacement. The bioactivity of these CaPs is strongly related to their solubility 
in the physiological environment, which increases with increasing amount of β-
TCP (i.e. β-TCP > biphasic CaP > HA) [2]. In addition to compositional 
effects, surface morphologies have been shown to affect biological 
performance [8, 9]. It is now clear that micro- and nanoscale morphologies of 
the CaP surface can strongly influence osteoblast and stem cell adhesion, 
proliferation and differentiation [10-12]. During the last decades, Ripamonti 
and co-workers extensively investigated the osteogenic effect of repetitive 
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surface concavities on either bulk ceramics [13] or CaP-coated titanium 
implants [14]. The starting hypothesis for these studies was that concavities, by 
resembling the hemi-osteon trench observable at different stages of 
osteoclastogenesis, are able to initiate the ripple-like cascade of bone induction 
and morphogenesis [15]. Actually, Ripamonti and co-workers found that the 
presence of concavities (diameter 800-1600 µm, depth 400-800 µm) strongly 
affected the osteoinductive capacity, noteworthy without the need for 
exogenous osteogenic soluble molecules [13]. More recently, Scarano et al. 
showed that 500 x 500 µm hemi-spherical concavities prepared at the surface of 
CaP-coated titanium implants inserted into the tibia of rabbits, led to a 
significant increase in bone formation inside the concavities compared to the 
convex areas [16]. 
Despite this increasing number of in vivo studies demonstrating a 
positive effect of concavities on osteogenesis, no attempts have been carried 
out in order to rationalize the mineralization process through in vitro tests. 
Consequently, the aim of the current study was to evaluate the role of 
concavities on the in vitro mineralization of different bioceramic materials. To 
this end, HA and β-TCP disks sintered at 1100 °C or 1200 °C were prepared 
with concavities of hemi-spherical shape with different diameters. 
Mineralization at the surface of these bioceramic disks upon immersion in 
simulated body fluid (SBF) for up to 28 days was assessed by means of 
scanning electron microscopy (SEM), Energy Dispersive Spectroscopy (EDS), 
X-ray Diffraction (XRD) and calcium quantification assays. Our starting 
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hypotheses were that (i) concavities prepared at the surface of bioceramic disks 
could effectively guide the surface mineralization process in vitro, and (ii) that 
concavity dimension represents a key parameter for controlling the extent of 
surface mineralization in vitro. 
 
2. Materials and Methods 
2.1 Fabrication of heat-treated calcium phosphate disks 
Ceramic disks were prepared from hydroxyapatite (HA, Merck, 
Germany) or β-tricalcium phosphate (β-TCP, CAM Bioceramics BV, The 
Netherlands) powder source materials. Powders were uniaxially pressed at 103 
MPa (15000 lb/psi) for 10 min in a cylindrical steel mold (internal diameter ~ 
21 mm). Subsequently, cylindrical HA and β-TCP green ceramics were heat-
treated in a furnace at 800°C for 6h (1.67°C/min) to provide suitable strength to 
the ceramic to withstand the stresses applied during the machining process. 
Subsequently, heat-treated HA and β-TCP cylinders were cut into disks 
(thickness ~4 mm, diameter ~21 mm). 
 
2.2. Role of composition and sintering temperature on mineralization onset 
For a preliminary evaluation of the role of chemical composition and 
sintering temperature on the onset of the mineralization process, drill tips with 
different diameter sizes (2.1, 1 and 0.5 mm, Horico, Germany) were used to 
prepare the hemi-spherical concavities (4 of each diameter) at the surface of 
CHAPTER 5 
 
157 
 
heat-treated HA and β-TCP disks (Table 1 and Figure 1a) of the following 
diameters: 1.8 mm (large concavities), 0.8 mm (medium concavities) and 0.4 
mm (small concavities). The center-to-center distance between similar 
concavities was set at twice the concavity diameter in order to display the 
maximum number of concavities on the same disk while minimizing possible 
mutual effects on the deposition of calcium phosphate. Subsequently, the disks 
were sintered in a furnace for 6h (1.67°C/min) at either 1100°C (HA11_LMS 
and TCP11_LMS; LMS: large, medium and small concavities) or 1200°C 
(HA12_LMS and TCP12_LMS). Freshly prepared, filter-sterilized simulated 
body fluid (SBF; pH 7.4, ionic composition: 142.0 mM Na+, 5.0 mM K+, 1.5 
mM Mg2+, 2.5 mM Ca2+, 147.8 mM Cl-, 4.2 mM CO3
2-, 1.0 mM HPO4
2- and 0.5 
mM SO4
2- was used to assess the surface mineralization capacity of the 
experimental CaP disks [17]. HA and β-TCP disks (n = 3 for each experimental 
group) were transferred into 6-well plates and immersed in SBF solution (10 
ml/well) for 7, 14, 21 and 28 days. The plate was kept at 37 °C while shaking 
moderately (1 Hz). Additionally, controls (n = 3) consisting of empty wells 
filled with only SBF were used for each time point in order to detect any 
homogeneous nucleation in the solution or heterogeneous nucleation on the 
walls of well plates. The SBF was changed daily, and the supernatant was 
collected to determine calcium levels using the ortho-cresolphthalein 
complexone (OCPC, Sigma-Aldrich) method. To this end, 100 µl of the 
supernatant was mixed with 100 µl of 1N acetic acid (Boom BV, Meppel, The 
Netherlands) and incubated overnight on a shaking table. Calcium 
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concentrations were calculated with respect to the controls (empty wells) and 
averaged for three samples per group. At 7, 14, 21 and 28 days, disks were 
removed from the SBF, gently washed with distilled water and dried at 40 °C 
for 24 hours. 
 
          Study 
CaP 
ceramics 
investigate
d 
Concavity 
dimension 
investigated 
Nº of 
concavities 
on each 
disk 
Distribution 
of 
concavities 
on each 
disk 
Sintering 
T 
Sample 
acronym 
Role of 
chemical 
composition 
and sintering T 
on 
mineralization 
process 
HA, β- 
TCP 
Large 
 (1.8 mm) 
Medium  
(0.8 mm) 
Small  
(0.4 mm) 
12 
4L + 4M + 
4S 
1100 °C 
1200 °C 
HA11-LMS 
TCP11-LMS 
HA12-LMS 
TCP12-LMS 
Role of 
concavity size 
on 
mineralization 
process content 
HA  12 
12L or 12M 
or 12S 
1200 °C 
HA12-L 
HA12-M 
HA12-S 
 
Table 1. Overview of the experimental setup 
 
2.3. Role of concavity dimension on mineralization process 
For the quantitative evaluation of the effect of concavity size on the 
mineralization process, a different surface geometry was adopted: 12 
concavities of either 1.8 mm, 0.8 mm, or 0.4 mm in diameter were prepared 
onto the surface of HA green ceramic disks heat-treated at 800 °C (Table 1 and 
Figure 1b). The center-to-center distance was set at 4 mm in order to maximize 
the distance between adjacent concavities. Finally, disks were sintered for 6h at 
1200°C (1.67°C/min). For surface mineralization experiments, 2 HA12 disks 
containing 12 surface concavities of large (HA12_L), medium (HA12_M) or 
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small diameters (HA12_S) were immersed in SBF for 14 days according to the 
protocol as described above. Additionally, the disks were weighed before and at 
the end of the experiment, after being gently washed with distilled water and 
dried at 40 °C for 24 h. 
Figure 1. Schematic representation of disks surface geometry employed in the 
current study. (a) Schematic distribution of the concavities at the surface of the 
disks for the preliminary experiment on the effect of chemical composition and 
sintering temperature on the mineralization process in vitro. For each size, 4 
concavities were prepared onto the surface of the disks: 1.8 mm (large 
concavity, L), 0.8 mm (medium concavity, M) and 0.4 mm (small concavity, S); 
the center to center distance was kept at twice the concavity diameter. (b) 
Scheme of the distribution of the concavities at the surface of the disks for the 
experiment on the effect of concavity size on mineralization process in vitro. 
Disks were machined with 12 concavities of the same size (L, M or S). 
 
2.4 Disk characterization 
The mineralization process on the surface of the CaP disks was 
followed through SEM, EDS and XRD analyses. Surface morphology and 
microstructure of the specimens were observed using a scanning electron 
microscope (JSM6310, JEOL, Japan operating at a accelerating voltage of 10 
CALCIUM PHOSPHATE CERAMICS FOR BONE REGENERATION 
160 
 
kV and a current ~ 10 mA) after coating the samples with a thin gold layer (5-
10 nm). The elemental analysis was carried out using a Scanning Electron 
Microscope (Philips XL30, the Netherlands) equipped with an Energy 
Dispersive Spectrometer (EDS, EDAX, AMETEK Materials Analysis Division, 
USA) at an accelerating voltage of 10 kV, a working distance of 10 mm and 
different magnifications. To improve the surface conductivity of the samples, a 
thin gold layer was deposited on the samples using a common sputtering 
instrument, which did not affect the measurement of the phosphorus content 
using EDS. The crystal phase composition of the specimens was characterized 
by means of a PW3710 X-Ray Diffractometer (Philips, The Netherlands, thin 
film configuration (fixed angle of incidence of 2.5 º), Cu Kα radiation, voltage 
40 kV, current 30 mA, step-size 0.02º 2θ, scanning speed 0.005 º 2θ/s and a 
sample time of 4s/step). 
 
2.5 Statistical analysis 
All quantitative data were expressed as mean ± SD and statistical 
analyses were performed with GraphPad® Instat 3.05 software (GraphPad 
Software Inc, San Diego, CA, USA), using one-way analysis of variance 
(ANOVA) with Tukey Kramer Multiple Comparison’s post-hoc tests. Results 
were considered significant at p < 0.05. 
 
3. Results 
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3.1 Role of chemical composition and sintering temperature 
The effect of sintering temperature on crystallite size in base materials 
and sintered disks is presented in Table 2. 
Material Temperature (°C) 2 θ Crystallite size (nm) 
HA powder - 25.888 44.3 
β-TCP powder - 25.822 46.6 
HA 1100 25.920 140.6 
HA 1200 25.885 151 
β-TCP 1100 25.801 140.5 
β-TCP 1200 25.856 262.9 
 
Table 2. Crystallite size of the ceramics used, obtained via de Scherrer 
equation. 
 
Initial evaluations focused on the effect of disk chemical composition 
and sintering temperature on the mineralization process in vitro. SEM images 
of the surface of HA and β-TCP disks containing four large, four medium and 
four small (LMS) concavities on their surface at different experimental time 
points are depicted in Fig. 2. After the first week of soaking in SBF, large CaP 
aggregates up to several hundred micrometers long were observed only within 
the concavities of HA12_LMS disks and not on the planar surface (Fig. 2a and 
b). In contrast, only small isolated CaP particles of about 1-5 m were detected 
on the planar surface of HA12_LMS disks (outside concavities; Fig. 2c). From 
the second to the third week of immersion in SBF, a globular CaP layer was 
formed inside concavities (Fig. 2d), while the planar surface between 
HA12_LMS disks was homogeneously covered with CaP after three weeks of 
soaking (Fig. 2e), which finally dissolved during the fourth week (Fig. 2f).  
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Figure 2. SEM evaluation 
of the mineralization 
process on HA and β-TCP 
disks sintered at 1100 °C 
and 1200 °C at different 
experimental time points. 
(a) low magnification 
image of the surface of 
HA12_LMS after week 1 
showing macroscopic 
CaP aggregates inside a 
large concavity; (b) 
detail of a CaP aggregate 
inside a large concavity of 
HA12_LMS after week 1; 
(c) planar surface between 
concavities at the surface of 
HA12_LMS after week 1; 
(d) small concavity at the 
surface of HA12_LMS 
completely filled by CaP 
between week 2 and 3; (e) 
planar surface between 
concavities at the surface of 
HA12_LMS after week 3; 
(f) low magnification image 
of the surface of 
HA12_LMS after week 4; 
(g) CaP aggregate inside 
small concavity at the 
surface of HA11_LMS after 
week 1; (h) CaP aggregate 
inside medium concavity at 
the surface of HA11_LMS 
after week 3; (i) small CaP 
aggregate inside small 
concavity at the surface of 
TCP12_LMS after week 1; 
(j) medium concavity surface of TCP12_LMS after week 3; (k) small concavity 
surface of TCP11_LMS after week 1; (l) medium concavity surface of 
TCP11_LMS after week 3.  
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Analysis of the HA11 samples revealed no formation of such globular 
layer, but only the presence of CaP aggregates inside large, medium and small 
concavities and not at the planar surface at any of the experimental time points 
(Fig. 2g,h). Less and smaller aggregates were found inside concavities of 
TCP12_LMS (Fig. 2i,j), whereas hardly any CaP aggregates were detected 
within the concavities of TCP11_LMS disks (Fig. 2k,l). Further, the surface of 
TCP11_LMS showed partial degradation after three weeks of soaking in SBF, 
as evidenced by the decreased intensity of machining features inside 
concavities, whereas the surface of TCP12_LMS was only slightly changed and 
the surfaces of HA11_LMS and HA12_LMS retained their original appearance. 
Calcium quantification analysis revealed that all experimental disks 
induced calcium uptake during immersion in SBF (Fig. 3). Similar calcium 
uptake profiles were observed for TCP11_LMS and TCP12_LMS; a 
significantly (p < 0.001) higher calcium uptake was observed for HA11_LMS 
compared to the calcium uptake of the β-TCP disks, whereas the largest 
calcium uptake was observed for HA12_LMS. From the second week onward, 
a significant difference (p < 0.001) between the calcium uptake of HA12_LMS 
and HA11_LMS was observed. The final cumulative calcium uptake for 
HA12_LMS was 2-fold higher compared to the uptake for HA11_LMS and 
4.6- and 5.4-fold higher compared to the uptake for TCP12_LMS and 
TCP11_LMS (p < 0.001). Due to the observed superior ability to induce 
surface mineralization for HA12_LMS, further studies were carried out using 
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HA12_LMS disks in order to rationalize the mineralization process and the 
effect of concavity size on CaP mineralization at the surface. 
 
Figure 3. Calcium uptake of TCP11_LMS, TCP12_LMS, HA11_LMS and 
HA12_LMS disks during SBF immersion. Each data point represents the 
average and standard deviation of values obtained from three disks (n=3): (a) 
significantly different compared to TCP11_LMS within the same experimental 
time; (b) significantly different compared to TCP12_LMS within the same 
experimental time; (c) significantly different compared to HA11_LMS within 
the same experimental time; (*) significantly different compared to the same 
group (same disk type) between one experimental time and the previous one. 
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3.2 Mineralization process 
SEM and XRD analyses were performed to follow the onset of the 
mineralization process. SEM images of CaP deposition onto HA12_LMS disks 
after different immersion times in SBF are presented in Fig. 4. The large 
aggregates found within concavities after the first week of immersion were 
composed of micron-sized CaP spherical-like cohesive particles (Fig. 4a).  
EDS analysis (Fig. 5a) revealed a molar ratio of calcium to 
phosphorus (Ca/P) of 1.9-2.0 for these CaP spherical-like particles. At two 
weeks immersion in SBF, a globular CaP deposition layer grew within the 
concavities that gradually covered the underlying spherical-like CaP particles 
(Fig. 4b and c). This globular CaP deposition layer was composed of ~ 50 nm 
thick crystals (Fig. 4d) with a Ca/P ratio of 1.4-1.5 arranged into a reticular 
porous structure. EDS analysis (Fig. 5b) revealed a slightly higher atomic % of 
carbon (C; ~ 15%) compared to spherical-like particles (9–10%), next to small 
amounts of sodium (Na; 1-1.5%) and magnesium (Mg; 1-1.1%) and traces of 
potassium (K; < 1%) and chlorine (Cl; <1%). SEM images presented in Fig. 4e 
and 4f, show two small concavities on the same HA12_LMS disk after a 2-
week incubation period in SBF completely filled by the globular CaP. 
Specifically, in Fig. 4e initial outgrowth of CaP from the concavity can be 
detected (black arrows), while in Fig. 4f the globular CaP was already spread 
over the planar surface close to the concavity (black head arrows show the 
directions of the CaP outgrowth).  
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Figure 4. SEM images of different morphologies of CaP deposits on 
HA12_LMS disks observed during SBF immersion. (a) Detail of the spherical-
like structure of a CaP aggregate (large concavity, week 1); (b) Transition 
phase between the spherical-like and the globular macro-porous structure 
(medium concavity, week 3); (c) globular CaP deposits (medium concavity, 
week 3); (d) detail of globular CaP deposits (medium concavity, week 3); (e) 
small concavity completely filled by globular CaP deposit (week 3); arrows 
indicated the initial outgrowth of CaP outside the concavity; (f) spreading of 
CaP deposits outside a small concavity onto the planar surface (week 3, same 
disk of (e)); arrowheads indicate the outgrowth direction of the CaP outside the 
concavity on the planar surface. 
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Figure 5. EDS and XRD spectra of HA12_LMS. (a) EDS spectrum of 
spherical-like CaP deposits; (b) EDS spectrum of globular CaP deposits; (c) 
XRD spectra diffractograms of HA12_LMS at different SBF soaking times: 0 
(i), 7 (ii), 14 (iii), 21 (iv) and 28 (v) days; (d) detail of the XRD diffractograms 
spectra of (c) between 31 and 33.5 °. 
 
XRD diffractograms of HA12_LMS after different SBF immersion 
times are presented in Fig. 5c. The intensity of all main reflection peaks of the 
diffractogram of HA12_LMS virgin disks decreased from week 0 (before 
soaking) to week 1, until a minimum was reached at 2 and 3 weeks. After a 4-
week SBF immersion period, the spectrum showed an increase in intensity 
again. Fig. 5d shows the HA12_LMS diffractograms between 31°-33° 2θ 
((211), (112) and (300) crystal planes), where the main hydroxyapatite peaks 
can be found, in order to observe the above-mentioned behavior in more detail. 
Several secondary reflection peaks were observed between 43 °- 46 ° 2θ ((113), 
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(400) and (203) crystal planes) corresponding to the CaP deposited on the 
disks. The intensity of these peaks corresponding to the deposited CaP 
increased from week 0 to week 3, followed by a decrease at week 4. 
 
3.3 Role of concavity dimension on SBF mineralization 
In order to quantify the effect of concavity dimension on CaP 
nucleation in vitro, HA12_L, HA12_M and HA12_S disks were soaked in SBF 
at 37 °C for 14 days and characterized for morphology, crystal phase and 
calcium uptake. The final time point of 14 days was selected in order to study 
the mineralization process before the spreading of CaP deposits over the planar 
surface of the disks. Fig. 6 displays representative SEM images of the 
concavities of HA12_L, HA12_M and HA12_S after a 2-week immersion 
period in SBF. From detailed SEM investigation, it was observed that nearly all 
(23 out of 24, 96 %) of the concavities at the surface of HA12_S disks were 
filled with spherical-like CaP. In contrast, filling of concavities at the surface of 
HA12_M and HA12_L disks were only partially or scarcely filled with CaP 
deposits, respectively. Similar to the results described above, substantial CaP 
aggregates were only observed inside concavities and not at the planar surface. 
This absence of a planar surface CaP layer was confirmed by XRD spectra of 
HA12_L, HA12_M, and HA12_S, which did not show differences between the 
various experimental disks or as compared to the non-soaked HA12 control 
samples (data not shown). 
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Figure 6. SEM images of large, medium and small concavities at the surface of 
HA12 disks after 14 days immersion in SBF. Top view SEM images of large 
cavities (top), medium cavities (middle) and small cavities (bottom) on 
HA12_L, HA12_M and HA12_S respectively, after 14 days of immersion in 
SBF at 37°C. Representative concavities for each dimension are displayed. 
Panels on the right show magnifications of the mineralization inside the 
concavities. 
 
 
Differences in the extent of calcium uptake by HA12_L, HA12_M, 
and HA12_S revealed a clear effect of the concavity dimension on the extent of 
mineralization (Fig. 7a). Calculated amounts of calcium uptake relative to the 
concavity volume are presented in Table 3. The total calcium uptake of 
HA12_S was ~ 1.7- and ~ 1.8-fold higher compared to HA12_M and HA12_L, 
respectively. Direct weight measurements of the disks before and after the SBF 
immersion experiment revealed a weight increase (ΔW) of 0.36 % for HA12_S, 
a weight increase of 0.33 % for HA12_M, and a weight increase of 0.24 % for 
HA12_L. The total calcium uptake per volume unit (Ca/mm3, calculated by 
assuming that all CaP was deposited in the concavities) of the concavities of 
HA12_S (Fig. 7b) was ~ 123- and ~ 10-fold higher compared to HA12_L (S/L) 
CALCIUM PHOSPHATE CERAMICS FOR BONE REGENERATION 
170 
 
and HA12_MC (S/M), respectively, whereas ΔW per volume unit of the 
concavities (mg mm3) of HA12_S was ~109- and ~7-fold higher compared to 
HA12_L (S/L) and HA12_MC (S/M), respectively. 
 
4. Discussion 
The aim of this study was to evaluate the effect of surface concavities 
on the surface mineralization of different CaP ceramics in vitro. Our hypothesis 
was that concavities prepared at the surface of bioceramic disks (i) could 
induce surface mineralization in vitro, as surface concavities have been 
previously demonstrated to induce bone formation at ectopic locations in vivo 
[13], and (ii) that concavity dimensions affect the extent of surface 
mineralization. The results of this study clearly demonstrated a strong effect of 
both disk chemical composition (HA > β-TCP) and sintering temperature (1200 
°C > 1100 °C) on CaP deposition from SBF. Further, it was shown that CaP 
deposition was initiated exclusively within concavities and not on the planar 
surface of the disks. Finally, concavity dimensions showed a strong effect on 
surface mineralization with a 4-fold reduction of concavity dimensions 
resulting in a ~123-fold increase of calcium uptake. 
The results of the present study showed that only HA disks sintered at 
1200 °C supported abundant CaP deposition. Sintering has a strong effect on 
the density, grain size, porosity, crystalline phases and surface charge of 
ceramics [18, 19]. HA sintered at lower temperature is known to be composed 
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of grains of smaller size, thus exhibiting a higher porosity and lower 
crystallinity compared to HA sintered at higher temperature [19]. 
Consequently, it can be envisaged that dissolution rates were higher for 
HA11_LMS compared to HA12_LMS, which in turn limited the extent of 
nucleation and growth of stable CaP aggregates for HA11_LMS compared to 
HA12_LMS. Similarly, the faster dissolution of β-TCP surface compared to 
HA most likely prevented nucleation of stable CaP nuclei, despite locally (i.e. 
at the surface) increased ionic concentrations of calcium and phosphate ions. β-
TCP disks sintered at lower temperature were even more unstable, as partial 
degradation of the surface without CaP nucleation on the surface was observed 
for these disks, corroborating previously reported results [20]. 
The results of the present study suggest the occurrence of a two-step 
mineralization process on the HA disks heat treated at 1200 °C, represented by 
an initial aggregation of spherical-like CaP particles within the concavities (no 
large aggregates were found on the planar surface of the disks), which were 
subsequently replaced by a globular-like CaP phase consisting of crystals 
arranged into a reticular macro-porous structure, exhibiting a chemical 
composition which resembled the the inorganic phase in bone tissue more 
closely  [21]. At this stage of complete filling of small concavities, globular 
CaP started to spread out from the concavities, ultimately coverage the planar 
surface of the disks completely, as suggested by SEM images like Figs. 4e and 
4f. The formation and subsequent dissolution of the globular CaP coating on 
the HA12 disk surface could also be monitored by XRD analysis: specifically, 
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the intensity of the main peaks of the HA substrate decreased with soaking 
time, indicating the establishment of a layer of lower crystallinity on the surface 
of the disks that limited x-ray diffraction from the more crystalline underlying 
substrate; after week 4, peak intensity increased again toward the starting 
conditions, which most likely suggests a partial re-dissolution of the globular 
CaP layer. 
Concavities resemble the hemi-osteonic trenches (from few to several 
hundreds of micrometers) generated during osteoclastogenesis [22, 23]. The 
effect of concavities on bone growth in ectopic extra-skeletal sites in vivo has 
been already well-documented [24], whereas no study attempted to rationalize 
this phenomenon in vitro.  
The results of the current study evidenced a very strong templating 
effect of surface concavities on CaP surface mineralization, whereas no 
significant CaP deposition occurred on planar surface. Although no solid 
explanation could be found yet to account for this intriguing phenomenon, we 
speculate that supersaturation with respect to calcium and phosphate ions 
increased with decreasing curvature of the concavity according to the 
Thompson-Freundlich equations [25]. In addition, flow rates of the incubation 
media were lower within concavities compared to the planar surface, thereby 
allowing for a further local up-concentration of Ca2+ and PO4
3- ions within the 
concavities. 
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Figure 7. Quantification of the mineralization process at the surface of HA12 
disks after 14 days immersion in SBF. (a) Cumulative calcium uptake for 
HA12_L (rhombus), HA12_M (triangle) and HA12_S (square) after 14 days 
immersion in SBF. (b) Graph showing the calcium uptake per concavity volume 
unit of the disks normalized to the uptake of HA12_L (left bars, log scale) and 
the weight variation for concavity volume unit of the disks normalized to the 
uptake of HA12_L (right bars, log scale). 
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Concavity 
diameter 
(mm) 
Mean 
disk 
surface 
area  
(mm
2
) 
SBF vol. 
to surf. 
area  
(ml/mm
2
) 
Vol. of 1 
concavity 
(mm
3
) 
Vol. of 12 
concavities 
(mm
3
) 
Total 
Ca 
uptake 
(mg) 
Ca uptake 
per 
concavity 
vol. 
(mg/mm
3
) 
ΔW 
(mg) 
ΔW per 
concavity 
vol. 
(mg/mm
3
) 
LC 
1.79 ± 
0.03  
376 ± 
39 
0.027 ± 
0.003 
1.5  
± 0.1 
18  
± 2 
25 
± 3 
1.4 
± 0.3 
5.0 
± 
0.2 
0.28 
±0.04 
MC 
0.80 ± 
0.02   
352 ± 
35 
0.028 ± 
0.003 
0.13 ± 
0.01 
1.6 
 ± 0.1 
27 
± 2 
17± 
3 
7.1 
± 
0.2 
4.4 ± 
 0.5 
SC 
0.44 ± 
0.01  
348 ± 
34 
0.029 ± 
0.003 
0.022 ± 
0.001 
0.27 
 ±0.01 
46 
± 2 
172 
± 14 
8.1 
± 
0.2 
30.5 ± 
 0.09 
LC = Large concavity; MC = Medium concavity; SC = Small concavity; ΔW = (Weight)final – 
(Wight)initial 
 
Table 3. Quantification of the in vitro mineralization process. 
 
Accordingly, smaller concavities were able to induce more 
mineralization than larger concavities also due to the more static 
microenvironment of the concavities, which in turn lead to an accelerated 
increase of local ionic concentrations of Ca2+ and PO4
3-
 compared to larger 
concavities, where higher flow rates are expected due to the larger size. Finally, 
since mineralization is a unique process involved in bone tissue formation, the 
herein presented data represent a first attempt to link mineralization to 
osteoinduction, which by itself is a completely novel approach. 
 
5. Conclusions 
The results of the present study showed that the in vitro surface 
mineralization process of CaP ceramics with surface concavities starts 
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preferentially within the concavities and not on the planar surface of the 
ceramics, indicating a strong templating effect of the concavities on CaP 
surface mineralization. Further, concavity dimensions revealed to be an 
extremely effective parameter for controlling the extent of in vitro surface 
mineralization with small concavity dimensions resulting in considerably 
increased surface mineralization. 
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6 
INFLUENCE OF CERAMIC 
DISK MATERIAL, 
SURFACE HEMISPHERES, 
AND SBF VOLUME ON IN 
VITRO MINERALIZATION 
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1. Introduction 
Calcium phosphate (CaP) ceramics closely resemble the inorganic 
component of bone and teeth and hence have been extensively investigated 
synthetic materials for bone regenerative applications. As a major asset, 
surfaces of synthetic CaP implants have the capacity to chemically bond with 
surrounding osseous tissue [1,2]. Biological properties of CaP materials upon 
implantation in bone tissue, such as osteoconductivity [3] (i.e. the process by 
which bone conforms to a material’s surface) and bioactivity [4-6] (i.e. the 
ability to stimulate bone tissue formation and directly bond to bone without an 
intervening soft tissue layer), are related to their physicochemical properties, 
for which both CaP chemistry and crystallinity are key factors. 
Bioactive behavior of a material surface is generally tested 
predictively in vitro using Simulated Body Fluid (SBF) [7-9]. During such a 
test, partial dissolution of CaP materials with subsequent nucleation and re-
precipitation on the surface can occur, which is suggested to be predictive for 
actual in vivo bioactive behavior and bone bonding ability [10]. Additionally, it 
is known that the formed carbonate apatite layer creates an ideal environment 
for cellular attachment and subsequent new bone formation that has strong 
bonding to the material surface [11,12]. 
Although the use of SBF as an in vitro test for examining bone 
bonding potential is widely accepted, some researchers have argued its 
predictive validity [13] and efforts have been made to improve the current 
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protocol [14]. According to Bohner et al., the protocol needs to have a simple 
SBF preparation procedure able to mimic the main features of blood serum and 
results of in vivo and in vitro test must correspond [14]. Furthermore, Bohner et 
al. claimed that a change of volume or sample size is expected to modify the 
rate of apatite formation [14]. Kokubo et al. [15] suggested to calculate the 
volume of SBF following the equation VS  = Sa / 10, (where Vs is the volume of 
SBF in ml and Sa is the apparent surface area of the specimen). However, the 
optimal SBF volume ratio remains unclear and variations in experimental set-
up could provoke changes in results. 
In a previous study, we assessed the surface mineralization process 
through an in vitro test in SBF and surface concavities were used as additional 
parameter to CaP chemistry and cristallinity [16]. The study showed that 
mineralization started preferentially within concavities in hydroxyapatite (HA) 
disks sintered at 1200 °C and that concavity size controlled the extent of 
mineralization. In the current study, we focused on how SBF volume variations 
(i.e., material liquid/ratio) influence the rate of apatite formation. Using 
titanium (Ti) disks, we anticipated to be able to differentiate between effects of 
material chemistry (initiation of nucleation due to release of Ca2+ and PO4
3- ions 
from the material) and surface geometry and nucleation induced by concavity 
roughness. 
In the current study, four different materials (i.e., HA, β-tricalcium 
phosphate [β-TCP], biphasic calcium phosphate [BCP] and titanium [Ti]) were 
used in which hemispherical surface concavities were created. Nucleation and 
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crystal growth was assessed after immersion of the samples in SBF up to 14 
days by means of calcium assay and scanning electron microscopy (SEM). It is 
known that CaP disks, immersed in SBF, release calcium and phosphate ions 
into the medium at a rate dependent on the solubility and Ca/P ratio of the 
ceramic. In view of this, we hypothesized that smaller SBF volumes would 
more rapidly increase the concentration of ionic species within the SBF 
solution compared to larger volumes, thus accelerating nucleation and re-
precipitation on the CaP material surface compared to a titanium surface. 
 
2. Materials and Methods 
Materials 
HA (Ca/P molar ratio 1.67; Merck, Darmstadt, Germany) and β-TCP 
(Ca/P molar ratio 1.50; CAM Bioceramics b.v., Leiden, the Netherlands) 
commercial powders were used in this study (Table 1). 
 
Nomenclatur
e 
Abbreviatio
n 
Chemical 
Formula 
Theorica
l 
Ca/P ratio 
Solubilit
y 
-log(Ks)
a
 
Hydroxyapatite HA 
Ca10(PO4)6(OH)
2 
1.67 116.8 
β-Tricalcium 
phosphate 
β-TCP Ca3(PO4)2 1.50   28.9 
a
 The solubility at 25°C in water is given as the 
logarithm of the ion product of the given 
formulas with concentrations in mol/l 
31
. 
 
Table 1. Chemical composition, Ca/P molar ratio and solubility in aqueous 
solutions of the calcium phosphate powder materials 
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Also, custom-made commercially pure titanium disks (16 mm diameter, 3 
mm height; Machinefabriek G Janssen, Valkenswaard, the Netherlands) with 
twelve hemispheres (400 µm diameter x 200 µm height) arranged over the 
surface were used for the study. 
 
Preparation of ceramic disks 
HA and β-TCP powders were solid state mixed with a weight ratio of 
50:50 to obtain biphasic calcium phosphate  (BCP) powder (composition of the 
experimental groups is shown in Table 2). 
 
 
 
 
Table 2. Composition of prepared disks. 
 
Ceramic powders (HA, β-TCP and BCP) were uniaxially pressed at 
103 MPa (15,000 psi) for 10 min in a cylindrical steel mold (internal diameter 
~21 mm). After pressing, the blocks were heat treated in a furnace at 800°C for 
6 h (1.67°C min-1) to provide suitable strength to the ceramic to withstand the 
stresses applied during machining. Subsequently, heat-treated blocks were cut 
into disks (21 x 4 mm). A drill tip with a diameter size of 500 µm (Horico, 
Berlin, Germany) was used to create twelve hemispherical concavities across 
 HA (wt %) TCP (wt %) 
HA 100 0 
β-TCP 0 100 
BCP 50 50 
Ti 0 0 
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the surface of the disks with a center-to center distance of 4 mm between 
hemispheres (Figure 1). Subsequently, disks were sintered in a furnace for 6 h 
(1.67°C min-1) at 1200°C, resulting in reduced disk dimensions (16 mm 
diameter, 3 mm height) as well as reduced hemisphere sizes (400 µm diameter x 
200 µm height). 
 
Figure 1. Schematic representation of disk surface geometries employed in the 
current study. Twelve hemispherical concavities were made on the surface of 
the disk with a hemisphere radius value of 200 µm. 
 
X-ray diffraction 
The crystallographic structure of the CaP ceramics was studied by 
thin-film X-ray diffraction (XRD, Philips, PW3710, Eindhoven, the 
Netherlands) using CuKα-radiation (PW 3710, 40 kV, 30 mA). The phase 
composition of the powder materials was determined by X-ray diffraction 
(XRD), diffraction scans were recorded between 10° 2θ to 50° 2θ with a step 
size of 0.02º 2θ and a sample time of 6 s/step. The crystal structure of the disks 
after sintering at 1200°C was analyzed and diffractograms were collected for 2θ 
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values between 10º and 50º with a step size of 0.02º 2θ and a sample time of 2 
s/step. 
 
Scanning electron microscopy 
The surface morphology and microstructure of the ceramic and Ti 
disks were observed using a scanning electron microscope (SEM, Jeol, 
SEM6310, Tokyo, Japan) with an electron accelerating voltage of 10 kV and a 
current of  ~10 mA. All SEM samples were sputter-coated with a thin, gold 
layer (5-10 nm) to minimize negative charge accumulation from the electron 
beam during scanning. A working distance of 10 mm was used for the scans. 
 
SBF studies and assessment of the mineralization process 
Freshly prepared filter-sterilized simulated body fluid (SBF) [15] was 
used throughout the study to determine the surface nucleation and crystal 
growth of the experimental disks. All disks (Table 2; n = 3 for each 
experimental group), with the side containing the hemispherical concavities 
facing up, were incubated for 14 days into 50 ml sterile conical centrifuge tubes 
(one disk per tube) (Greiner Bio-One, Berlin, Germany) filled with SBF 
solution (5, 10 or 20 ml per tube). The tubes were tightly closed with a tube cap 
to minimize evaporation during incubation and kept at 37°C on a shaking table 
(1 Hz). Additionally, controls (n = 3) consisting of empty tubes filled with only 
SBF were used for each time point in order to detect any homogeneous 
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nucleation in the solution or heterogeneous nucleation on the walls of well 
plates. The SBF was daily refreshed, and the supernatant was collected to 
determine calcium levels using the ortho-cresolphthalein complexone (Sigma–
Aldrich, St. Louis, MO, USA) method. To this end, 100 µl of the supernatant 
was mixed with 100 µl of 1 N acetic acid (Boom BV, Meppel, the Netherlands) 
and incubated overnight on a shaking table. The amount of calcium uptake by 
the disk was calculated with respect to the controls (SBF in empty tubes) and 
averaged for three samples per group. At 14 days, disks were removed from the 
tubes, gently washed with distilled water and dried at 40°C for 24 h. 
Subsequently, the surface of the studied disks was observed using SEM 
analysis. 
 
Statistical analysis 
All statistical analyses were performed with GraphPad Instat® 3.05 
software (GraphPad Software Inc, San Diego, CA, USA), using analysis of 
variance (ANOVA) combined with a post-hoc Tukey-Kramer Multiple 
Comparisons Test. Results were considered significant at p < 0.05. 
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3. Results 
Characterization of starting powders 
The starting HA and β-TCP ceramic powder materials were 
characterized using XRD in order to confirm their phase composition before 
disk preparation. Figure 2 shows peak position and relative peak intensities for 
the HA and β-TCP powders that correspond closely to those indicated in the 
International Center for Diffraction Data (ICDD) data file no. 09-0432 (HA) 
and no. 70-2065 (β-TCP). The main characteristic peaks associated with HA 
were assigned to the 002, 102, 210, 211, 112, 300 and 202 reflections 
corresponding to 25.9°, 28.1°, 28.9°, 31.9°, 32.2°, 33.0° and 34.1° 2θ values. 
For β-TCP, a series of sharp characteristic diffraction peaks were observed at 
25.7°, 27.7°, 31.0°, and 34.3° 2θ values, corresponding to the crystal planes of 
1010, 214, 0210 and 220 respectively. 
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Figure 2. Diffraction patterns obtained using XRD for calcium phosphate 
starting ceramic powder materials. A) HA powder with main characteristic 
peaks assigned to the 002, 211, 112 and 300 reflections. B) β-TCP powder with 
main characteristic peaks assgned to the 1010, 214, 0210 and 220 reflections. 
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Characterization of prepared CaP disks 
The apatitic nature of prepared CaP disks was revealed by XRD 
analysis. HA disks showed an XRD pattern with main reflection peaks at 25.9°, 
31.9°, 32.4 and 33.2° 2θ corresponding to the  
002, 211, 112 and 300 reflections, respectively (Fig. 3a). β-TCP disks showed a 
strong reflection at 2θ values of 27.7°, 31.0° and 34.2° corresponding to 214, 
210 and 220 reflections for β-TCP, respectively. BCP ceramic disks had a 
biphasic structure consisting of HA and β-TCP, illustrated by main diffraction 
peaks at 25.9°, 28.9, 31.9°, 32.4° and 33.2° 2θ corresponding to the 002, 210, 
211, 112 and 110 reflections for HA, respectively, and diffraction  
peaks at 2θ values of 27.7°, 31.1° and 34.2° corresponding to 214, 0210 and 
220 reflections for β-TCP, respectively. 
  
CALCIUM PHOSPHATE CERAMICS FOR BONE REGENERATION 
192 
 
 
Figure 3. XRD pattern of the sintered ceramic disks produced from the ceramic 
powder materials. A) HA disk sintered at 1200 °C B) β-TCP disk sintered at 
1200 °C and C) BCP disk sintered at 1200 °C.  
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Influence of SBF volume on mineralization 
The surface area of the disks used in this study was 202.9 mm2. Each 
disk had 12 hemispherical concavities at its surface (one side only). The 
volume of SBF was calculated following Kokubo’s equation [15]: 
 
Vs = Sa / 10 
 
where Vs is the volume of SBF (ml) and Sa is the apparent surface area of the 
specimen (mm2). Using Kokubo’s equation, an approximate value of 20 ml of 
SBF per disk is required. In the current study, 5, 10, and 20 ml were selected 
for the experiments based on our initial hypothesis. 
All disks were immersed in parallel in different SBF volumes (i.e., 5, 
10, or 20 ml) at 37°C for 14 days (Figure 4). Ti and CaP disks immersed in 
either 5 or 20 ml of SBF showed very low calcium deposition on their disks 
surfaces. Calcium amounts deposited on the disks reached 4.3 ± 2.5, 1.1 ± 0.7, 
0.6 ± 0.5 and 0.3 ± 0.8 mg for HA, TCP, BCP and Ti, respectively, for 5 ml 
volumes after 14 days immersion in SBF. Significantly higher calcium 
deposition was observed for HA vs. Ti disks (p < 0.05), TCP vs. Ti (p < 0.01) 
and BCP vs. Ti (p < 0.05). Calcium uptake deposited on the disks reached 5.9 ± 
2.5, 9.2 ± 2.6, 8.8 ± 1.6 and 3.3 ± 2.0 mg for HA, TCP, BCP and Ti, 
respectively, for 20 ml volume after 14 days immersion in SBF.  
Significantly higher calcium deposition was observed for TCP vs. Ti 
disks (p < 0.05). In contrast, the cumulative calcium uptake after a 14 days 
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immersion period in 10 ml of SBF reached 41.6 ± 1.8 mg for HA disks, 
whereas 11.0 ± 1.8, 3.2 ± 0.6 and 1.2± 0.6 mg was reached for TCP, BCP and 
Ti disks, respectively. Significantly higher calcium deposition was observed for 
HA vs. TCP disks (p < 0.001), HA vs. Ti (p < 0.001) and TCP vs. Ti (p < 
0.001). 
Figure 5 shows representative SEM images of HA disks in different 
SBF volumes after 14 days SBF soaking experiments. Hemispherical 
concavities of HA disks immersed in either 5 or 20 ml SBF were scarcely 
populated with CaP nanoparticles. 
The amount of CaP deposited within the concavities observed for 5 
and 20 ml SBF was in contrast with the results of concavities of HA disks 
immersed in 10 ml SBF volume, the latter for which nearly all concavities were 
filled with an agglomeration of CaP deposited material. 
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Figure 4. Cumulative calcium uptake by experimental disks Ti, HA, β-TCP and 
BCP after 14 days SBF soaking experiment. A) Disks immersed in 5 ml of SBF. 
B) Disks immersed in 10 ml of SBF. C) Disks immersed in 20 ml of SBF. Each 
data point respresents the average and standard deviation of values obtained 
from three different disks (n=3). 
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Figure 5. SEM 
images of 
hemispherical 
concavities on the 
surface of HA disks 
when using either 5, 
10 or 20 ml of SBF 
after 14 days 
immersion. 
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Influence of disk material and surface hemispheres on mineralization 
An apparent effect of disk material on mineralization occurred in 10 
ml SBF volume. Therefore, experimental substrate disks were immersed in 10 
ml of SBF for 14 days at 37°C. Ti disks showed no calcium deposition during 
the 14 days of immersion in SBF (Figure 4b). However, all CaP disks showed 
calcium deposition after immersion in SBF for 14 days. From day 5, HA disks 
showed a continuous significant (p < 0.05) temporal increase in calcium 
deposition compared to β-TCP and BCP ceramic disks. The cumulative calcium 
deposition reached 41.6 ± 1.8 mg for HA disks, whereas 11.0 ± 1.8 and 3.2 ± 
0.6 was reached for β-TCP and BCP, respectively. 
 
Figure 6. SEM images of hemispherical concavities after 14 days 
immersion in SBF. A) Ti disks, B) HA disks, C) β-TCP disks and D) 
BCP disks. 
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Figure 6 shows representative SEM images of disk concavities for 
different groups after 14 days SBF soaking  experiments. While no difference 
was observed between the Ti disk at days 0 and 14, for which the disks surface 
remained unaltered during 
the 14 days soaking in SBF (Figure 6a), a clear growth of mineralized 
structures was observed for HA disks (Figure 6b). β-TCP and BCP disks 
(Figure 6c and d respectively) showed few aggregates of CaP deposits inside of 
the hemispherical concavities after 14 days of immersion. 
 
4. Discussion 
The aim of this study was to investigate the effect of disk material, 
surface geometry, and simulated body fluid (SBF) volume on the in vitro 
surface mineralization capacity. We hypothesized that smaller SBF volumes 
would lead to more rapidly increased concentrations of ionic species within 
SBF solution compared to larger volumes, thus accelerating nucleation and re-
precipitation of calcium phosphate. Disk material was also included as a factor 
in the study to investigate the effect on mineral deposition. This study showed 
that different SBF volumes have different effects on mineralization, with an 
optimum SBF volume of 10 ml. Additionally, at this volume, apparent 
differences based on disk material became obvious. Finally, also surface 
hemispherical concavities acted as initiator areas for nucleation and crystal 
growth. 
CHAPTER 6 
199 
 
In agreement with previous observations [16], nucleation and re-
precipitation started preferentially within the concavities, rather than on the 
planar surface of the disks. However, in contrast to our initial hypothesis, our 
results showed that higher surface mineralization was achieved when half of the 
volume suggested by Kokubo’s protocol was used [15]. According to Kokubo’s 
protocol and the surface area of our disks, SBF volume should be around 20 ml 
per disk. Although we can reason that effects of (partial) dissolution on CaP 
disks on the concentration of SBF will be lower with larger volumes (i.e. 20 
ml), our results demonstrate the presence of an optimal volume for nucleation 
and re-precipitation in SBF. Our finding is remarkable, and the reason for an 
optimal calcium deposition at the intermediate volume of 10 ml remains 
unclear. Nevertheless, based on our findings we recommend an optimal 
material/liquid ratio of 5 ml SBF per cm2. 
Significant CaP mineralization on HA disks was observed within 14 
days of immersion in SBF compared to low and insignificant mineralization on 
β-TCP, BCP, and Ti disks. Surface mineralization depends on factors including 
calcium phosphate composition and solubility (i.e., β-TCP > BCP > HA 
[17,18]). Bioactive materials require a certain chemical solubility to allow the 
necessary reactions to take place between the SBF solution and the material 
surface [19]. The adsorption of Ca2+ and PO4
3- ions from the SBF combined 
with low flow inside the hemispherical concavity most likely increases the local 
ionic concentration and initiates nucleation of CaP nuclei within these 
microenvironments. CaP nucleation and subsequent crystal growth by 
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aggregation form a stable crystalline apatitic phase on the surface of HA disks 
[20]. However, in the case of β-tricalcium phosphate (β-TCP) disks, the 
continued dissolution of Ca2+ and PO4
3- ions from the disks followed by re-
precipitation during SBF immersion limited the formation of a stable carbonate 
apatite layer, impeding with the mineralization process. The fact that β-TCP 
sintered ceramics show a poor ability for apatite formation in vitro in SBF has 
been previously reported [21-23]. Although β-TCP ceramic is widely 
considered to be bioactive in vivo [24,25], the lack of in vitro apatite-forming 
ability confirms the potentially limited validity of the SBF test to predict in 
vivo bone bonding. 
Biphasic calcium phosphate (BCP) ceramic disks are made of intimate 
mixtures of HA and β-TCP (50:50), for which we expected to have and 
intermediate dissolution behavior. However, our results showed higher calcium 
deposition for β-TCP disks compared to BCP disks. Lower calcium deposition 
by BCP disks can be attributed to the selected mixture ratio of the two CaP 
ceramics, which exhibited a negative interaction effect of BCP on Ca2+ and 
PO4
3- ion dissolution. Comparing CaP ceramics with Ti disks, we observed no 
mineralization on Ti, although all disk types had rough concavity surfaces, 
indicating no interference of concavity roughness on the initiation of surface 
nucleation. 
The rate and ability of CaP ceramics to form apatite is dependent on 
the SBF type used. More particularly, the presence of other species (e.g. 
buffers, such as Tris (tris-hydroxymethyl-aminomethane)–HCl or Hepes (2-(4-
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(2-hydroxyethyl)-1-piperazinyl)ethane sulphonic acid-NaOH) and other 
concentrations of calcium and phosphate ions in the SBF influence the rate of 
apatite formation. In recent years, several studies have used high ionic 
concentrations of SBF, often referred to as supersaturated calcification 
solutions (SCSs). Concentrations of calcium and phosphate in SCSs of 1.5, 2, 5 
and 10 times higher than blood serum values have been used to accelerate the 
SBF precipitation process [26-30]. The idea of using SCS is to enhance the 
kinetics of apatite formation in order to increase the utility of SBF and to 
reduce the immersion period. Although SCSs are suitable for use with materials 
that have fast degradation rates (e.g. polymers), conventional SBF is 
recommendable to mimic in vivo reactions in a more optimal manner. Since 
conventional SBF has similar ion concentrations to human blood plasma, rates 
of apatite formation can more accurately be estimated with SBF than with SCS. 
 
5. Conclusion 
This work suggests an optimal material/liquid ratio of 5 ml SBF per 
cm2 disk surface to observe mineralization. HA disks showed considerable 
mineralization capacity in contrast to β-TCP and BCP ceramic disks, for which 
little mineralization was observed. Mineralization preferentially started within 
the hemispherical concavities, which acted as initiator areas for nucleation and 
crystal growth. 
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1. Introduction 
One of the most challenging aspects in tissue regenerative research is 
to find an appropriate material for bone regeneration therapy. Because of high 
osteoinductive and osteoconductive capacities, autologous bone graft still is the 
most frequently applied material for bone regeneration [1]. However, bone 
grafting is an invasive procedure, associated with high morbidity due to a 
second surgery site and the amount of grafted bone is rather limited [2]. In view 
of this, it has become a scientific challenge to find effective alternatives for 
autologous bone graft. 
Calcium phosphate (CaP) based biomaterials are the most frequently 
used synthetic alternatives in bone regenerative research, because their 
chemical composition resembles the inorganic part of bone [3] and these 
materials possess a a high bioactive and osteoconductive capacity [4]. It has 
been demonstrated that an implant surface, coated with a layer of CaP, favors 
bone healing resulting in firm fixation between bone and implant [5]. For this 
biological osseointegration process, surface topography is known to play a 
crucial role [6]. Even more interestingly, Ripamonti et al. have extensively 
investigated the osteoinductive effect of (repetitive) surface concavities of bulk 
CaP ceramics and CaP-coated titanium implants [7-9]. These studies have 
demonstrated that the presence of surface concavities provides osteoinductive 
capacity without loading any osteogenic factors or osteogenic cells on the CaP 
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ceramics. Evidently, CaP ceramics in combination with implant surface 
geometry can have a strong effect on the final biological performance [7]. 
The concept of mineralization within the concavities was studied 
recently, and it was shown that concavity dimensions can control cell-free 
mineralization process in simulated body fluid [10]. Among the concavities in 
different CaP ceramic materials, the mineralization process started 
preferentially in small concavities (~440 µm hemispheres) on hydroxyapatite 
(HA) disks sintered at 1200 °C, where the mineralization was increased 124- 
and 10-fold in the small concavities compared to large (~1800 µm 
hemispheres) and medium (~800 µm hemispheres) concavities respectively 
[10]. 
From a cellular perspective, it is known that CaP ceramics (e.g. 
hydroxyapatite, HA, and tricalciumphosphate, TCP) can promote proliferation 
and osteogenic differentiation of cells [11, 12]. Several studies indicated that 
micro- and nano-scale surface morphology of CaP ceramics strongly influence 
cell adhesion, proliferation and differentiation [13-15]. However, little is known 
about the effect of such surface concavities on the cell behavior of MSCs [16]. 
To evaluate the effect of surface concavities on CaP ceramics on the 
cellular behavior of MSCs, human adipose tissue derived mesenchymal stromal 
cells (AT-MSCs) were cultured on CaP ceramic scaffolds with different surface 
concavity sizes. The outcome parameters included analyses on cellular 
organization, cell proliferation, and osteogenic differentiation. We hypothesized 
that compared to planar control surfaces, the pronounced 3D microenvironment 
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of surface concavities promotes proliferation, organization as well as 
osteogenic differentiation of cells, resulting in mineral (CaP) nucleation in the 
concavities [10]. Additionally, we hypothesized that the proliferation and 
differentiation of cells increases with smaller concavity size due to a lower flow 
rate and more rapidly occurring 3D cell–cell interactions and subsequent 
molecular cross-talk.  
 
2. Materials and methods 
Substrate preparation and geometrical characteristics of disks 
HA powder (Merck, Darmstadt, Germany) with a Ca/P molar ratio of 
1.67 was used in this study. The powder was uniaxially pressed at 103 MPa 
(15,000 psi) for 10 min in a cylindrical steel mold (internal diameter ~21 mm). 
Subsequently, cylindrical HA ceramics were heat-treated in a furnace at 800°C 
for 6 h (1.67 °C min-1) to provide suitable strength to the ceramic to withstand 
the stresses applied during the machining process. Thereafter, heat-treated HA 
cylinders were cut into disks (thickness 4 mm, diameter 21 mm). Drill tips with 
different diameter sizes (2.1, 1.0 and 0.5 mm; Horico Dental, Berlin, Germany) 
were used to prepare hemispherical concavities at the disk surfaces. 
Subsequently, the disks were sintered in a furnace for 6 h (1.67°C min-1) at 
1200°C, by which disk dimensions were reduced to 3 mm thickness and 16 mm 
diameter and cavities sizes to diameters of 440 µm (small concavity; SC), 800 
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µm (medium concavity; MC) and 1800 µm (large concavity; LC). Afterwards, 
the disks were prepared based on the experimental setup. 
For imaging methods, the heat-treated HA disks were divided (without 
cutting) in three different regions, each containing a specific cavity 
size/diameter (SC  440 µm, MS 800 µm or LC 1800 µm) with a total 6 
cavities for each size. The flat surface in the centre of the disk was considered 
as a control surface (Figure 1a). 
 
Figure 1. Schematic representation of disk surface geometry employed in the 
study. (A) Schematic distribution of the concavities at the surface of the disks 
for confocal microscopy; 6 concavities of each size (small cavity (SC) 440 
µm, medium cavity (MC) 800 µm; and large cavity (LC) 1800 µm) were 
prepared on the surface of the disks, and the center to center distance was kept 
the same (SC=2.1, MC=2.5, LC=2.8 mm). The planar surface in the centre of 
the disk was considered as a control planar surface (PS). (B) Schematic 
distribution of the concavities at the surface of the disks for biochemical assays. 
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Disks were completely covered with each size of concavities (SC, MC, LC) and 
the center to center distance was kept the same (SC=0.6, MC=1.2, LC=2.7 
mm). 
 
For the evaluation of cellular behavior and gene expression, the heat-
treated HA disks were covered completely with the same type of concavities 
i.e. only SC, MS or LC. The total number of hemispherical concavities in each 
disk was 148 for SC, 42 for MC, and 36 for LC, resulting in a total surface area 
respectively 2.23 cm2 (SC), 2.22 cm2 (MC) and 2.92 cm2 (LC). As a control 
group, disks with planar surface (PS) were used with a total surface area of 2,01 
cm2 (Figure 1b). Each disk was cut into four equal parts (n=4). Before cell 
seeding, disks were sterilized by autoclavation. 
 
AT-MSC isolation, expansion and characterization  
AT-MSCs were isolated from fat tissue of healthy donors via the 
Department of Plastic Surgery (Radboudumc, Nijmegen, the Netherlands) after 
written informed consent, following a previously described AT-MSCs isolation 
procedure [17, 18]. Harvested cells were cultured in proliferation media, 
consisting of alpha Minimal Essential Medium (α-MEM; Gibco®, Life 
Technologies, Grand Island, USA) supplemented with 5% platelet lysate (PL, 
Sanquin Blood Bank, Nijmegen, the Netherlands), 100 U/ml penicillin 
(Gibco®), 10 µg/ml streptomycin (Gibco®), and 10 U/ml heparin (LEO Pharma, 
Amsterdam, the Netherlands) at 37°C in a humid atmosphere with 5% CO2. 
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Medium was changed twice a week. Cells were passaged upon reaching ~80% 
confluency using 0.25%w/v trypsin/0.02% EDTA (Gibco®). 
 
Biochemical assays for cellular behavior 
AT-MSCs were cultured in osteogenic media with 10.000 cells/cm2 
seeding density (relative to planar surface), consisting of α-MEM supplemented 
with 5% PL (Sanquin), 100 U/ml penicillin (Gibco®), 10 µg/ml streptomycin 
(Gibco®), 10 U/ml heparin (LEO Pharma), 0.2 mM L-ascorbic acid-2-
phosphate (Sigma-Aldrich, St. Louis, MO, USA), 2mM L-glutamine (Gibco®), 
10-8M dexamethasone (Sigma-Aldrich) and 0.01 M β-glycerophosphate, at 
37°C in a humid atmosphere with 5% CO2. Cell proliferation was evaluated 
with a DNA assay and osteogenic differentiation was evaluated with an ALP-
activity assay. Samples were collected at 3 time points relative to cell seeding 
(i.e. day 3, 14, 28). The same samples were used for DNA and ALP assay. 
 
Cellular DNA content 
The cellular DNA content was measured using a QuantiFluor® dsDNA 
System Kit (Promega, the Netherlands). For the standard curve, serial dilutions 
of dsDNA stock (range: 0-2000 ng/ml) were prepared. Next, 100 µl of either 
sample of standard solution was added into the wells, followed by 100 µl of 
working solution. The plate was incubated at room temperature for 5 min, and 
then the absorbance of samples/standards was measured at 450 nm using a 
fluorescence microplate reader (FL600, BioTek, Canada). 
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Alkaline phosphatase (ALP) activity 
ALP activity was measured using a 5 nM p-nitrophenyl phosphate (4-
NP) colorimetric assay (Sigma Aldrich). According to the manufacture 
instructions, 80 µl of sample solution (the same samples used for the 
measurement of cellular DNA content) was combined with 20 µl of buffer (0.5 
M 2-amino-2methyl-1-propanol). For the standard curve, serial dilutions of 4-
NP (range: 0-25 nmol) were used. Next, 100 µl substrate solution (5 nM p-
nitrophenyl phosphate) was added to the samples/standards and the plates were 
incubated for 60 min at 37°C. The reaction was stopped by adding 50 µl 0.3M 
NaOH. The absorbance of samples was measured at 405 nm using an ELISA 
microplate reader (EL800, BioTek, Abcoude, the Netherlands). The ALP 
content was normalized using the corresponding cellular dsDNA amount. 
 
Immunofluorescence and quantitative cell measurements  
For the immunofluorescence and quantitative cell measurements, the 
seeding density was 10.000 cells/cm2 (relative to planar surface). At selected 
time points (3, 14, 21 and 28 days), cells were washed 2x in phosphate buffered 
saline (PBS, Gibco®), fixed in 2% paraformaldehyde (PFA, Sigma-Aldrich) for 
20 min, permeabilized by 0.25% Triton X100 (Koch, Light-Laboratories, 
Colebrook, UK) in PBS for 10 min, washed again 2x in PBS and blocked in 1% 
BSA (Sigma Aldrich) for 1 hour. Thereafter, cells were washed 2x in PBS and 
stained as follows: 
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1. For the visualization of dsDNA in nucleus, cells were stained with 
blue fluorescent DAPI (Invitrogen, Molecular probes) for 1 min, 
in a dilution of 1:2500. Afterwards, cells were washed 2 x 5 min 
in PBS; 
2. For the visualization of cytoskeletal morphology, the filamentous 
F-actin was stained with Alexa Flour® 568 phalloidin (Invitrogen, 
Molecular probes, Eugene-Oregon, USA) for 2 hours, in a dilution 
of 1:250. Afterwards cells were washed 2 x 5 min in PBS; 
3. For visualization of the osteogenic marker osteocalcin, cells were 
stained with a monoclonal osteocalcin antibody, labeled with 
Alexa Flour® 488 (Novus Biologicals, Cambridge, UK) for 2 
hours in a dilution of 1:1000. Afterwards, cells were washed 2 x 5 
min in PBS. 
Subsequently, the samples were mounted with Mowiol® 4.88 solution 
(Merk Millipore, Darmstadt, Germany), covered with cover-glasses, and stored 
at +4°C for immunofluorescence analysis. 
For visualization of calcium crystals at the same time points (3, 7, 14, 
and 28 days), separate samples were stained in 2% (2g in 100ml) Alizarin Red 
S 598 (ScienCell Research Laboratories, Carlsbad CA, USA) for 15 min. 
Subsequently, samples were washed 5x with PBS for 1 min and stained with 
blue fluorescent DAPI for 1min in a dilution 1:2500. Afterwards, the samples 
were mounted with Mowiol® 4.88 solution (Merk Millipore, Darmstadt, 
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Germany), covered with coverglasses, and stored at +4°C for 
immunofluorescence analysis. 
In order to visualize the presence of cells on the scaffold surface and 
the presence of molecules of interest, after each staining, the samples were 
analyzed first with a fluorescence microscope (Axio Imager Microscope Z1, 
Carl Zeiss Micro imaging, Gottingen, Germany). The excitation and emission 
wavelength for a filamentous F-actin was 568 and 603 nm respectively, for 
dsDNA (DAPI) was 405 and 428 nm, for osteocalcin was 495 and 519 nm, and 
for alizarin red staining was 590 and 617 nm, respectively. The images were 
captured with 20x/0.75 objective. 
To obtain high-resolution 3D images for analysis of cellular 
organization within concavities, the samples were analyzed using confocal laser 
scanning microscopy (CLSM; Olympus FV1000, Olympus, Center Valley PA, 
USA). The images were captured with 20x/0.75 objective. In order to obtain 
qualitative and quantitative data on concavity volumes, the images were 
analyzed with Image J software (Centre for Information Technology, National 
institutes of Health, Bethesda MD, USA). Cell nuclei were quantified with 3D 
object counter plugin from image J, prior to analysis the number of object’s 
voxels and threshold were set on the images [19]. 
 
Statistical analysis 
Data are presented as mean ± standard deviation. Statistical analysis 
was performed with Graphpad Prism® 5.03 software (Graphpad Software Inc, 
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San Diego, CA, USA). Quantitative results were analyzed using a one-way 
ANOVA with a posthoc Tukey Multiple Comparisons Test. A probability (p) 
value <0.05 was considered statistically significant. 
 
3. Results 
Cellular behavior 
According to results of DNA content, in the first 14 days, the highest 
cell proliferation was observed on the PS disks, where the proliferation of SC 
disk showed the lowest cell proliferation. However, after 28 days of culture, an 
increase of cell proliferation was observed on the SC and MC disks compared 
with the PS disks at the same time point (Figure 2a). Because of the 
differences between the available surface area of the disks (PS 2.01 cm2 
SC2.23 cm2, MC2.22 cm2 and LC2.92 cm2), the results of DNA content 
were normalized for surface area (Figure 2b). After normalization, the pattern 
of the cell proliferation in each group remained similar, showing at day 14 
significantly lower DNA-content values for SC (p<0.001), MC (p<0.001), and 
LC (p<0.05), and at day 28 significantly higher DNA-content values for SC 
(p<0.01) and MC (p<0.01) compared to PS. Additionally, DNA-content values 
showed a tendency to decrease with smaller surface concavity size at day 14, 
and to increase with smaller surface concavity at day 28. 
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Figure 2. (A) Cellular DNA content (ng/ml)/proliferation level during 
28 days of culture. (B) Cellular DNA content normalized for surface 
area of the disks. (C) ALP-activity during 28 days of culture. Cellular 
behavior within different concavity sizes. P-values (*p<0.05, (**p<0.01, 
(***p<0.001) indicate significant differences compared to PS at the 
same time point. ND means not determined. 
 
 
 At day 28, ALP-activity was significantly lower (p<0.001) for SC, 
MC, and LC compared to PS. Similar as for DNA-content values, a tendency to 
decreasing ALP-activity values with decreasing surface concavity size was 
observed at day 28. 
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Cellular organization 
Analysis of Immunofluorescence measurement 
The samples for immunofluorescence measurements were stained with 
3 different dyes, i.e. DAPI (in blue) for nuclear visualization, actin (in red) for 
visualization of the cytoskeleton, and osteocalcin (in green) for the 
identification of this late stage marker of osteogenic differentiation. 
  
Figure 3. Fluorescence microscopy images. For visualization of dsDNA in 
nuclei, cells were stained with fluorescent DAPI (in blue); for cytoskeletal 
structure visualizations, filamentous F-actin (in cells) was stained with Alexa 
Flour® 568 phalloidin (in red); for visualization of osteocalcin, cells were 
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stained with a monoclonal osteocalcin antibody, labeled with Alexa Flour® 488 
(in green). 
 
After each staining, samples were checked with fluorescence 
microscopy (Figure 3). The simultaneous visualization of the 3 stainings was 
possible only for the 28 day samples, as osteocalcin staining was not detectable 
at earlier time points. According to the fluorescence microscopy results, 
osteocalcin was detectable in SC and MC concavities. In SC, the green color 
was distributed within the entire concavity volume, while in MC osteocalcin 
was detected only on the edges of the concavities (Figure 3). 
To analyze the mineralization pattern of AT-MSCs, samples were 
stained with Alizarin Red S 598 (Figure 4). During 28 days of culture a gradual 
increase of calcium crystals (stained in red) was observed on the surface of 
experimental scaffolds onto which cells had been cultured. The negative control 
at day 28 showed no positive Alizarin staining. 
 
  
Figure 4. Qualitative evaluation of calcium deposition during 28 days of 
culture. Samples were stained with Alizarin Red S 598 (in red). 
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Qualitative analysis of confocal microscopy results 
In the confocal microscopy images after 3 days of culture, only few 
cells were observed for all concavity sizes (Figure 5a). However, several 
differences in cellular organization, i.e. cell distribution in the different 
concavity sizes, were detectable. In the SC and MC, cells were distributed 
already in a 3D volume, where in LC cells generally covered the concavity 
walls (Figure 5a). 
After 14 days of culture, a high increase in the number of cell nuclei 
was observed for all concavity sizes. In SC and MC, cells created an apparent 
multilayered cell sheet, covering the surface area of concavity walls, and in SC 
cells started to fill the entire concavity volume (3D cellular organization). The 
planar surface area between concavities was also covered with a cellular 
multilayer. In contrast to SC and MC, the cellular organization in LC was 
different, where cell populations were localized in two levels on the concavity 
walls close to planar surface area of the disk and at the bottom of the 
concavities. At day 14, still a gap between these two cell populations in LC was 
observed (Figure 5b). 
After 21 days of culture, very densely distributed cell nuclei were 
observed in SC and MC. In SC, cells were homogenously distributed the entire 
concavity volume. In MC, the cellular organization was different from SC with 
a less dense cell population in the concavity center compared to the edges of the 
concavities. The cellular organization in LC at day 21 was similar to the LC at 
day 14 with a separation in two cell populations (on the concavity walls close to 
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surface area of the disk and at the bottom of the concavities), and still a gap 
between those populations (Figure 5c). 
After 28 days of culture, cells in SC and MS were homogenously 
distributed within the entire concavity volumes. At day 28, cells also reached 
the highest deepness within the concavities in SC and MC. However, in LC the 
cellular organization was still different from SC and MC, with still the 
existence of two separated cell populations, but the distance between those 
populations was smaller compared to day 21 (Figure 5d). 
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Figure 5. Confocal microscopy images with 3D reconstruction of SC, MC and 
LC. Cell nuclei were stained with fluorescent DAPI (in blue); filamentous F-
actin (in cells) was stained with Alexa Flour® 568 phalloidin (in red). (a) 
Samples with different concavity sizes after 3 days of culture. 
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(b) Samples with different concavity sizes after 14 days of culture 
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(c) Samples with different concavity sizes after 21 days of culture. 
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(d) Samples with different concavity sizes after 28 days of culture. 
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Quantitative analysis of cellular organization 
The cell nuclei were quantified in SC, MC and LC at all time points. 
For SC and MC, a gradual increase of cell nuclei was observed until day 28. 
The number of the nuclei was normalized for concavity volume (Figure 6). In 
the first 3 days, the average number of cell nuclei per mm3 (based on n=3) in 
SC was 793 ± 181, in MC 464 ± 529 and in LC 497 ± 46. After 14 days, an 
increase of cell nuclei was observed for all groups, where the average (based on 
n=3) number of nuclei per  
 
 
Figure 6. Results of quantitative analysis of the number of cell nuclei within the 
concavities normalized for concavity volume. P-values (*p<0.05, **p<0.01, 
***p<0.001) indicate significant differences compared to PS at the same time 
point. ND means not determined. 
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mm3 in SC was 6939 ± 247, in MC 5138 ± 1481, and in LC 3310 ± 2585. Then, 
at day 21 even higher cell densities were observed with per mm3 in SC 11096 ± 
4416 nuclei and in MC 15412 ± 1481 nuclei. Cell nuclei counts in LC at days 
21 and 28 were not possible due to large data information and limited capability 
of the software (Image J). Finally, at day 28 a significantly higher cell density 
(p=0.0329) was observed in SC with an average number of nuclei per mm3 of 
25153 ± 3736) compared to MC with 16601 ± 1476 nuclei. 
 
4. Discussion and conclusion 
The aim of this study was to evaluate the effect of surface concavities 
in CaP ceramic scaffolds on cellular organization, cell proliferation, and 
osteogenic differentiation. We hypothesized that compared to planar control 
surfaces, the pronounced 3D microenvironment of surface concavities promotes 
proliferation, organization as well as osteogenic differentiation of cells, 
resulting in mineral (CaP) nucleation in the concavities [10]. Additionally, we 
hypothesized that the proliferation and differentiation of cells increases with 
smaller concavity size due to a lower flow rate and more rapidly occurring 3D 
cell–cell interactions and subsequent molecular cross-talk. The main findings of 
this study were that surface concavities evoked cell proliferation pattern, which 
was dependent of concavity sizes. The small size concavities increased cell 
proliferation to a larger extent compared to medium and large concavities. 
Additionally, concavity size influenced cellular organization within concavities, 
CHAPTER 7 
231 
 
and their distribution in 2D or 3D. Finally, concavity size influenced osteogenic 
differentiation of cells, based on results of osteocalcin expression only in small 
(440 um) and medium (800 um) surface concavities. 
Our study indicated that surface concavities affect cell proliferation, 
which was proven by quantitative analysis of cell nuclei within the concavities. 
In addition, the proliferation pattern promoted by different concavity sizes was 
altered. The small concavities increased cell proliferation to a larger extent, 
because at day 28 the highest cell number (nuclei) was found in small 
concavities. The quantitative analysis of cell nuclei showed that concavities can 
affect on cell proliferation and that proliferation potential of cells increases with 
smaller concavity size, possibly due to the cell proximity, because the distance 
between cells have shown to influence cellular communication [20]. The cell-
cell interaction and cellular communication is based on molecular exchange, 
which activates appropriate signals in cells. This phenomenon is called sense of 
smell [21, 22]. In addition, cells are able to adhere to the surface and recognize 
its geometrical properties, and they sense and respond to geometrical stimuli 
[23, 24]. This adhesion-mediated signaling provides cells with information 
about their microenvironment, including geometrical and chemical 
characteristics of substrate [25]. Our results indicate that cells were able to 
recognize the geometrical properties of surface, based on proliferation and 
differentiation results in different concavity sizes. 
The fact that CaP based biomaterials with specific surface geometry 
can promote bone formation in vivo, was proven by several studies [26-29]. 
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However, little is known about the influence of CaP based biomaterials 
combined with geometrical properties (size, shape) on cellular organization and 
cell differentiation [14]. In this study, we found that concavity size can 
influence cellular organization, because already at day 3 in small and medium 
concavities cells were distributed in a 3D manner in contrast to large 
concavities, in which cells were distributed still at a 2D level. This observation 
can be explained by the fact that cells recognize geometrical properties of the 
surface and respond differently to their cellular organization [23, 24]. 
Next, the results of mineralization of cells on the surface of 
experimental scaffolds (covered with different size concavities) showed a 
gradual increase of Ca deposition, which indicates that cells can proliferate as 
well as differentiate on the surface of CaP based biomaterials. However, the 
method to visualize Ca deposition (Alizarin Red S staining) was not selective 
for the quantification of mineralization level in different concavity sizes. 
Therefore, for the analysis of osteogenic differentiation/mineralization within 
the concavities, the secretion of osteocalcin (osteogenic differentiation marker) 
was analyzed. We observed that concavity size influences osteogenic 
differentiation of MSCs, because osteocalcin was found in small and medium 
concavities, but not in large concavities. This is an indication that extracellular 
stimulation factors (e.g. geometrical properties, cell-cell communication, and 
local calcium nucleation) can provide specific signal activation and osteogenic 
differentiation of MSCs. 
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In conclusion, CaP disks covered with different surface concavities (in 
size) were able to affect MSCs behavior in terms of proliferation and 
osteogenic differentiation. The results of this study suggest a correlation 
between concavity size, cell proliferation, cellular organization and osteogenic 
differentiation of cells within surface concavities. Finally, in order to develop 
advanced scaffolds able to mimic the natural bone microenvironment, it is 
critical to understand how cells interact with 3D matrices, recognize their 
surface properties (e.g. at geometrical, physical, and chemical levels), and use 
intracellular signaling pathways responsible for that interaction and subsequent 
behavior [30]. 
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English summary and address to the aims 
The aim of the current thesis was to investigate the physicochemical 
and biological properties of various calcium phosphate (CaP) ceramics as either 
CaP coatings or bulk CaP ceramics for biomedical applications, with major 
focus on CaP composition and surface morphology. Specifically, Chapter 1 
provides a general introduction on properties of bioceramics, the characteristics 
of each bioceramic, their use as coatings, coating deposition techniques, and 
physical and biological interaction of these implants with bone tissue. This 
summary addresses the research questions as described in the first chapter in 
successive order. 
 
1. What is the current knowledge on coatings using inorganic and/or 
organic materials and which techniques are available for the deposition of such 
coatings on metallic materials? 
Synthetic inorganic and organic materials have been extensively 
investigated in the field of bone regeneration in an attempt to mimic the 
composition and structure of the extracellular matrix (ECM) of bone tissue with 
the ultimate aim of generating suitable synthetic bone substitute materials and 
modifying the surface of bone implants. For load-bearing applications, bone 
implants are generally made of a bioinert metal with appropriate mechanical 
properties and a modified surface (i.e. roughened, coated or a combination 
thereof), to enhance the surface biocompatibility and osteoconductivity. 
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Currently, biomaterials research is evolving from the use of bioinert and 
biologically passive implants toward interactive implants that stimulate tissue 
regeneration. Therefore, surface physico-chemical properties of bone implants 
need to be optimal and capable to biologically instruct and stimulate the 
regeneration of bone tissue. 
Chapter 2 was focused on surface modification approaches in the field of bone 
regeneration for load-bearing bone implants with emphasis on the use of 
inorganic and organic coating compounds that actively participate in the 
biological processes that occur upon implantation. The review shows that 
appropriate surface modifications can be helpful to achieve desired tissue 
responses in healthy as well as compromised conditions. 
 
2. What are the effects of CaP composition in sputter coatings on in 
vitro and in vivo performance? 
Calcium phosphate (CaP) ceramic coatings have been used to enhance 
the biocompatibility and osteoconductive properties of metallic implants. The 
chemical composition of these ceramic coatings is an important parameter, 
which can influence the final bone performance of the implant. In Chapter 3, 
the effect of phase composition of CaP-sputtered coatings was investigated on 
in vitro dissolution behavior and in vivo bone response. Coatings were prepared 
by a radio frequency (RF) magnetron sputtering technique; three types of CaP 
target materials were used to obtain coatings with different stoichiometry and 
calcium to phosphate ratios (hydroxyapatite (HA), α-tricalciumphosphate (α-
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TCP), and tetracalciumphosphate (TTCP)) were compared with non-coated 
titanium controls. The applied ceramic coatings were characterized by X-ray 
diffraction, Fourier transform infrared spectroscopy, scanning electron 
microscopy, and inductively coupled plasma optical emission spectroscopy. 
The in vitro dissolution/precipitation of the CaP coatings was evaluated using 
immersion tests in simulated body fluid (SBF). To mimic the in vivo situation, 
these compositionally different CaP coatings were also evaluated in a femoral 
condyle rabbit model. TCPH and TTCPH showed morphological changes 
during 4-week immersion in SBF. The results of bone implant contact (BIC) 
and peri-implant bone volume (BV) showed a similar response for all 
experimental coatings. An apparent increase in tartrate-resistant acid 
phosphatase (TRAP) positive staining was observed in the peri-implant region 
with decreasing coating stability. In conclusion, the experimental groups 
showed different coating properties when tested in vitro and an apparent 
increase in bone remodeling with increasing coating dissolution in vivo. 
 
3. What is the effect of different micrometer hydroxyapatite coating 
thicknesses on residual stress? 
Bioceramic coatings, including calcium phosphate coatings composed 
of hydroxyapatite (HA), represent a common surface modification for metallic 
bone implants. In view of the mismatch in material properties between the 
ceramic coating material and the metallic substrate material, Chapter 4 aimed 
to evaluate the residual stress within an HA-coating deposited using RF 
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magnetron sputtering via two different analyses, based on either the Stoney 
formula (i.e. based on curvature measurements of the substrate [Stoney, 1909]) 
or the sin2 ψ method (i.e. based on X-ray diffraction patterns of the coating). 
Additionally, the effect of HA-coating thickness (i.e. 1 or 4 μm) on residual 
stress and surface topography were addressed. We hypothesized that (i) both 
methods to determine residual stress would show similar results, and that (ii) 
thick coatings would increase residual stress compared to thin coatings. The 
curvature measurements showed low residual stress values (ranging from -60 to 
80 MPa), which showed relaxation upon post-deposition heat treatment at 650 
ºC. Similarly, lattice-based measurements of residual stress showed relaxation 
of HA coatings upon post-deposition heat treatment. Coating thickness 
variation in the micrometer scale showed no major effects on residual stress 
magnitude. For reasons of accuracy and similarity to the actual conditions, 
determination of residual stress via lattice-based techniques is preferable. 
 
4. What is the role of hemispherical concavities on the in vitro 
mineralization of bioceramic materials? 
Repetitive concavities on the surface of bone implants have recently 
been demonstrated to foster bone formation when implanted at ectopic 
locations in vivo. In Chapter 5, we aimed to evaluate the effect of surface 
concavities on the surface mineralization of hydroxyapatite (HA) and β-
tricalcium phosphate (β-TCP) ceramics in vitro. Hemispherical concavities with 
different diameters were prepared at the surface of HA and β-TCP sintered 
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disks: 1.8 mm (large concavity), 0.8 mm (medium concavity) and 0.4 mm 
(small concavity). HA and β-TCP disks were sintered at 1100 or 1200°C and 
soaked in simulated body fluid for 28 days at 37°C; the mineralization process 
was followed by scanning electron microscopy, energy-dispersive 
spectroscopy, X-ray diffraction and calcium quantification analyses. The results 
showed that massive mineralization occurred exclusively at the surface of HA 
disks treated at 1200°C and that nucleation of large aggregates of calcium 
phosphate started specifically inside small concavities instead of on the planar 
surface of the disks. Regarding the effect of concavity diameter size on surface 
mineralization, it was observed that small concavities induce 124- and 10-fold 
increased mineralization compared to concavities of large or medium size, 
respectively. The results of this study demonstrated that (i) in vitro surface 
mineralization of calcium phosphate ceramics with surface concavities starts 
preferentially within the concavities and not on the planar surface, and (ii) 
concavity size is an effective parameter to control the spatial position and 
extent of mineralization in vitro. 
 
5. What is the influence of SBF volume change, disk material, and 
surface hemispheres on mineralization? 
Calcium phosphate ceramics are the main mineral constituents of bone 
and teeth and hence have been extensively investigated for bone regenerative 
applications. Therefore, in Chapter 6, the effect of disk material, surface 
geometry, and SBF volume on mineralization capacity was investigated. 
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Hemispherical concavities were created on the surfaces of disks made of 
different materials (i.e. hydroxyapatite (HA), β-tricalcium phosphate (β-TCP), 
biphasic calcium phosphate (BCP) and titanium (Ti)), of which the ceramic 
materials were sintered at 1200°C. Mineralization of CaP was assessed on disk 
surfaces after immersion of the samples in different volumes of simulated body 
fluid (SBF) up to 14 days by means of calcium assay and scanning electron 
microscopy (SEM). This study showed that different SBF volumes have 
different effects on mineralization, with an optimum material/liquid ratio of 
4.92 ml of SBF per cm2 surface area. Additionally, at this volume, apparent 
differences based on disk material became obvious. Evidently, surface 
hemispherical concavities acted as initiator areas for nucleation and crystal 
growth. 
 
6. How do cells populate hemispherical concavities and to what extent 
does concavity size influence 3-dimensional cellular organization? 
Calcium phosphate ceramics in combination with implant surface 
geometry have been shown to influence biological performance. It is also 
known that micro- and nano-scale morphology of the calcium phosphate 
surface can strongly influence osteoblast and stem cell adhesion, proliferation, 
and differentiation. Therefore, in Chapter 7, hemispherical cavities with a size 
of 440, 800 and 1800 µm were created on the surface of HA disks sintered at 
1200°C and cultured with adipose tissue mesenchymal stem cells (AT-MSCs) 
in osteogenic medium for up to 28 days at 37°C. At selected time points (3, 7, 
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14, 21, and 28 days), samples were removed and after fixation, cells were 
fluorescently labeled with phalloidin-Alexa 568 for filamentous (F-)actin and 
DAPI for nuclear staining. Cells were imaged and examined with a confocal 
laser scanning microscopy (CLSM). Immunofluorescence-based three-
dimensional (3D) image analysis showed differences in cell number between 
concavities. The highest number of cell nuclei was found in the 440 µm cavity 
and the lowest number in the 1800 µm. Additionally, cells were able to migrate 
toward the concavities and adhere to their edges and walls. Preferential 
mineralization was observed inside the concavities. Cells spread over and to the 
bottom of concavities covering all their volume and creating multilayers on 
their surfaces. Results from this study suggest a correlation between concavity 
size, cellular organization, mineralization and osteogenic differentiation. 
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Dutch summary / Samenvatting   
Het doel van dit proefschrift was te onderzoeken wat het effect is van 
de fysisch-chemische en biologische eigenschappen van verscheidene 
calciumfosfaat (CaP) keramieken voor biomedische toepassingen, met daarbij 
nadruk op CaP compositie en oppervlakte-morfologie. Hoofdstuk 1 geeft een 
algemene introductie over de eigenschappen van biokeramiek, de 
eigenschappen van ieder type biokeramiek, het gebruik van biokeramiek als 
coating, coating depositie-technieken, en de fysische en biologische interactie 
van zulke implantaten met botweefsel. Deze samenvatting behandelt 
opeenvolgend de onderzoeksvragen zoals beschreven in het eerste hoofdstuk. 
 
1. Wat is de huidige kennis van coatings o.b.v. inorganische en/of 
organische materialen, en welke technieken zijn beschikbaar voor het 
aanbrengen van dergelijke coatings op metalen? 
Synthetische inorganische en organische materialen zijn veelvuldig 
onderzocht voor botregeneratie in een poging de compositie en structuur van de 
bot extracellulaire matrix (ECM) na te bootsen, met als uiteindelijk doel het 
genereren van geschikte, synthetische botvervangers en modificaties van 
botimplantaat-oppervlakken. Voor lastdragende toepassingen bestaan 
botimplantaten veelal uit bioinert metaal met geschikte mechanische 
eigenschappen en een aangepast oppervlak (bijv. opgeruwd, gecoat, of een 
combinatie daarvan) om de biocompatibiliteit en osteoconductieve 
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eigenschappen te verbeteren. Momenteel ondergaat het biomaterialen 
onderzoek een transitie van inerte, biologisch-passieve implantaten naar 
interactieve implantaten, welke weefselregeneratie bevorderen. Daartoe dienen 
de fysisch-chemische eigenschappen optimaal en in staat te zijn om de 
regeneratie van botweefsel te instrueren en stimuleren. 
Hoofdstuk 2 was gericht op oppervlakte-modificaties voor 
lastdragende botimplantaten binnen de botregeneratie, met nadruk op het 
gebruik van inorganische en organische coatingbestanddelen, die actief 
deelnemen aan het biologisch proces dat in gang gezet wordt na implantatie. 
Dit overzicht toont dat met de juiste oppervlakte-modificaties een bijdrage 
geleverd kan worden om gewenste weefselreacties in zowel gezonde als 
gecompromitteerde condities te bewerkstelligen. 
 
2. Wat zijn de effecten van CaP compositie in sputtercoatings op in 
vitro en en in vivo prestatie? 
Keramische calciumfosfaat (CaP) coatings zijn gebruikt om de 
biocompatibiliteit en osteoconductieve eigenschappen van metalen implantaten 
te verbeteren. De chemische compositie van deze keramische coatings is een 
belangrijke parameter, die de uiteindelijke botprestatie van het implantaat kan 
beinvloeden. In Hoofdstuk 3 werd het effect van compositie van CaP-
sputtercoatings op in vitro oplosgedrag en in vivo botprestatie onderzocht. De 
coatings werden gegenereerd via radio frequency (RF) magnetron sputtering; 
drie types CaP target materiaal werden gebruikt om coatings te maken met 
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verschillende stoichiometrie en calcium/fosfaat ratio’s (hydroxyapatiet,(HA), 
alfa-tricalciumfosfaat (alfa-TCP), en tetra-calciumfosfaat (TTCP)) en 
vergeleken met ongecoat titaan. De aangebrachte coatings werden 
gekarakteriseerd via X-ray diffractie, Fourier transform infrared spectroscopie, 
scanning elektronen microscopie, en inductively coupled plasma optische 
emissie spectroscopie. Het in vitro oplossen/precipiteren van de CaP coatings 
werd bestudeerd middels incubatie testen in simulated body fluid (SBF). Om de 
in vivo situatie na te bootsen werden deze verschillende CaP coatings ook 
geevalueerd in een femorale condyle model in konijnen. TCPH en TTCPH 
vertoonden morfologische veranderingen gedurende de 4 weken incubatie in 
SBF. De resultaten van bot-implantaat contact (BIC) en peri-implantaat 
botvolume (BV) toonden een gelijke prestatie voor alle experimentele coatings. 
Een klaarblijkelijk verschil in tartrate-resistant acidic phosphatase (TRAP) 
positieve kleuring werd waargenomen in het peri-implantaat gebied met 
afnemende coating stabiliteit. Concluderend toonden de experimentele groepen 
in vitro verschillende eigenschappen en een duidelijke toename in 
botremodelering met toenemend oplossen van de coating in vivo. 
 
3. Wat is het effect van verschillende micrometer dikke 
hydroxyapatietcoatings op de residual stress? 
Biokeramische coatings, inclusief calciumfosfaat coatings o.b.v. 
hydroyapatiet (HA), vertegenwoordigen een gebruikelijke oppervlakte-
modificatie voor metalen botimplantaten. T.a.v. de mismatch in 
CALCIUM PHOSPHATE CERAMICS FOR BONE REGENERATION 
250 
 
materiaaleigenschappen tussen het keramisch coatingmateriaal en het metalen 
substraatmateriaal had Hoofdstuk 4 als doel om de residual stress in een HA-
coatings gedeponeerd middels RF magnetron sputtering te evalueren via twee 
verschillende analyses, gebaseerd op enerzijds de Stoney formule (via meting 
van de curvatuur van het substraat [Stoney, 1909]) en anderzijds de sin2 ψ 
methode (via röntgen diffractie patronen van de coating). Bovendien werd het 
effect van dikte van de HA-coating (1 or 4 μm) op residual stress en 
oppervlakte-topografie bekeken. We veronderstelden dat (i) beide methoden 
eenzelfde residual stress beeld zouden geven, en dat (ii) dikke coatings de 
residual stress zouden verhogen in vergelijking met dunne coatings. De 
curvatuur metingen toonden een lage residual stress (range: -60-80 MPa), 
welke relaxeerde na post-depositie hittebehandeling op 650 ºC. Ook 
kristalstructuurmetingen van residual stress toonden relaxatie van HA coatings 
na post-depositie hittebehandeling. De coatingdikte variaties in de micrometer-
range lieten geen duidelijke effecten op residual stress zien. O.b.v. 
nauwkeurigheid en gelijkheid met werkelijke condities is het bepalen van 
residual stress via kristalstructuur metingen aan te bevelen. 
 
4. Wat is de rol van hemisferische concaviteiten op de in vitro 
mineralisatie van biokeramische materialen? 
Voor herhalende concaviteiten op het oppervlak van botimplantaten is 
recentelijk aangetoond dat ze een rol spelen in ectopische botvorming in vivo. 
In Hoofdstuk 5 was ons doel om te evalueren wat het effect van oppervlakte 
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concaviteiten op de oppervlakte-mineralisatie van hydroxyapatiet (HA) en β-
tricalcium phosphate (β-TCP) keramiek in vitro is. Hemisferische concaviteiten 
met verschillende diameters werden aangebracht op het oppervlak van HA en 
β-TCP gesinterde discs: 1.8 mm (grote concaviteit), 0.8 mm (middelgrote 
concaviteit) en 0.4 mm (kleine concaviteit). HA en β-TCP discs werden 
gesinterd op 1100 of 1200 ºC en geïncubeerd in SBF voor een periode van 28 
dagen bij 37 ºC; het mineralisatie proces werd gevolgd via scanning elektronen 
microscopie, energy-dispersive spectroscopie, X-ray diffractie en calcium 
quantificatie analyses. De resultaten toonden dat extreme mineralisatie 
plaatsvond alleen aan het oppervlak van HA discs gesinterd op 1200 ºC en dat 
nucleatie van calciumfosfaat specifiek in de kleine concaviteiten startte en niet 
op het vlakke deel van de discs. T.a.v. het effect van de diameter van de 
concaviteiten op oppervlakte-mineralisatie werd gezien dat kleine concaviteiten 
124 en 10 keer zoveel mineralisatie gaven dan grote of middelgrote. De 
resultaten van deze studie toonden dat (i) in vitro oppervlakte-mineralisatie 
voor CaP keramiek met concaviteiten preferentieel start in deze concaviteiten 
en niet op het vlakke oppervlak, en dat (ii) concaviteit grootte een effectieve 
parameter is om de ruimtelijke positie en mate van in vitro mineralisatie te 
beïnvloeden. 
 
5. Wat is de invloed van SBF volume verandering, disc materiaal, en 
oppervlakte hemisferen op mineralisatie? 
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Calciumfosfaat keramiek is het belangrijkste bestanddeel van bot- en 
tandweefsel en derhalve veel onderzocht voor toepassingen voor botregeneratie. 
Derhalve werd in Hoofdstuk 6 het effect van disc materiaal, oppervlakte 
geometrie, en SBF volume op mineralisatie onderzocht. Hemisferische 
concaviteiten werden aangebracht aan het oppervlak van discs (HA, β-TCP, 
BCP, en titaan), waarvan de keramische materialen werden gesinterd op 
1200°C. CaP mineralisatie aan het oppervlak van de discs werd bestudeerd na 
incubatie van de discs in verschillende volumina SBF voor een periode tot 14 
dagen middels een calcium assay en scanning electronen microscopie (SEM). 
Deze studie toonde dat verschillende SBF volumina een verschillende effect 
hebben op mineralisatie, met een optimale materiaal/vloeistof ratio van 4.92 ml 
SBF per cm2 oppervlak. Bovendien toonde deze ratio een duidelijk verschil in 
mineralisatie o.b.v. disc materiaal. Het was duidelijk dat oppervlakte 
hemisferen fungeerden als initiator voor nucleatie en kristalgroei. 
 
6. Hoe bevolken cellen hemisferische concaviteiten en in welke mate 
beïnvloedt concaviteit grootte de 3D cellulaire organisatie? 
CaP keramiek gecombineerd met implantaat oppervlakte geometrie 
heeft aangetoond een rol te spelen in de biologische prestatie. Daarnaast is 
bekend dat micro- en nano-schaal morfologie van CaP oppervlakken sterk de 
adhesie, proliferatie en differentiatie van stamcellen kan beïnvloeden. Derhalve 
werden in Hoofdstuk 7 hemisferische concaviteiten met een grootte van 440, 
800 en 1800 μm aangebracht op het oppervlak van HA discs gesinterd op 
CHAPTER 8 
253 
 
1200°C en daarop celkweekexperimenten met vetweefsel mesenchymale 
stamcellen uitgevoerd in osteogeen medium voor een periode van 28 dagen. Op 
geselecteerde momenten (3, 7, 14, 21 en 28 dagen) werden samples genomen 
en de cellen, na fixatie, fluorescerende gelabeld met phalloidin-Alexa 568 voor 
filamenteus (F-actine) en DAPI voor kernkleuring. Analyses werden uitgevoerd 
middels confocal laser scanning microscopie (CLSM). 3D immunofluorescentie 
beelden toonden verschillen in celaantal tussen de concaviteiten. Het hoogste 
aantal celkernen werd gezien in de 440 μm concaviteiten en het laagste aantal 
in die van 1800 μm. Bovendien bleken cellen in staat te migreren naar de 
concaviteiten en te hechten aan de randen en wanden ervan. Preferentiële 
mineralisatie werd waargenomen in de concaviteiten. Cellen spreidden zich in 
de concaviteiten, waarbij ze multilagen maakten op het oppervlak. De 
resultaten van deze studie suggereren een correlatie tussen concaviteit grootte, 
cellulaire organisatie, mineralisatie en osteogene differentiatie. 
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Afsluitende opmerkingen en toekomstperspectief 
Dit proefschrift beschrijft onderzoek naar calciumfosfaat (CaP) 
keramiek in laboratorium en dierexperimenten gericht op uiteindelijke 
toepassing in de kliniek. CaP keramiek wordt gebruikt als coating materiaal om 
de biocompatibiliteit en osteoconductieve eigenschappen van metalen te 
verbeteren. De ontwikkeling van substantieel (inter)actievere CaP implantaat 
coating materialen heeft significant bijgedragen aan de voortgang in de 
wetenschap van oppervlakte-modificatie. Echter, vele wetenschappelijke en 
technologische uitdagingen blijven bestaan binnen het biomaterialen 
onderzoek. De laatste ontwikkelingen hierin, inclusief CaP coatings met 
kristalstructuur vervangingen, CaP coatings gebruikt als therapeutische 
coatings, en meer interactieve CaP coatings voor gebruik in gecompromitteerde 
condities werden beschreven in ons overzichtshoofdstuk. T.a.v. de klinische en 
commerciële toepassing van coatings ontwikkeld voor ons onderzoek dient te 
worden opgemerkt dat CaP sputtercoatings (in de vorm van 1-2 μm dikke 
hydroxyapatiet coatings op dentale implantaten) reeds klinisch gebruikt 
worden. Wij hebben aangetoond dat verschillende targetcomposities een effect 
hebben op het oplos- en precipitatiegedrag van de resulterende CaP coatings in 
vitro. Voorts werd in vivo een toename in botremodelering gezien voor CaP 
coatings met een hoger oplosgedrag, bijv. voor coatings gemaakt met 
tetracalciumfosfaat (TTCP) als target materiaal. De weinige onderzoeken die 
TTCP gebruikt hebben als coating materiaal hebben een veelbelovende 
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biologische prestatie laten zien [1,2]. Verder onderzoek dient zich te richten op 
het gebruik van radio-frequency (RF) magnetron sputtering voor het maken van 
TTCP coatings in fase-combinatie met hydroxyapatiet (bijv. HA/TTCP 
coatings) om zich te verzekeren van coatingstabiliteit, alsook het gebruiken van 
het oplosgedrag van TTCP voor biologische optimisatie. 
Naast de compositie van CaP keramiek zijn ook andere parameters van 
belang voor de optimalisatie van oppervlakte-eigenschappen van implantaten. 
Dit proefschrift heeft de relevantie aangetoond van oppervlakte topografie 
gecombineerd met CaP keramiek als bulk materiaal voor de promotie van 
mineralisatie in vergelijking met vlakke oppervlakken. Dat dergelijke 
oppervlakte topografie in staat was celgedrag te beïnvloeden, waaronder 
proliferatie en osteogene differentiatie, werd ook aangetoond. Daarom is de 
combinatie van oppervlakte topografie in een mechanisch sterk materiaal met 
een bioactieve CaP coating veelbelovend; toekomstig onderzoek is 
noodzakelijk om de fundamentele principes verantwoordelijk voor cel- en 
weefselresponse op ‘off-the-shelf’ beschikbare medische hulpmiddelen (bijv. 
botimplantaten) te ontrafelen. 
Hoewel het gebruik van SBF als een voorspellende in vitro test voor 
onderzoek naar botbinding algemeen geaccepteerd is, hebben sommige 
onderzoekers bezwaren tegen de vermeende voorspellende waarde ervan, 
waardoor inspanningen hebben geleid tot een aangepast protocol voor dergelijk 
onderzoek. Echter, parameters zoals het optimale volume SBF blijven 
onduidelijk. Onze inspanningen poogden duidelijkheid te verkrijgen hierin door 
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drie verschillende volumina SBF te vergelijken. Een optimale ratio werd 
gevonden voor het intermediaire volume, hetgeen de mineralisatie van CaP 
keramiek bevorderde. Ondanks deze opvallende vondst blijft het mechanisme 
hierachter onduidelijk en is er dus meer onderzoek noodzakelijk. 
Zoals eerder aangegeven lijkt het gebruik van optimaal CaP keramiek 
gecombineerd met optimale oppervlakte geometrie veelbelovend en 
waarschijnlijk te leiden tot de ontwikkeling van een nieuwe generatie CaP 
keramische biomaterialen met verbeterde biologische prestaties. Toch is meer 
aandacht nodig voor onderzoek naar hoe cellen een interactie aangaan met 3D 
matrices, hun oppervlakte-eigenschappen herkennen, en intracellulaire 
signaling netwerken gebruiken. Deze kennis t.a.v. fundamentele cel-materiaal 
interacties is uitermate belangrijk om te begrijpen waarom een CaP keramiek 
met specifieke eigenschappen (e.g. compositie, oppervlakte morfologie, etc.) 
een bepaalde response teweegbrengt i.p.v. het enkel aantonen van een 
verbeterde biologisch prestatie. Bovendien zijn slechts enkele dierstudies 
beschikbaar waarin CaP keramiek gecombineerd met gewenste oppervlakte 
geometrie werd gebruikt. Echter, enkele CaP keramieken hebben aangetoond 
osteoinductieve eigenschappen te hebben (het materiaal induceert de novo 
botvorming) wanneer geïmplanteerd op een ectopische locatie (subcutaan of 
intramusculair) [3-5]. Het ontrafelen van de grondslag van dit osteoinductieve 
fenomeen zal leiden tot breed gebruik van CaP keramiek eigenschappen voor 
de ontwikkeling van instructieve implantaten. Hierdoor kan het in de toekomst 
mogelijk worden om synthetische materialen te ontwikkelen met een 
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biologische prestatie gelijk aan die van autoloog bot. 
Closing remarks and future perspectives 
In this thesis, calcium phosphate (CaP) ceramic materials were 
investigated in a laboratory and preclinical setting for their eventual use in 
clinical applications. CaP ceramics are used as coating materials to enhance the 
biocompatibility and osteoconductive properties of metallic implants. 
Development of substantially more (inter)active CaP implant coating materials 
has significantly propelled the science of surface modification. However, many 
scientific and technological challenges remain in biomaterials research. The 
latest developments in biomaterials research, including CaP coatings with 
crystal lattice substitutions, CaP coatings employed as therapeutic coatings, and 
more interactive CaP coatings for use in compromised conditions were 
explored in our review chapter. Concerning the clinical and commercial 
application of the coatings developed in this thesis, it is important to mention 
that sputter deposited CaP coatings (in the form of 1-2 µm thick hydroxyapatite 
coatings on dental implants) are already clinically used. We showed that 
different target phase composition influences dissolution and precipitation 
formation of the resulting CaP coatings when tested in vitro. Moreover, when 
these coatings were tested in vivo, an increase in bone remodelling was 
observed for CaP coatings with higher dissolution rate, such as coatings 
deposited using tetracalcium phosphate (TTCP) as target material. The very 
few studies that have used TTCP as a coating material have shown promising 
biological performance [1, 2]. Further research should focus on the use of 
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radio-frequency (RF) magnetron sputter deposition to generate TTCP coatings 
in phase combination with hydroxyapatite (i.e. HA)/TTCP coatings) to ensure 
long-term stability of the coating, while exploiting the higher dissolution 
properties of TTCP for biological optimization. 
In addition to the composition of CaP ceramics, other parameters are critical to 
optimize surface properties of implants. This thesis has shown the relevance of 
surface topography in combination with CaP ceramics as bulk material to 
promote mineralization compared to a planar surface. That this surface 
topography was able to affect cell behavior in terms of proliferation and 
osteogenic differentiation was also demonstrated. Therefore, the combination of 
surface topography in a mechanically strong material with a bioactive CaP 
coating is promising and should be considered for future studies to unravel the 
fundamental basics responsible for cell and tissue response to off-the-shelf 
available medical devices (i.e. bone implants). 
Although the use of simulated body fluid (SBF) as a predictive in vitro 
test for examining bone bonding potential is widely accepted, some researchers 
have argued the predictive validity of this test, and efforts have been made to 
improve the current protocol. However, parameters such as the optimal SBF 
volume ratio remain unclear. Our efforts attempted to reveal an optimal SBF 
volume/surface area ratio using three different SBF volumes. An optimal ratio 
was found for the intermediate volume, which favoured mineralization of CaP 
ceramic materials. Despite this remarkable finding, the mechanism behind this 
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optimal calcium deposition at the intermediate volume is still unclear and 
further research is needed. 
As mentioned above, the use of optimal CaP ceramics in combination 
with optimized surface geometry seems promising and likely to attain a novel 
generation of CaP ceramic biomaterials with further improved biological 
performance. Still, more attention should be paid to specifics of how cells 
interact with 3D matrices, recognize their surface properties, and use 
intracellular signaling pathways. This knowledge on the fundamentals of 
cell/material interactions is pivotal to understand why a CaP ceramic with 
certain characteristics (i.e. composition, surface morphology, etc.) induces a 
certain response rather than empirically demonstrate superior biological 
performance. Moreover, few animal studies are available in which CaP 
ceramics in combination with (intended) substrate geometry were used. 
However, several CaP materials have shown osteoinductive capacity (i.e. 
potential of a material to induce bone formation while implanted in an animal at 
ectopic sites (e.g. subcutaneously or intramuscularly)) [3-5]. Unraveling the 
nature of this osteoinductive phenomenon will pave the way for broad 
utilization of CaP ceramic characteristics for instructive implant manufacturing, 
for which accounts that rapprochement to synthetic materials with equal 
biological performance as autologous bone can become realistic. 
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